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THE IMPACT OF TELEMONITORING ON SELF-EFFICACY, EMOTIONAL
WELL-BEING, AND CLINICAL OUTCOMES IN PATIENTS WITH
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
OR HEART FAILURE
Jaclyn West-Frasier, Ph.D.
Western Michigan University, 2008
Telemonitoring is the remote monitoring of patients' health status using
telecommunications and information processing technologies. This pilot study analyzed
data collected through a parent study that randomized 46 home health patients to either
standard care (SC) or standard care with the addition of telemonitoring {TM). The
telemonitoring device used in this study provided daily transmission of physiologic data
and patients responses to questions about their disease and symptom management.
Data analysis was completed to address the question whether telemonitoring, as part of
standard home care for patients with chronic obstructive pulmonary disease (COPD)
and patients with heart failure (HF), has an effect on patients' perception of self-efficacy
(confidence) for managing their disease, overall emotional well-being, and clinical
outcomes. Independent variables were diagnosis (COPD or HF) and treatment group
(SC or TM). Dependent variables for this pilot study were measures of self-efficacy
(SE); emotional well-being (EWB); and data collected on mortality, emergency room
use, and hospitalization. Data also were analyzed to identify significant relationships
among 3-month variables.

By 3 months, patients in COPD-TM showed greater improvement in SE to
evaluate effectiveness of strategies to relieve symptoms and a significant positive
relationship between EWB and SE when compared to patients in COPD-SC. There were
no differences between the groups on the other measures. Patients in HF-SC showed
greater improvement on EWB and a significant positive -relationship between EWB and
SE, and a significant negative relationship between EWB and hospitalization, and EWB
and emergency room use, when compared to the HF-TM patients. Patients in HF-TM
reported more hospitalization than patients in HF-SC. There were no differences
between the HF groups on the other measures.
For patients with COPD, TM was associated with improved SE for evaluating
strategies used to relieve symptoms, and a positive relationship between SE and EWB.
For patients with HF, TM did not have an effect other than an association with greater
patient-reported hospitalization.
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CHAPTER I
INTRODUCTION
Telemonitoring is the remote monitoring ofpatients' health status using audio,
video, and other electronic information processing technologies to monitor patient status
from a distance (Committee on Evaluating Clinical Applications ofTelemedicine &
Institute ofMedicine, 1996). Systems range from simple mechanisms that use patient
call-in ofphysiologic data for receipt by a computerized voice-answering system to more
complex systems installed in the patient home, using video and audio data collection
technology (Burgiss & Dimmick, 2003). Systems installed in the home may also include
computerized disease-management educational programs (Laframboise, Todero,
Zimmerman, & Agrawal, 2003).
This study addressed the question whether telemonitoring, as part ofstandard
home care for patients with heart failure (HF) and patients with chronic obstructive
pulmonary disease (COPD), has an effect on patients' perception ofself-efficacy
(confidence) for managing their disease and on their emotional well-being. Health
outcomes also were compared for patients randomly selected to receive either standard
care (SC) or standard care with the addition oftelemonitoring (TM).
This study was conducted with patients with COPD and patients with HF
recruited from patients receiving services from a home health agency in southwest
Michigan who agreed to participate in this dissertation research study in addition to the
1
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parent study. Patients in the parent study were randomized into SC (usual) care (SC) or
SC+TM (TM) and were followed for 12 months. Standard care included assessment,
establishment of treatment goals in collaboration with patient and family, education to
patient and family on disease management, and coordination of care with the primary
physician.
The telemonitoring technology device used in this study is called the Health
Buddy®. It is a device that allows daily transmission of physiologic data and the recording
of patient response to disease management questions. The questions relate to physiologic
information such as shortness of breath, knowledge of the disease process, symptom
recognition, and symptom management.
This chapter begins with definitions of key concepts and background on COPD,
HF, and telemonitoring. The purpose and conceptual framework for the study are
described, followed by the research questions and study design. The potential value of the
study is discussed, as well as study limitations. The chapter concludes with a summary.
Definitions
Telehealth: The broadest term for the use of information technology in the
delivery of healthcare and in the promotion of health.
Telemonitoring: A process that uses a device for home monitoring of patients via
phone line or broadband connection. Medical attachments include items such as
stethoscope, blood pressure cuff, and glucometer. The device may also include
computerized disease management education.
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Chronic obstructive pulmonary disease (COPD): A group of diseases
characterized by air flow obstruction that is typically associated with breathing-related
problems such as chronic coughing, shortness of breath, sputum production, and
wheezing. COPD is often undetected until the latter stages. It is managed with
medications and lifestyle changes.
Heart failure (HF): A disorder whereby the heart loses its ability to pump blood
efficiently. HF is a chronic, long-term condition that is managed with medications and
lifestyle changes.
Self-care management: Behaviors undertaken by patients to promote health and
well-being.
Home health: Provision of health services by health care professionals directly in
the patient's home.
Standard care: Diagnostic and treatment process that a clinician should follow for
a certain type of patient, illness, or clinical circumstance.
Self-efficacy (SE): Degree of confidence an individual has in his or her ability to
effectively perform a specific behavior. In this study, self-efficacy is measured with the
confidence component scores from the Self-Care of Heart Failure Index (SCHFI) (Riegel,
Carlson, & Glaser, 2000).
Emotional well-being (EWB): Individual's overall perception of satisfaction with
his or her quality of life, including happiness and pleasant emotions, and the perceived
ability to meet personal goals and fulfill important life roles. In this study, EWB is
measured with the SF 36 Mental Component Summary Scale (MCS) (Ware, 2005).
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Clinical outcome: lmpact an intervention has on the health and/or well-being of

patients. Outcomes commonly measured include physiologic parameters, mortality,
physical and/or mental health, ability to carry out daily activities (function), and
utilization of healthcare resources. 1n this study, clinical outcomes were defined as
mortality, emergency room use, and hospital admissions using frequency counts based
upon patient/family report and data retrieved through a regional health care system.
Statement of Problem
Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are among
the top four causes of death in the U.S. COPD includes emphysema and chronic
bronchitis. It is the most common form of lung disease, with annual costs (direct and
indirect) in the U.S. estimated to exceed $30 billion. Hospitalization is the largest
contributor to direct costs. COPD mortality rates continue to climb, perhaps related to the
tendency for late diagnosis and lack of prevention as compared to the other diseases such
as coronary artery disease, cancers, and stroke (Briggs, 2004; Feifer, Aubert, Verbrugge,
& Khalid, 2002; Pauwels, Buist, Calverley, Jenkins, & Hurd, 2001; Thom et al., 2006).
COPD is the only major disease continuing to show an increase in prevalence, morbidity,
and mortality (Miller, George, & Halbert, 2005).
HF is one of the most serious cardiac problems in the United States, with over
50,000 new cases each year. It is the leading reason for hospitalizations for patients over
65, with a readmission rate of 44% within 6 months. HF is also the most costly reason for
hospital admission; with the annual cost over $20 billion. The increasing size of the aging
population has resulted in greater numbers of patients with this condition, and these
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numbers are continuing to rise (J. Anderson, 2002; Thom et al., 2006; Hunt et al., 2001).
The seriousness and prevalence of these two conditions (COPD and HF) make it essential
that health care practitioners develop interventions that can reduce the negative
consequences of these diseases.
Healthcare providers need to look beyond historic, traditional methods of working
with HF and COPD to develop and implement interventions designed to address the
barriers to effective self-management and to critically evaluate the impact of those
interventions. Studies show that multidisciplinary management, patient education, and
home-based monitoring improve mortality and may reduce medical care use and related
expenditures for HF and COPD (Cleland, Louis, Rigby, Janssens, & Balk, 2005;
Finkelstein et al., 2004; Goldberg et al., 2003).
Telemonitoring is a relatively new intervention in the area of home health care.
This technology permits home monitoring of patients using a special device connected to
a phone line or broadband technology. Interest and utilization of telemonitoring
technology has increased due to rising healthcare costs; advances in communication
technology; and low-cost, user-friendly devices (Burgiss & Dimmick, 2003; Meystre,
2005).
HF telmonitoring studies have focused on areas such as acceptability to patients
and providers, hospitalizations and mortality, and cost-effectiveness (Louis, Turner,
Gretton, Baksh, & Cleland, 2003). A review by Louis et al. suggested that telemonitoring
reduces hospital utilization and may play an important role in the delivery of health care
for HF patients. The review also indicated that further studies, especially large
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randomized clinical trials, are needed to evaluate the usefulness of this method, including
benefits and cost-effectiveness.
Pilot studies using telemonitoring with COPD have reported positive results in
terms of acceptability to patient and clinician and reliability of transmitted physiological
data (Finkelstein et al., 2004; Lusignan et al., 2000; Rice & Doughty, 2004). As with HF,
randomized clinical trials are needed to evaluate the cost/benefit of telemonitoring and
the impact on clinical outcomes of patients with COPD. Medical management and
technology, while valuable, are not enough to minimize the effects of chronic disease.
Patients must make substantial changes in their personal health behaviors.
Effective HF management requires major lifestyle adjustments by patients,
including adherence to a complex medical regimen and symptom monitoring (Thom et
al., 2006; Hunt et al., 2001). Poor adherence to treatment recommendations is a
considerable problem in HF patients. It is estimated that up to one third of
hospitalizations are related to nonadherence (Bennett et al., 1998; Hong, Morrow-Howell,
& Enola, 2004; Michalsen & Thimme, 1998). Studies have shown that poor adherence is
associated with greater morbidity and poorer quality of life (Evangelista & Dracup,
2000).
Effective management of COPD also requires adherence to a complex medical
regimen and significant lifestyle adjustments by patients, with smoking cessation as the
most significant in terms of reducing mortality. Several studies have shown problems
with adherence to medical regimen such as broncho-dilators and recommended lifestyle
adjustments (Gallefoss & Bakke, 1999; Make, 2003).
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Barriers to effective self-care management in HF are numerous and include lack
of knowledge (Horowitz, Rein, & Leventhal, 2004; Riegel & Carlson, 2002; Sneed &
Paul, 2003), problems with symptom recognition and management (Bennett, Cordes,
Westmoreland, Castro, & Donnelly, 2000; Francque-Frontiero, Riegel, Bennett, Sheposh,
& Carlson, 2002), low confidence in ability to manage care (B. Carlson, Riegel, & Moser,
2001), and negative physical and emotional symptoms (Bennett et al., 2000; Riegel &
Carlson, 2002). In addition, patients with HF display a high rate of depression and
anxiety, which are associated with poor clinical outcomes and higher mortality (Freedland
& Camey, 2000; Jiang et al., 2001; Richardson, 2003).
In contrast to the literature on HF, there is very little in the COPD literature on
factors that contribute to nonadherence/poor self-management in this population. Turner,
Wright, Mendella, Anthonisen, and Group (1995) analyzed data collected from 985
patients in five U.S. sites. They found that age, marital status, education, symptom
severity, and race acted as predictors of adherence to nebulizer. George, Kong, Thoman,
and Stewart (2005) performed a cross-sectional study (N = 525) in Australia to explore
COPD patient perspectives on adherence. Investigators found that patient beliefs,
experiences, and behaviors were more powerful than sociodemographic and clinical
factors in predicting adherence to medical regimen.
In order to address issues of nonadherence, healthcare providers must develop an
awareness of the factors that contribute to noncompliance. Once those factors are
understood, healthcare providers may be better equipped to determine if strategies, such
as telemonitoring, might improve compliance with recommended treatment and lifestyle
modifications, and improve patients' confidence in their ability to recognize symptoms.
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Purpose of the Study
The primary purpose of this study was to examine the impact of telemonitoring on
SE, EWB, and clinical outcomes of mortality, emergency room use, and hospitalization in
patients with COPD and HF. The secondary purpose was to determine if there was a
relationship among the variables of telemonitoring, self-efficacy, emotional well-being,
clinical outcomes, and diagnosis.
Conceptual Framework
Bandura's (1986) theory of self-efficacy informed the study hypothesis that
telemonitoring, enhanced with an educational component and in combination with
standard care, would produce changes in the level of patients' self-efficacy and emotional
well-being. Bandura's assertion that self-efficacy predicts health-related self-care has
found support in studies of chronic illness and the cardiac population (Carroll, 1995;
Kempen, Sanderman, Miedema, Meyboom-de Jong, & Ormel, 2000; Perkins & Jenkins,
1998). Bandura (1998) also hypothesized that self-efficacy impacts emotional and
physical well-being due to the "mind-body" connection in the autonomic nervous system.
The mind-body connection has also been studied in the COPD and HF population
to clarify the relationship between disease severity and depression (Joynt, Whellan, &
O'Connor, 2004; Michalsen & Thimme, 1998; Richardson, 2003). Research has
demonstrated that there is a strong association between depression and mortality in
patients with COPD and HF (Freedland & Camey, 2000; Jiang et al., 2001; Richardson,
2003; Yohannes, Baldwin, & Connolly, 2005) Less is known about reciprocal
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relationships between emotional well-being and survival, and specifically, whether the
addition of telemonitoring can influence either or both. Although randomized studies
with HF patients have shown that the use of telemonitoring is associated with reduced
mortality and increased survival (Benatar, Bondmass, Ghitelman, & Avitall, 2003;
Cleland et al., 2005; Goldberg et al., 2003; Jerant, Azari-, Martinez, & Nesbitt, 2003), no
prior studies were located that closely examined the factors that might explain this effect.
This study was based on a theoretical assumption that, with the addition of
telemonitoring, patients would learn to manage their disease effectively and therefore
would increase self-efficacy. As confidence increases, patients should experience a
corresponding increase in emotional well-being, because of a greater sense of control and
satisfaction in their ability to manage their health and perform role-related activities.
Further, if patients increase both self-efficacy and emotional well-being (as an indicator
of improved disease management), they should improve their health and clinical
outcomes as shown by reduced emergency room visits and/or hospitalization, and by
lower mortality.
In this study, the experimental intervention involved a three-way interchange
among patient, nurse, and telemonitoring device (TD). A study investigator, either a nurse
or occupational therapist, introduced the device and provided initial training to the
patient. Patients then had the responsibility to utilize the TD on a daily basis to complete
daily physiologic measures and respond to disease management questions. It was
expected that this process would facilitate patients to develop proficiencies and habits in
monitoring physiologic measures related to their condition. They also received positive
and constructive feedback from the TD as they responded to disease management
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questions. This educational process was expected to allow patients to develop a greater
understanding of their condition, reinforce appropriate disease management behavior, and
build confidence in their ability to manage COPD or HF.
The TD unit automatically transmitted daily physiologic data and patient
responses to questions to a secure webpage. The home health nurse assigned to the patient
may have used the TD information to adjust standard education content provided during
routine home visits so as to address the most pertinent learning needs of the individual
patient. TD information may have been used to notify the primary care physician of any
negative trends in the physiologic data, which may have resulted in more timely medical
intervention.
Figure 1 illustrates a simple model of the theorized relationships among variables
that were evaluated in this study.

Chronic
Disease:
Heart Failure
or Chronic
Obstructive
Pulmonary
Disease

Clinical
Outcomes

Telemonitoring
Emotional
well-being

Figure 1. Impact of telemonitoring on self-efficacy, emotional well-being, and clinical
outcomes.
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Research Questions and Hypotheses
Primary Research Question
Do patients who receive telemonitoring (TM), in addition to standard homecare,
show differential improvement when compared with those who receive standard care only
(SC) in the following outcome variables: (a) self-efficacy for disease management; (b)
sense of emotional well-being; and (c) clinical outcomes of mortality; emergency room
use, and hospitalization?
Secondary Research Question
Is there a significant relationship among the variables of self-efficacy, emotional
well-being, and clinical outcomes at 3-months post index hospital discharge?
Experimental Hypotheses
The following hypotheses were examined within this study:
H 1: Patients with HF or COPD who are randomly assigned to receive standard
care plus telemonitoring, compared with patients with HF or COPD who
receive standard care only, will demonstrate greater improvement in the
following variables:
a. Self-efficacy as measured by Section C (SCI-C) from the Self-Care of
Heart Failure/COPD Index at 3-months post hospital discharge compared
to baseline.
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b. Emotional well-being as measured by the SF 36 Version One Mental
Health Component Score (MCS) at 3-months post hospital discharge
compared to baseline.
c. Clinical outcomes of mortality, emergency room use, and hospital
admissions at 3-months post hospital discharge, with the TM group
experiencing less mortality, emergency room use, and hospitalization.
H2 : Three-month scores in self-efficacy and emotional well-being will correlate
positively with each other, and negatively with 3-month clinical outcomes of
emergency room use and hospitalization; the relationships will be of greater
magnitude in the TM versus SC groups.
Design of Study
This was a randomized controlled trial to study the difference between standard
care (control), and standard care plus telemonitoring (experimental) in terms of patient
perception of self-efficacy and emotional well-being, and clinical outcomes. Data to
conduct this study were gathered as part of a larger project (HSIRB approved protocol
#05-02-22) in which home health patients recruited from a Midwestern home health
agency had been randomly assigned to either the control or experimental group and
followed over a 12-month period. The goal for the larger study was to recruit 200 subjects
each to participate in the HF and COPD arms of the main study, and it is those subjects
whose baseline and 3-month data were analyzed in this study.
Dependent variables analyzed in this study were self-efficacy, emotional well
being, and clinical outcomes. The tool used to measure self-efficacy is the Confidence
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Component score (SCI-C) from the Self-Care of Heart Failure Index (SCHFI). The tool
used to collect data on emotional well-being is the SF-36 Mental Component Summary
(MCS) scale. Utilization rates for hospital and emergency services were derived from
data retrieved from medical records and from structured patient interview. Mortality was
determined by review of hospital records and other valid sources, such as family report.
Study Value
As the incidence of COPD and HF increases, there can be little question that
better, more cost-effective treatments are essential. Although medical management of
both diseases has evolved, hospitalization episodes and use of emergency services
continue at high rates. Research on chronic disease has demonstrated association between
compliance to disease regimen and positive clinical outcomes. Health care providers need
to explore ways to improve adherence in patients with COPD and HF. This research will
add to the growing knowledge base of telemonitoring and individualized patient
education and the combined effect they may have on self-efficacy, emotional well-being,
and clinical outcomes. This research will provide an early "glimpse" (3 months) of the
effect of telemonitoring and help to identify similarities and differences between patients
with COPD and HF on the dependent variables and relationships among those variables
at baseline and at 3 months.
Patients
Prior research findings suggest that telehealth technology may improve the
effectiveness of treatment for patients with chronic disease (Liss, Glueckauf, & Ecklund-
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Johnson, 2002). Recent studies have shown that HF patients who received telemonitoring
had lower hospitalization and improved survival compared to those who received
standard care (Cleland et al., 2005; Goldberg et al., 2003). Comparable studies for COPD
were not found. This study may add evidence about whether patients with COPD or HF
may receive a significant health benefit from telemonitoring.
Practitioners

An important aspect of care to those with chronic disease is education. Research
has indicated that despite the emphasis on education, knowledge and skill "gaps" exist in
the HF and COPD populations. Clinicians need to assess for barriers, design education
that takes these barriers into account, and consider incorporating newer aids to learning
such as computer-based, telecare and telemonitoring supports (Stromberg, 2005a).
Practitioners involved in HF and COPD education include physicians, nurses,
pharmacists, dieticians, social workers, and rehabilitation professionals. Insights gained
from this study may help practitioners across disciplines improve the effectiveness of
patient education programs.
Policy Makers

Advances in healthcare and healthcare technology provide opportunities to
increase access and accessibility to patients with chronic disease. Policymakers need
empirical evidence on the effectiveness of telehealth interventions to help guide
healthcare policy decisions (Liss et al., 2002). Knowledge gained from this study may add
to the growing empirical evidence that supports telemonitoring effectiveness. Such
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information will be utilized by policy makers as they make decisions on coverage,
providers and reimbursement.
Limitations
This study has several limitations that should be considered when interpreting the
results. These limitations are:
1. The number of participants may not be sufficient to demonstrate differences
between control and treatment groups.
2. The duration of intervention (30-60 days) may not be sufficient to improve
self-efficacy, emotional well-being, and ability to self-manage disease.
3. Self-efficacy and emotional well-being are subjective concepts, due to diverse
intrinsic and extrinsic influences, and thus problematic to measure.
Additional issues may impact the ability to attribute causality by contributing to
contamination of the control group. This is a randomized study. However, some of the
nurses who provided care to the TM may have also provided care to those in the SC
group. Due to the nature of the parent study, it was not possible to blind the nursing care
providers to the SC and TM condition. It is possible that the type of education provided
under the SC model was altered as a result of nurses working under both conditions,
affected by their attitudes toward the addition of the TM technology. On the other hand,
nurses were not systematically assigned to one group or the other. Thus, any effect of the
participating nurses may have been spread across the two groups.
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Summary
This chapter provided an overview of the literature on COPD and HF and
telemonitoring. Both diseases are debilitating chronic illnesses that affect a significant
number of elderly individuals in the United States. Medical advances in the treatment of
both have been made, but optimal disease management has not been attained due to
factors at least partially related to insufficient self-care management in this population.
Few studies of COPD and HF, including those that used telemonitoring, have
directly examined the relationship between self-efficacy (SE) and emotional well-being
(EWB). The current study was designed to determine whether TM would have a
significant effect on either SE or EWB. Additionally, this study was designed to examine
the nature of the relationship between SE and EWB and provide a preliminary glimpse
into the ability of TM to increase positive health outcomes and reduce negative ones.

CHAPTER II
REVIEW OF THE LITERATURE
Heart failure (HF) and Chronic obstructive pulmonary disease (COPD) are
chronic medical conditions that require systematic monitoring of intricate treatment
regimens. Treatment consists of both pharmacological and nonpharmacological methods.
The patient must comply with lifestyle changes in addition to following prescribed
medical therapies so as to achieve optimal disease management. Both conditions are
associated with high medical costs and mortality, with patient noncompliance related to
both of those factors. Additional support mechanisms, such as telemonitoring combined
with patient education, may help improve patient adherence to treatment and have a
favorable impact on outcomes. Operational descriptions of the key concepts addressed in
this study are provided below.
Defining Key Concepts
Chronic obstructive pulmonary disease (COPD) is a disease state characterized by
airflow limitation that is not fully reversible. The airflow limitation is a result of chronic
bronchitis or emphysema and is usually progressive and associated with airway
hyperreactivity to noxious particles or gasses. Chronic cough and sputum production
often precede airflow limitation, sometimes by years. Clinical symptoms include unusual
shortness of breath and increased forced expiratory time as displayed on spirometry.
17
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Function and quality of life are negatively affected as symptoms progress (American
Thoracic Society: Medical Section of the American Lung Association, 1995; National
Heart, Lung, and Blood Institute & World Health Organization, 2001).
Heartfailure (HF) is a complex medical condition that results from inefficiency in
the ability of the left ventricle to fill with, or eject, blood. The primary manifestations of
this disease are fatigue and dyspnea (shortness of breath), which can interfere with
exercise tolerance and create fluid retention. Fluid retention may lead to pulmonary
congestion and peripheral edema, with associated weight gain. These symptoms have a
negative impact on function and quality of life. Symptoms may affect individuals
differently. Some may have significant fatigue but little edema, or vice versa. Many, but
not all, patients present with pulmonary congestion; therefore, the term heart failure is
preferred over congestive heart failure, although both terms are used in the literature to
refer to similar conditions (Hunt et al., 2001).
Compliance is the degree to which a patient follows through on recommendations
from health care providers. Some practitioners suggest that the term compliance should
not be used due to the paternalistic overtones. A more germane term is adherence, which
implies that patients take a more active role in making informed decisions regarding their
care (Haynes, 1979) Although the two terms are often used interchangeably in the
literature, the term adherence will be used throughout this paper.
Self-care has been defined as an active cognitive process that a patient uses to
maintain health or manage his or her disease process. Self-care in HF and COPD involves
adherence to lifestyle changes, such as smoking cessation, proper diet, regular exercise, as
well as adherence to medication regimen. Patients must be able to recognize subtle
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symptoms that signal a change in their condition, formulate a response to the signals, and
evaluate if the response has achieved the desired effect. This additional decision-making
process is described as self-care management (B. Carlson et al., 2001).
Emotional well-being is described here as a state of positive emotion, including
happiness and vitality, as well as the ability to function fully in life roles. This subjective
state is related to basic need satisfaction and social relatedness. Daily experiences of
autonomy, competence, and relatedness contribute to the prediction of happiness and
vitality (Ryan & Deci, 2001).
Telemonitoring is a specific term used to describe the practice of remote
monitoring of patients from a distance through the use of information technology such as
audio and video. Telemonitoring uses special devices that transmit information, such as
physiological data, via standard telephone lines, cable-networks or broadband technology.
These devices allow monitoring on a daily or continuous basis and may contain "alarm"
features that notify healthcare providers if the physiological data exceed preset parameters
(Bondmass, Bolger, Castro, & Avitall, 1999; Louis et al., 2003; Meystre, 2005).
Telemonitoring devices may also include educational components and collect data on
patient response to disease management questions (Cordisco, Beniaminovitz, Hammond,
& Mancini, 1999; Goldberg et al., 2003; Laframboise et al., 2003)
Self-efficacy was defined by theorist Albert Bandura (1997) as people's belief in
their capability to organize and execute the course of action required to manage a
prospective situation. He believed that efficacy beliefs had an influence on how people
think, feel, motivate themselves, and how they act. Self-efficacy is developed through
mastery experiences (success), vicarious experiences (observing others succeed), social
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persuasion (encouragement from others), and is influenced by physical and emotional
state (physical capability and positive mood state) (Bandura, 1997).
Review Methods
A review of the literature on key concepts, including those described in the above
section, was conducted using articles selected through a search of the MEDLINE and
CINAHL databases for the time period January 1995-February 2008. Search terms
included the following used in various combinations: heart failure, congestive heart
failure, chronic obstructive pulmonary disease, telemonitoring, monitoring, treatment,
disease management, intervention, self-management, self-care, adherence/nonadherence,
compliance/noncompliance, self-efficacy, mental health, emotional well-being,
psychosocial, quality of life, patient education, home care, home health, hospitalization,
rehospitalization, and clinical outcomes. Additional articles were identified by reviewing
article referency lists to ensure that all relevant articles were gathered.
Articles selected for preliminary review were those that pertained directly to the
search topic and provided theoretical insights, reported an original data-based study, or
synthesized results of multiple studies. Program evaluation studies were excluded. The
National Advisory Panel guideline titled the "Guide to Reading Research Articles" was
used to conduct the article critique (Forrest & Miller, 2001). This guide provided a basic
framework for assessing the quality of article content based on the purpose of the study,
the investigative methods used, results and conclusion, and applicability to theory or
practice. Articles that did not include a full explanation of areas identified in this guide
were excluded from review.
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Heart Failure and Chronic Obstructive Pulmonary Disease
Biomedical Perspective
COPD Description and Risk Factors
COPD is a progressive disorder characterized by a chronic inflammation in the
lungs which narrows the bronchi and produces symptoms of dyspnea, chronic cough,
sputum production, and wheezing. It develops over time, is typically referred to as
chronic bronchitis, chronic emphysema, and the severity is often described by the degree
of lung impairment. As the condition worsens, patients cannot exhale efficiently,
especially during exertion, trapping air, which reduces inspiratory capacity, and so they
become short of breath. The damage to lung tissue is irreversible (Booker, 2005; Briggs,
2004). The primary risk factor is tobacco use, which contributes to 80-90% of cases.
Another risk factor is a specific genetic abnormality that explains 1 % of cases. The
remaining cases may be explained by other risk factors, such as passive smoking, air
pollution, occupational airborne toxins, and hyperresponsive airways such as with asthma
(National Heart, Lung, and Blood Institute & World Health Organization, 2001; Pauwels
et al., 2001). .
HF Description and Risk Factors
HF is a chronic progressive disorder due to myocardial dysfunction that results in
the inability of the heart to deliver enough oxygenated blood to meet the metabolic
requirements of the body. HF is classified as either systolic or dystolic dysfunction, with
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systolic the most common (Fletcher & Thomas, 2001). Heart failure presents with
symptoms of dyspnea and fatigue in the individual's medical history and specific signs of
rales (lung sounds heard through stethoscope that indicate fluid) and/or edema during the
physical exam. Risk factors assoc;iated with HF include hypertension; diabetes;
hypercholesterolemia; coronary, valvular, or peripheral -vascular disease; exposure to
cardiotoxic agents; rheumatic fever; and chest irradiation (Hunt et al., 2001).
Impact ofCOPD and HF
Epidemiology. COPD is the fourth leading cause of death in the United States and
the mortality rate is increasing. Over 10.2 million or 5.9% of the adult population have
COPD, with estimates of 4-6% in males and 1-3% in females. Actual prevalence is
higher because COPD is usually not diagnosed in the early stages (Mannino, 2003).
Mortality is low for those under 45 but then increases with age, and is the fourth leading
cause of death in those over the age of 65. The increased mortality rate may be related to
past smoking trends. Smoking is decreasing so it is hoped that the mortality trend will
reverse (Pauwels et al., 2001).
HF is a growing problem in the United States and is one of the most serious
diagnoses encountered in primary care (Thom et al., 2006). Mortality rates for other
cardiovascular disorders have decreased, but the incidence and prevalence_ of HF
continues to rise (J. Anderson, 2002). Currently almost 5 million Americans (2.3%) have
HF, with 550,000 new cases diagnosed each year. Mortality rate within 5 years of the
initial diagnosis is 50% (Thom et al., 2006).
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HF is more common in the elderly, and projected increases in the aging
population make a corresponding increase in HF a near certainty. One in 1,000 people
over the age of 65 currently have HF. This diagnosis represents the most common
Medicare hospital discharge diagnosis. The incidence of HF is increasing, despite better
medical management, due in part to improved mortality for other cardiac conditions such
as myocardial infarction (Thom et al., 2006). Current population trends project a
population of 75 million Americans, with 20% of the population over the age of 65, by
the year 2040. If the HF trend continues, the 2040 population would produce 1.5 million
new cases of HF per year (Masoudi, Havranek, & Krumholz et al., 1997).
Exacerbations. Both conditions are characterized by periods of relative stability or
remission, interspersed with episodes of acute symptoms, or exacerbations. In COPD,
exacerbations are defined as any worsening of symptoms. A major exacerbation includes
all of the symptoms of increased dyspnea, sputum volume and sputum purulence, alone or
in combination with cough, wheezing, or upper respiratory infection. Less severe
exacerbations include at least one of the major symptoms, alone or in combination with
cough, wheezing and/or upper respiratory infection. Exacerbations are a causative factor
in morbidity and mortality. Although many episodes are unreported by patients, major
exacerbations are an important cause of emergency room visits and hospital readmissions,
and have significant impact on quality of life and activities of daily living. Exacerbations
are also associated with physiologic deterioration and airway inflammatory changes
(Cross, 2005; Kim et al., 2004; Wedzicha & Donaldson, 2003).
HF exacerbation is a worsening of heart failure and may include a variety of
symptoms. Major HF relapse typically presents as pulmonary edema, with symptoms of
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shortness of breath, profound fatigue, hypotension, or gross edema. HF worsening is also
a contributing factor to other acute conditions such as myocardial infarction, pneumonia,
dysrhythmia, uncontrolled hypertension, worsening angina, sodium retention, infection,
and metabolic problems. As with COPD, HF exacerbations have serious consequences in
terms of morbidity and mortality, typically resulting in hospital readmissions, and with a
negative impact on patient quality of life and activities of daily living (Bennett et al.,
1998; Feenstra, Grobbee, Jonkman, Hoes, & Stricker, 1998).
Hospitalization and Emergency Department Visits
The number of hospital admissions/discharges is used frequently as a primary
outcome variable for studies on chronic illness, and in particular for the COPD and HF
population. Although less represented in the published literature, emergency room
admissions are also an indicator of exacerbations that are too serious to be treated on an
outpatient basis.
Chronic obstructive pulmonary disease. Acute exacerbation is a major cause of
emergency room visits and hospital admissions for COPD patients (Kim et al., 2004).
During 2000, COPD was responsible for 1.5 million emergency department visits and
726,000 hospitalizations in the United States (Mannino, Homa, Akinbami, Ford, & Redd,
2002). COPD patients who seek medical care in the emergency room have a high (up to
25%) relapse rate within days to weeks after receiving care (Kim et al., 2004). Forty to
50% of hospitalized patients are readmitted within 12 months, with the majority of
admissions occurring within the first 3 months after hospital discharge (Bourbeau et al.,
2003; Cao, Ong, Eng, Tan, & Ng, 2006). Cao et al. found hospital admission rates similar
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to other studies and also comparable factors associated with frequent readmissions which
included disease duration greater than 5 years, forced expiratory volume in 1 second
(FEV 1 ) less than 50% predicted, psychotropic drugs usage, and vaccination status (Cao et
al., 2006). Garcia-Aymerich et al. (2001) identified risk factors for admissions as patients
with three or more admissions the previous year, lower-FEY 1, and underprescription of
long-term oxygen therapy.
Hospitalization usually occurs in the later disease stages and so is associated with
mortality (Garcia-Aymerich et al., 2001). Almagro et al. (2002) found mortality rates of
22% by 12 months after hospital admission for acute exacerbation, a rate comparable to
similar studies. They also found that readmission was significantly related to previous
hospitalizations, hypercapnia (elevated CO2 in the blood) at discharge, and lower quality
of life scores.
Only one of the previous studies (Garcia-Aymerich et al., 2001) examined
compliance to medical regimen as a variable, and a significant association to
hospitalization was absent. However, self-management programs that emphasize
adherence to medications and lifestyle changes have been found to reduce hospital
admissions and emergency department visits (Bourbeau et al., 2003), suggesting that
adherence may be a factor in hospitalization.
Heart failure. Rehospitalization after hospital discharge also is a common concern
with the HF population, and Medicare surveillance data indicate this is a national
problem. In 1996, HF readmissions accounted for 8% of all readmissions at a rate of
212.8 per 1,000. This was the most common cause for readmission in the Medicare
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population. Nearly 50% of patients with a discharge diagnosis of HF were readmitted
within 6 months (Masoudi et al., 2002).
Krumholz et al. (1997) evaluated all HF Medicare admissions in Connecticut
during the years 1991 through 1994 to identify patient and hospital characteristics
associated with a higher tendency toward readmission. This study demonstrated that 44%
of HF patients were readmitted within 6 months of the index admission, and that 18% of
those admissions were directly related to HF. These rehospitalization rates are similar to
those found by other researchers (Hamner & Ellison, 2005; Schwartz & Elman, 2003).
Bennett et al. (1998) analyzed 1992 HF admissions to a Veteran Affairs medical
center and a tertiary care university medical center. Results indicated that of the 496
patients with HF, 79% were admitted due to worsening HF with sodium retention as the
leading factor (55%) in decompensation (deterioration). These factors did not change
with socioeconomic status. Noncompliance with HF meds and sodium restrictions
seemed to contribute to fluid overload, which leads to decompensation (Bennett et al.,
1998). Similar studies conducted in the U.S. and Germany found a significant
relationships between adherence and readmission rates (Hong et al., 2004; Michalsen &
Thimme, 1998).
In summary, both COPD and HF have been associated with the highest hospital
readmission rate in the United States (Shipton, 1996), with admissions related to
worsening of symptoms and nonadherence to treatment regimen. Recent study results
suggest that despite the advancement in disease management, rehospitalization in the U.S.
remains a critical factor.
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Disease Management
The Disease Management Association of America defines disease management as
coordinated healthcare interventions and communication systems for populations with
conditions that require significant patient self-care efforts. This process emphasizes the
patient/provider relationship and prevention of exacerbations through the use of evidence
based practice guidelines and patient empowerment (DMAA: The Care Continuum, n.d.).
Disease management of HF and COPD includes both pharmacologic and
nonpharmacologic therapies. Pharmacologic therapies use medication to reduce the
effects of the disease. Other medical interventions for HF include surgery such as
angioplasty and bypass; heart transplants are considered as last resort. Other medical
interventions for COPD include assisted ventilation, oxygen therapy, secretion
mobilization, lung resection, and lung transplants in certain advanced cases.
Nonpharmacologic nonsurgical disease management for both diseases includes
interventions such as rehabilitation and counseling, and lifestyle changes that are to be
made by patients in order to prevent or minimize disease-related symptoms.
The goals of disease management are to reduce symptoms, slow disease
progression, and improve quality of life (Leidy, Rentz, & Zyczynski, 1999). Both
pharmacologic and nonpharmacologic methods are disease management interventions
addressed in the 2001 Guidelines for the Evaluation and Management of Heart Failure
published jointly by the American College of Cardiology (ACC) and the American Heart
Association (AHA) (Hunt et al., 2001), the Global Initiative for Chronic Obstructive
Lung Disease by the National Institutes of Health (National Heart, Lung, and Blood

28
Institute & World Health Organization (2001), and the American Thoracic Society's
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Lung Disease
(GOLD) (American Thoracic Society, 1995; Pauwels et al., 2001).
Nonpharmacological Disease Management
The goals of nonpharmacologic disease management for COPD are to reduce
symptoms, improve quality of life, and increase the ability to participate in activities of
daily living. Pulmonary rehabilitation, long-term oxygen therapy, and surgery are the
methods used to achieve those goals. Pulmonary rehabilitation is a multidisciplinary
approach that offers exercise training, nutrition counseling, and education to address
issues such as physical deconditioning, social isolation, altered mood such as depression,
and weight loss.
The American Thoracic Society Standards (ATSS) provide a comprehensive
evidence-based description of the components of pulmonary rehabilitation including
recommended disciplines, education, exercise training, psychosocial support, and
breathing retraining. The GOLD document provides Level A recommendations for
therapy including nonpharmacologic interventions of smoking cessation, patient
education and counseling, long-term oxygen therapy, and exercise training. Both GOLD
and ATSS provide guidelines for disease severity/stage-specific intervention, and
pulmonary rehabilitation is integrated into the overall approach to disease management
(American Thoracic Society, 1995; Pauwels et al., 2001).
The goal of nonpharmacologic disease management for HF is to prevent or
minimize the consequences of HF through ancillary services such as rehabilitation,
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dietetics, counseling, and associated changes in patient lifestyle. Patients are advised to
reduce sodium intake, eliminate smoking, reduce/eliminate alcohol and caffeine, and
exercise on a regular basis (J. Anderson, 2002). In addition to lifestyle changes, patients
are advised to monitor and report HF symptoms to healthcare providers, manage stress,
and seek treatment for depression (Centers for Disease Control and Prevention, 2006).
ACC/AHA HF practice guidelines list recommended stage-specific lifestyle
modifications. However, specific methodologies are not provided. The guidelines do not
contain language related to the use of ancillary services such as rehabilitation, counseling
or psychotherapy; nor is depression on the list of potential comorbid conditions.
However, they do contain a general recommendation to use multidisciplinary disease
management programs. "Multidisciplinary disease-management programs for patients at
high-risk for hospital admission or clinical deterioration are recommended to facilitate the
implementation of practice guidelines, attack different barriers to behavior change, and
reduce the risk of subsequent hospitalization for HF" (Hunt et al., 2001). This
recommendation has been assigned a Class One rating. An ACC/AHA Class One rating
indicates a condition for which there is evidence and/or agreement among expert
practitioners that a procedure or therapy is beneficial and effective (Hunt et al., 2001).
Successful COPD and HF disease management requires that the medical provider
and the patient adhere to evidence-based practice guidelines for both pharmacologic and
nonpharmacologic interventions. A requirement of successful nonpharmacologic
intervention is patient understanding and adherence with the prescribed treatment
regimen and recommended lifestyle changes. Other professionals, such as nurses,
dieticians, pharmacists, psychologists, and rehabilitation professionals can supplement
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patient education provided by the primary care physician. Because the focus of this study
was on factors related to self-management and quality of life, the next sections will
provide a detailed overview on factors related to lifestyle changes and self-management
required by individuals diagnosed with COPD or HF.
Patient Perspective of Disease
There is an abundance of published research on both COPD and HF from a
biomedical perspective. It seems that less research has been devoted to exploration of the
patients' perspective on the impact of these chronic diseases upon their daily lives. In
order to understand why patient adherence to medical regimen is suboptimal, insight into
disease impact at the individual level is crucial. If health professionals have a greater
awareness of these factors, intervention programs can be tailored to address these issues
and to have a positive impact on patients adherence and ability to self-manage their
disease process. Fortunately several studies have been completed that give insight into
patient perspectives on living with COPD or HF. For this section, studies were reviewed
that examined the patient perspective, organized into main categories suggested by the
content, and summarized under two headings: symptoms and impact on daily lives.
Reported Symptoms
Symptoms identified most frequently by patients with COPD were dyspnea
(breathlessness) and fatigue (R. Arnold, Ranchor, Koeter, Jongste, & Sanderman, 2005;
Bailey, 2004; Barnett, 2005; Breslin et al., 1998; Caroci & Lareau, 2004; Costi, Brooks,
& Goldstein, 2006; Jonsdottir, 1998; Kapella, Larson, Patel, Covey, & Berry, 2006; Small
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& Lamb, 1999) Additional symptoms include cold symptoms, changes in sputum color or
volume, and cough (Costi et al., 2006).
Symptoms identified most frequently by patients with HF were dyspnea and
fatigue (R. Arnold, Ranchor, Koeter, et al., 2005; Bosworth et al., 2004; Caroci & Lareau,
2004; Lainscak & Keber, 2003). Other symptoms included chest pain, coughing and
congestion, difficulty sleeping, dry mouth, and ankle and leg swelling (Bekelman et al.,
2007).
Perception of the Impact ofDisease
The literature review identified various descriptors of disease impact on daily
living and quality of life. Based on content of the literatures the investigator identified the
following categories: physical ability, social roles, and emotional, economic, and
cognitive issues.
COPD patients commonly reported that COPD directly impacted physical ability
and activity of daily living performance (Breslin et al., 1998; Jonsdottir, 1998; Small &
Lamb, 1999). Impaired physical performance also affected patient ability to carry out
role-related activities such as home management, vocational activities, socialization, as
well as physical intimacy with partners (Barnett, 2005; Breslin et al., 1998; Small &
Lamb, 1999).
Associated with the loss in role performance were feelings of inadequacy (Bailey,
2004) and the perception that others did not understand what they were experiencing and
how it affected their physical abilities (Jonsdottir, 1998). Other emotions commonly
described by patients included anxiety, panic, fear, frustration, irritability, depressed
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mood, and resignation. (Barnett, 2005; Breslin et al., 1998; Kapella et al., 2006; Small &
Lamb, 1999). Additional problems reported included sleep disturbances (Kapella et al.,
2006), pain (Jonsdottir, 1998), and difficulty concentrating (Small & Lamb, 1999)
Many COPD patients described the fear of reoccurrence of exacerbations. Other
fears related specifically to dyspnea or breathlessness and described the fear of disease
progression and of suffocation and death during severe episodes (Kessler et al., 2006).
COPD patients also recognized the breathlessness-anxiety-breathlessness cycle and felt
emotionally vulnerable due to a perceived lack of control over the cycle. Patients avoided
situations that could provoke significant emotion that could worsen symptoms of
breathlessness, and thus tended to isolate themselves socially during exacerbations
(Bailey, 2004).
HF patients also reported problems performing customary ADL's and felt limited
physically (Lainscak & Keber, 2003; Martensson, Karlsson, & Fridlund, 1998). Patients
reported limitation in role performance including social, family and work roles (Bosworth
et al., 2004; Lainscak & Keber, 2003; Martensson, Karlsson, & Fridlund, 1997, 1998).
Loss of income due to difficulty performing work roles was an additional stressor. Both
genders experienced a loss of sexual intimacy with partners (Bosworth et al., 2004).
Patients reported many negative emotions related to the disease experience,
including stress, anxiety, depression, denial, and guilt (Bosworth et al., 2004; Lainscak &
Keber, 2003). Other emotions described included a sense of powerlessness and
resignation (Martensson et al., 1997, 1998), hopelessness and low self-worth. Patients
also described anxiety and fear related to what they perceived as an unpredictable course
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ofthe disease (Bosworth et al., 2004). Other issues included sleep disturbance and
impaired cognition (Bosworth et al., 2004; Lainscak & Keber, 2003).
It is evident from the above review that there are similarities between COPD and
HF symptoms and the impact ofthose symptoms on quality oflife. Although the etiology
ofthe lung dysfunction between the disorders is different, many ofthe physical symptoms
are comparable. The symptoms offatigue and breathlessness interfere with both patient
groups' ability to perform routine daily activities. Problems in performing role-related
activities and the reality ofliving with a progressive disorder generate negative emotions
such as fear and anxiety, depressed mood and lowered self-esteem. How does disease
management take into account the impact on quality oflife and the negative emotions
associated with these diseases?
Biopsychosocial Factors
In the medical model, the focus is typically on the diagnosis and treatment ofthe
physical symptoms, not on associated psychosocial issues. However, practitioners
"know" that psychosocial issues impact patient outcomes, even ifformal assessment is
not provided. Factors such as patient emotional and cognitive status, support systems,
coping abilities, and adaptability are all issues that may be informally noted but not
addressed directly in the treatment plan.
When compared to the normal population, considerably higher rates ofanxiety
and depression are found in the COPD (Anden�s & Kalfoss, 2004; Yohannes, 2005) and
HF (Friedmann et al., 2006; T. Rutledge, Reis, Linke, Greenberg, & Mills, 2006)
population. The link between these psychological factors and mortality and morbidity is
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significant and may be referred to as psychologic morbidity (Dracup et al., 2003) or
psychiatric comorbidity (Mikkelsen, Middelboe, Pisinger, & Stage, 2004). Unfortunately,
psychological distress is underdiagnosed and undertreated in both COPD (Lacasse,
Rousseau, & Maltais, 2001) and HF (Ferketich & Binkley, 2005) even though studies
repeatedly demonstrate the connection between psychological factors and disease
outcome (T. Rutledge et al., 2006). In the previous section, the review identified similar
negative emotions reported by COPD and HF patients. Although physical symptoms and
related quality of life issues seem similar, how do the psychosocial factors impact
mortality and morbidity between the two populations?
Relationship to Disease Process, Morbidity, and Mortality and Other Factors
Mikkelsen et al. (2004) reviewed the literature on COPD and found indications of
high psychiatric morbidity with prevalence of anxiety ranging from 2-50% with
corresponding levels of depression. Other studies suggested that both psychological and
organic factors may play a role. Dyspnea, hyperventilation, and panic are symptoms
shared by individuals with COPD and panic disorder. It is felt that people with COPD
may develop a dyspnea-anxiety-increased dyspnea cycle similar to a panic attack and in
reaction to a fear of suffocation. Biologic factors such as smoking, hypoxia,
exacerbations, and untreated depression may contribute to comorbid depression and
neurocognitive deterioration. (Mikkelsen et al., 2004).
Hunninen, Breitve, Wiborg, Pallesen, and Nordhus (2005) reviewed the literature
to examine psychological characteristics of COPD patients and associations among
psychosocial factors. They concluded a high prevalence of anxiety and depression existed
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in this population and that neuropsychological impairment is detrimental to day-to-day
function and to overall quality oflife. Although the majority offindings indicated
correlation between variables, no conclusions could be reached about causal factors. The
authors proposed that emotional distress, loss offunction, reduced quality oflife and
severity ofthe disease might have multiple connections with one another. Several recent
studies have found depression to be predictive ofmortality and morbidity in COPD
patients (Almagro et al., 2002; Cao et al., 2006; Yohannes et al., 2005)
Richardson (2003) performed a review ofthe literature to address depression in
the HF population. Growing evidence suggests that HF patients are more likely to be
depressed compared to the general population, and unlikely to be treated for depression.
Studies have shown rates ofmajor depression as high as 36% and minor depression as
high as 21% in HF (Richardson, 2003). This suggests that a reciprocal percentage ofonly
43% or less ofHF patients experience a sense ofemotional well-being.
Research shows the negative impact ofdepression on cardiovascular disease.
Depression is an independent risk factor in coronary heart disease (CHD) and a strong
predictor for recurrence ofcardiac episodes. Studies show increased mortality in CHD
with depression, including HF. Psychiatric comorbidity, with the most common coded
disorder as depression, also contributes to increased admission rates (Richardson, 2003;
Sayers et al., 2007). In a study of374 patients, Jiang et al. (2001) found that 35.3% had a
Beck Depression Inventory score of10 or higher and 13.9% had symptoms ofmajor
depression. Odd ratios indicated that depression was associated with increased risk for
hospital readmissions and mortality, independent ofNYHA level, age, and ischemic
etiology ofcongestive heart failure (Jiang et al., 2001 ). Other researchers have found that
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depression increases as patients advance to NYHA class 3 and 4 (Freedland & Camey,
2000).
Joynt et al. (2004) reviewed the literature regarding the link between depression
and heart failure. Early studies indicated that complex neuron-hormonal changes that
occur in both HF and depression could produce HF in susceptible individuals and hasten
the progression in those who already have the disease (Joynt et al., 2004). In their 2005
review, Konstam, Moser, and De Jong addressed the concern that psychological factors
have been neglected by researchers and clinicians. They summarized existing literature on
anxiety, depression and HF, including research supporting the physiologic interaction
between negative emotions and poor clinical outcomes in HF. Additionally they identified
the behavioral mechanism whereby negative emotions, especially depression, impacts
patient adherence. Nonadherance to medical regimen has been shown to increase
morbidity and mortality in patients with HF. Patients with both chronic illness and
depression are three times more likely to be nonadherent compared to patients without
depression.
T. Rutledge et al. (2006) performed a meta-analysis of research published prior to
September 2005 on the associations between depression and HF to identify prevalence of
depression and the magnitude of impact on clinical outcomes. Their review indicated that
depression occurs at a moderate-to-high prevalence and that HF patients with depression
have higher mortality and morbidity than those without. Prevalence rates varied widely in
published studies, with an aggregate rate of 21.6%, which is a rate 2 to 3 times higher
than the general population. Aggregate results also indicated that there is a substantially
worse prognosis in terms of mortality and morbidity, as well as higher rates of
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rehospitalization and health care use. Aggregate results indicated more than a two-fold
risk for mortality and clinical events for HF patients with depressive symptoms or a
diagnosis of depression. HF patients with depression had more than a two-fold risk of
using emergency room services and overall 29% increase in overall health care costs (T.
Rutledge et al., 2006)
Other studies have identified additional predictors of mortality/morbidity, such as
social isolation, lower emotional well-being, avoidance coping behavior, lack of
emotional support, and nonadherance (Bennett, Pressler, Hays, Firestine, & Huster, 1997;
Carels et al., 2004; Evangelista et al., 2002; Friedmann et al., 2006). In the review of
patient perspectives, disease impact on patient ability to carry out life roles and related
activities was a significant issue reported by patients. How do these psychosocial factors
impact QOL and is there an association with morbidity and mortality as there seems to be
with anxiety and depression?
Quality of Life
Researchers and health care administrators are interested in determining the
impact of interventions on nonmedical patient factors, such as quality of life. Quality of
Life (QOL) is a broad term that covers an individual's satisfaction with areas of life such
as work; leisure; relationships; love; spirituality; finances; and physical, emotional, and
social health (Johansson, Dahlstrom, & Brostrom, 2006). A concept used to measure
more specific health concepts in health care studies is health-related quality of life (Hr
QOL). Leidy et al. (1999) defined Hr-QOL as "a multidimensional concept describing the
patient's physical, social and psychological health." They asserted that to effectively
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evaluate Hr-QOL, the evaluator must measure various domains, including discomfort
related to disease, physical function and social function, and emotional well-being. The
patient is the chief informant and responds to tools such as surveys or interviews (Leidy
et al., 1999).
Measurement of QOL
Approaches to measuring Hr-QOL include global measures and condition-specific
measures. The utility of global measures is that comparisons can be made across
diagnostic categories. These measures typically evaluate the impact of an intervention on
overall quality of life and well-being. Examples of global tools are the Medical Outcomes
Study 36-item Short Form (SF-36) and the Nottingham Health Profile (NHP). The most
widely used generic outcome tool in research of chronic disease is the SF36 (Johansson,
Agnebrink, Dahlstrom, & Brostrom, 2003; Kaplan & Ries, 2005; Leidy et al., 1999).
Because COPD and HF were included in the parent study, the SF36 was chosen as the
Hr-QOL measure to allow comparisons between the two diagnoses.
Impact o.fCOPD and HF on Quality ofLife
Disease severity and symptoms, functional limitations, and psychological distress
have been found to be associated with lower quality of life in patients with COPD and HF
(De Jong, Moser, & Chung, 2005; Hu & Meek, 2005; Johansson et al., 2006; Juenger et
al., 2002). Hospitalization and mortality has been found to have a strong association with
lower quality of life in both diagnoses (Domingo-Salvany et al., 2002; Fan, Curtis, Tu,
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McDonnell, & Fihn, 2002; Rodriguez-Artalejo, Guallar-Castillon, Pascual, Rodriguez
Otero, & Montoto, 2005).
In COPD, the perception of breathlessness was associated with anxiety and
feelings of hopelessness, and impacted quality of life scores-in particular the mental
health component (Hu & Meek, 2005). Hu et al. found that breathlessness, physical
impairment and ADL limitations impacted the physical health component Hr-QOL
scores, and the mental health component was impacted by hopelessness and anxiety,
negative affective states (fear, anger, nervousness) and breathlessness. Fatigue is a
common complaint with COPD and greater perceptions of fatigue are associated with
)

greater impairment in QOL (Breslin et al., 1998).
HF studies comparing HF QOL to the normal population have found patients with
HF to have significantly lower QOL, higher levels of anxiety and depression, and QOL
scores dropping as disease severity increased (De Jong et al., 2005; Juenger et al., 2002)
Individuals with HF experience limitations in physical and social activities, ADLs, role
related activities, sexual activity, and in community mobility, which further impacts
social interactions with family and friends (Johansson et al., 2006)
Impact ofIntervention
Leidy et al. performed a systematic review of HF research published between
1990 and 1998 that used Hr-QOL as an outcomes measure. Analysis of the literature
indicated that both pharmacological and nonpharmacological interventions can have a
positive impact on Hr-QOL. Forty-four studies were included in the review analysis.
Findings suggested that the functional aspects (physical performance) of Hr-QOL were
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impacted to a greater degree by intervention than other domains measured. It was
suggested that due to chronicity of the disease, recovery of mental health domains, such
as emotional well-being, may be a longer process, occurring only as patients feel they are
able to be more independent (Leidy et al., 1999). A comparable review of the COPD Hr
QOL literature was not found.
Quality ofLive as a Predictor
Faller et al. (2007) conducted a prospective study and followed 231 subjects for
986 days. They found that both the generic (SF36) and disease-specific tools (Kansas City
Cardiomyopathy Questionnaire) predicted survival on univariate analyses. After
adjustment for prognostic factors, such as age, gender, disease severity and function, only
the disease-specific Hr-QOL and the mental health component of the SF36 remained
significant. When depression was added, both tools lost predictive significance,
indicating that the prognostic value of QOL may be confounded by level of depressive
symptoms and severity of the disease.
In summary, QOL studies document lower QOL in COPD and HF, and a
relationship among QOL and factors such as disease severity and depressive symptoms.
Studies on patient perspectives lend insight to the complexity that chronic illness imposes
upon the lives of patients and challenges they confront while performing day-to-day
activities, trying to maintain life-role responsibilities, and coping psychologically and
emotionally with the reality of living with a progressive disorder. The medical profession
is concerned by nonadherence in COPD and HF patients, and by the negative impact
nonadherence has upon disease severity and, ultimately, upon survival of the patient.
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What impact does the "reality" of the disease, as perceived by patients, have upon their
ability to adhere to a complex self-management regimen?
Adherence: Multiple Perspectives
Adherence can be defined as: the extent to which a person's behaviors such as
taking medication, following a diet, and/or executing lifestyle changes, corresponds with
recommendations from a health care provider (Sabate, 2003).
The World Health Organization (WHO) has identified lack of adherence to
medical recommendations as a global problem of significant consequence. Research has
shown that average adherence to treatment regimen in chronic disease patients in
developed countries is only 50%, and even less in undeveloped countries. Low adherence
has a negative impact on patient health, overall population health and health economics. It
stands to reason that improving adherence and self-management will have a positive
impact on patient health and general health of the population, and may ease the economic
burden of health care.
Adherence is not only a patient problem. Health care systems need to share the
responsibility by finding methods that improve patient adherence. Other factors, such as
family and community support, can make a difference in adherence levels. Adherence is a
long-term, dynamic process involving intense interaction between health care provider
and patient, and requiring a match between a patient's level of readiness for information,
and the process by which that information is made available to that patient (Sabate, 2003)
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Adherence in COPD and HF
Studies that measure compliance in COPD and HF have found low levels of
compliance in both populations (Corden, Bosley, Rees, & Cochrane, 1997; George et al.,
2005; Michalsen & Thimme, 1998; Turner et al., 1995). A literature search produced
relatively few HF studies that directly examined compliance/adherence as a variable,
despite the association with rehospitalization. Evangelista and Dracup (2000) conducted a
systematic literature review designed to increase understanding of compliance in the HF
population. They found 11 HF studies published between 1988 and 1998 that included a
compliance measure as a variable. The review indicated that there seems to be an
association between compliance and rehospitalization and thaflower compliance may
have a negative impact on mortality and quality of life. The reviewers concluded that
further research is needed to examine strategies that may enhance patient compliance.
However, they cautioned that no single strategy would be effective, due to the complexity
of compliance behavior in patients with a chronic disease.
Leventhal, Riegel, Carlson, and De Geest (2005) conducted a literature review to
provide an overview of research on HF adherence issues and to highlight remaining
issues and questions. Their review identified studies that have found adherence problems
(with some portion of the medical regimen) ranging from 20%-65%. Issues related to
patient compliance included knowledge, beliefs, attitudes, perceptions and expectations
that influence the individual's willingness to learn about the disease and to change health
behaviors. As complexity of the medical regimen increases, adherence decreases. Fewer
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studies exist that examine adherence in the COPD population and no review articles were
found comparable to the one by Evangelista and Dracup (2000).
To summarize findings across studies that examined factors that appear to
influence adherence and self-management in COPD and HF patients, Figures 2 and 3
present content based on the current review of the literature, and divided further by
factors that promote adherence, and those that hinder adherence. Figure 2 summarizes
factors that support adherence, and Figure 3 summarizes factors that are perceived as
barriers. The main concepts identified in the review and placed in the figures were
common between the two disorders. The few items not included in the figures were
specific to differences in symptoms and symptom management unique to each diagnosis.
To be included in the figure, each concept had to be identified in more than one study,
suggesting that these findings may be generalized to the larger population.
As indicated by the above figures, adherence is a multidimensional issue that
spans knowledge of the disease, coping ability, symptom burden and management, social
support, self-confidence, motivation, mental health, quality of life, and environmental
factors such as healthcare insurance. Quite often healthcare providers are frustrated, and
often mystified, by the tendency toward nonadherence.
Self-Management in COPD and HF
The terms self-care and self-management describe the self-initiated and self
directed action of participating in ADLs and other activities so as to maintain physical,
emotional, and social wellness (Orem, 1985). More specific to patients with COPD,
active participation of the patient in his or her disease management and is based on
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Facilitators to Adherence/Self-Management
Supported by Studies of COPD or HF or Both
Knowledge of disease and treatment/management
Acceptance of disease and changes to self 1
Belief in effectiveness of treatment
Experience in self-management 2

1 2 3

4

1 3

5 6 7 8 9

Symptoms provide opportunity for learning; experiencing positive results from
treatment/self-management
Routinization of medication/lifestyle changes

1 5

Example: environmental cues/structure to facilitate healthy behaviors
Willingness to learn and motivation to change behaviors 7

8 10 11

Fear of dying; desire to stay healthy; avoid hospitalization; maintain control over
life and health
Confidence/self-efficacy for disease self-management 2
Support from health care providers/good relationship
Social support from family, friends, and peers 4
Quality of life 5

12

1 4 5 10

7 8 10 13

8 12 13

Remain positive and adjust to changes; avoid depression and negative impact;
maintain balance between disease and desired life activities
. .
P os1tive

.

.

environment: commumty, hea l th care system 2

1

7 13

(George et al., 2005) \van der Wal, Jaarsma, & Van Veldhuisen, 2005) \van der Wal,
Jaarsma, Moser, Veeger, van Gilst, & van Veldhuisen, 2006) \Scotto, 2005) 5(Schnell,
Naimark, & McClement, 2006) 6(Rockwell & Riegel, 2001) 7(Duangpaeng, Eusawas,
Laungamomlert, Casemgitvatana, & Sritanyarat, 2002) 8(Cicutto & Brooks, 2006) \Bourbeau,
Nault, & Dang-Tang, 2004) 10(Leventhal et al., 2005) 11 (Riegel & Carlson, 2002) 1 2(E. Arnold,
Bruton, & Ellis-Hill, 2006) 1 3(Gary, 2006)

Figure 2. Facilitators to adherence/self-management.
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Barriers to Adherence/Self-Management
Supported by Studies of COPD or HF or Both
Lack of knowledge/confusion/distrust/low belief in effectiveness of disease
management/ less symptom experience 1-5
Symptom burden 4-IO
Negative symptoms: Shortness of breath, fatigue, pain, weakness, sleep difficulties,
poor concentration, memory loss, cognitive changes comorbidities
Slower to initiate self-management strategies 5

7

Low self-confidence in ability to make correct decision; slow to recognize
significance of symptoms
Complexity of treatment regimen and/or fitting into routine 3

8 11 12

"Cost" outweighs perceived "benefit
Lack of social support

1 3 7 13

Putting others first/caregiver tasks; not wanting to complain or alter routines that
would affect others; others not understanding limitations; others not supporting
healthy behaviors
Motivational factors:

1 6

Lack of energy; low self-control; difficulty dealing with changes in routine
Emotional distress/depression

1 3 8 14

Low satisfaction with health care/relationship with providers
Environmental issues 3

1 7

4 7

Insurance problems; difficulty accessing health care system when symptoms
worsen; low income; lack of transportation
'(Cicutto, Brooks, & Henderson, 2004) 2(Francque-Frontiero et al., 2002) 3(Gary, 2006)
\Horowitz et al., 2004) 5(Riegel & Carlson, 2002) \Evangelista et al., 2003) 7(Jaarsma et al.,
2000) 8(Leventhal et al., 2005) 9(Rockwell & Riegel, 2001) '°(Bourbeau et al., 2004)
11
(Dowson, Town, Frampton, & Mulder, 2004) 12(Schnell et al., 2006) 1 3(R. Arnold et al., 2006)
'4(Str6mberg, 2006)

Figure 3. Barriers to adherence/self-management.
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effective coping, compliance with inhaled medications, monitoring changes in disease
state, and using adequate inhalation technique (Worth, 1997).
Related to the HF population, Riegel et al.(2000) described self-care as a
cognitive process involving compliance with recommended lifestyle practices, such as
proper diet, exercise and adherence to prescribed medications. Self-care requires the
cognitive components of learning, perceiving, interpreting, reasoning, and responding
(Dickson, Tkacs, & Riegel, 2007). When self-care also involves monitoring and
responding to disease symptoms with the proper behavior, then evaluating the impact of
the behavior change on the disease symptom, self-care management has occurred (Gantz,
1990).
To organize results of the literature review of studies that examined patient
perception of behaviors needed to manage their disease, the main concepts identified in

the review that were common between the two disorders are placed in Figure 4. The few
items specific to differences in symptoms and symptom management were not included.
Content from multiple articles was used to construct the figures and each concept in the
figure was identified in more than one study.
In the studies cited in the Figure 4, behaviors/strategies used with the most
frequency were adherence,to medications, seeing a physician on a regular basis, obtaining
an annual flu shot, and planning and modifying activities according to energy level.
Activities related to lifestyle change included exercise and diet and symptom monitoring
such as daily weights. These were performed with less frequency, and seemed to be
related to knowledge deficits/misperceptions of symptoms and appropriate management
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strategies. Patients who have had the disorder for longer periods had greater proficiency
in symptom monitoring and management.

Patient-Identified Behaviors for Self-Care Management
Supported by Studies of COPD or HF or Both
Medical Regimen/Lifestyle:

1-11

Take medications/treatments as prescribed; keep doctor appointments; obtain annual
flu shot; smoking cessation/alcohol reduction; perform breathing exercises; follow
recommended diet; participate in regular exercise/physical activity
Monitor/respond to Symptoms:

1 -5 7-11

Monitor changes in status:
COPD: breathing, cough, sputum color and consistency
HF: shortness of breath, cough, nocturnal dyspnea, edema, weight gain, fatigue,
nausea, fluid intake/output
Perform the following:
Obtain daily weight; plan and pace activities; rest when tired; ask for help or use
assistive devices; call doctor for increased symptoms; adjust medication dose
(COPD&HF), oxygen (COPD only) and/or diet/fluid (HF only) in response to
symptoms; use strategies to improve breathing
Adjustment/Support:

1 2 5 7 9-11

Maintain a positive attitude; acceptance of disease and resultant changes; emotional
adjustment and coping; avoid depression; obtain support from family, friends, peers
and professionals; balance "living" as normally as possible, with "disease
management"; may use distracting or normalizing strategies
(Artinian, Magnan, Christian, & Lange, 2002) \Bennett et al., 2000) 3 (B. Carlson et al., 2001)
\Christenberry, 2005) 5 (Cicutto et al., 2004) 6(Cicutto & Brooks, 2006) 7(Gary, 2006) 8 (Ni et
al., 1999) \Riegel & Carlson, 2002) '°(Schnell et al., 2006) 11 (Small & Lamb, 1999)
1

Figure 4. Patient-identified behaviors for self-care management.
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Information gained from qualitative studies highlighted the psychosocial issues
related to living with chronic disease. In those studies patients emphasized the importance
of maintaining a positive attitude, and in adjusting both physically and emotionally to the
changes in their lives. Importance of social support was identified, along with the give
and-take process used to maintain quality of life as they tried to adhere to the
recommended lifestyle changes and medical regimen advocated by health care
professionals.

Disease Management Programs
How do patient-identified self-management strategies compare to those advocated
and "taught" by professionals in disease management programs that are designed to
improve adherence and self-management? To answer that question, this author reviewed
the literature for published studies on this topic. Program components identified in the
published studies were also organized into categories and summarized. Similar to
previous figures, content in each category was identified in more than one article for each
diagnosis. The content was then organized into topic areas of medical regimen/lifestyle,
monitoring and responding to disease symptoms, and adjustment/support. All programs
identified in the research provided education content related to the disease process,
symptoms and symptom management, but only a portion of those addressed psychosocial
aspects such as stress management. Figure 5 provides the detail of that review.
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Self-Care Management Program Components
Used in Studies of COPD or HF or Both
Medical Regimen/Lifestyle: 1 -s
Understand disease process, symptoms, treatment; understand medical regimen,
proper use of medications and treatment, and importance of adherence;
prevent/recognize exacerbations; annual flu shot; smoking cessation/alcohol
reduction; breathing exercises; low sodium diet/fluid restrictions for HF; adequate
nutrition for COPD; exercise program/physical activity
Monitor/respond to Symptoms:

1 9
-

Monitor changes in status:
COPD: breathing, cough, sputum color and consistency, chest pain; HF: shortness
of breath, cough, nocturnal dyspnea, edema, weight gain, fatigue, nausea, fluid
intake/output, chest pain
Weight monitoring:
HF-daily to check for gain; COPD-weekly to check for loss
Energy conservation techniques:
Proper positioning during activity; planning and pacing; rest when tired
Other strategies:
Asking for help or using assistive devices; call doctor for increased symptoms;
when to seek emergency help; adjust medication dose (COPD&HF), oxygen (COPD
only) and/or diet/fluid (HF only) in response to symptoms; breathing strategies
Adjustment/Support:

1 3 5 7
-

Stress management and coping; support from family, peers, professionals
\Bourbeau et al., 2004) 2(DeWalt et al., 2006) 3(Flynn et al., 2005) \Gallefoss & Bakke, 2002)
(Jaarsma, Abu-Saad, Dracup, & Halfens, 1999) 6(McGeoch et al., 2006) 7(Monninkhof, van
der Valk, van der Palen, van Herwaarden, & Zielhuis, 2003) 8(Wright et al., 2002) 9(Worth,
1997)

5

Figure 5. Self-care management program components.
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Comparison ofDisease Management Factors
More similarities than differences are evident for the two conditions across the
figures. Gaps are evident between what patients do and view as important for self-care
management and what is provided by the formal disease management programs. For
instance, a primary goal of disease management programs is to increase patient
understanding of the disease process and medical regimen, as well as to instruct patients
to monitor and adjusting the regimen based upon symptoms. Patients placed greater
emphasis on adhering to the treatment regimen, monitoring and reporting symptoms, and
making simple adjustments in medication and/or diet, versus developing a thorough
understanding of the disease process and rationale to the treatment regimen. This
comparison seems to support other studies that have identified a "knowledge" gap with
patient ability to understand the disease and the meaning of symptoms, which is needed in
order to make the appropriate adjustments to treatment regimen.
Another difference noted was in the emphasis patients place upon the importance
of accepting the reality of having a chronic disease and maintaining a positive attitude,
avoiding negative emotions such as depression, and grappling with the challenge of
balancing a "normal" life with a life that is directed by the necessity of living with and
managing chronic disease. Patients consistently identified these factors in the reviewed
studies, whereas only a few of the disease management programs placed significant
emphasis on this content, and some omitted education on psychosocial factors entirely.
Overall, disease management programs seem to place only minor emphasis on the
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psychosocial factors that patients indicate are of significant importance to self
management.
Healthcare providers routinely provide education to patients and families. It is
often assumed that an increase in knowledge will produce the required behavioral
changes needed for effective disease management. If behavior changes do not occur as a
result of education, that behavior is considered nonadherence. Despite customary
education, a significant knowledge gap often remains for patients, and this disparity
interferes with successful self-care management (Horowitz et al., 2004; Riegel & Carlson,
2002; Sneed & Paul, 2003). Additionally, patients identify psychosocial factors as
important to adherence and self-management, but only minimal content from formal
education programs is directed toward such areas of concern. Despite the differences
identified in the above comparison, how effective are formal disease management
programs?
Outcomes of Self-Management Component ofDisease Management Programs

In a review of randomized controlled trials on COPD self-management programs
by Bourbeau et al. (2003) found that 8 of the 10 programs analyzed included content on
lung and COPD, and 5 also addressed exacerbation and action planning. Four of the
programs were fairly comprehensive and covered all of the areas in the above figure but
did not include content on coping or balancing quality of life with disease management.
The remaining 6 programs covered 2--4 items listed in the disease management or disease
monitoring areas of the figure.
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Four of the studies in the Bourbeau (2003) review showed an improvement in
health status compared to the control. Two of the six that measured health resources
found a reduction in physician visits and one found a reduction in emergency room visits
compared to control. Some of the studies showed improvement in patients' knowledge of
their disease and care but did not necessarily lead to improved behaviors or improved
health outcomes. The analysis indicated that self-management programs can improve
health status and reduce physician visits and hospital use.
In a meta-analysis of randomized controlled trials of patients with HF, Jovicic,
Holroyd-Leduc, and Straus (2006) summarized the content of the six self-management
programs described in studies that qualified for their review. Content typically included
education on HF process and symptoms, importance of daily weights, and compliance to
medications and dietary restrictions. Only one study focused on the interrelationship
between these content areas and healthy behaviors. Outcome of the analysis indicated that
self-management programs resulted in reduction in all-cause hospital admissions and HF
readmissions. Adherence to medical regimen improved but no significant difference in
functional capabilities, quality of life, or symptoms were supported. All studies that
compared costs showed cost savings.
Patient Education
Patient education is defined as the process of improving knowledge and skills so
that patients can manage their disease appropriately. Patient education may include
therapeutic education, general health education, and clinically based health promotion.
Patient education is usually a key feature of multidisciplinary disease management
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programs (Stromberg, 2005a). Although patient education seems to be a key component
in disease management programs, studies have shown that a knowledge gap exists and
that patients feel they are not well informed (M. L. Carlson, lvnik, Dierkhising, O'Byrne,
& Vickers, 2006; Frattini, Lindsay, Kerr, & Park, 1998; Stromberg, 2005a). Stromberg
(2005a) suggested that clinicians should carefully assess for barriers, design educational
delivery methods that take into account these barriers, and consider incorporating newer
aids to learning, such as computer-based educational delivery, telecare and
telemonitoring.
Lack of knowledge, misconceptions, and difficulty applying knowledge to self
care management is a reported concern in both COPD and HF population (Artinian et al.,
2002; M. L. Carlson et al., 2006; Horowitz et al., 2004; Riegel & Carlson, 2002; Sneed &
Paul, 2003; Stromberg, 2005b). To answer this question as to how this deficiency has
been addressed in practice, several investigators conducted systematic reviews of
published research.
Devine and Pearcy ( 1996) conducted a meta-analysis on 65 studies to examine the
effect of education, exercise and/or psychosocial support in COPD adults. Publication
dates ranged from 1954 to 1994. The meta-analysis indicated that education-only
programs provided limited benefit for COPD patients. Greatest benefit was achieved
through pulmonary rehabilitation programs that included education, large muscle
exercise, breathing training, relaxation training, physical and occupational therapy,
psychosocial support, nutritional education, and vocational counseling. The authors
concluded that comprehensive pulmonary rehabilitation programs improve multiple
measures of function and well-being in the COPD population.
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Blackstock and Webster (2007) completed a systematic review of publications
from 1966-2005 to examine changes in QOL, self-efficacy, physical function,
psychological function, and resource utilization in trials comparing disease-specific
patient education and usual care for COPD. A total of 13 articles were included in the
review. The authors concluded that a didactic approach alone had minimal effect on
outcomes and is not the recommended delivery method. Education emphasizing self
management showed positive results on clinical outcomes, QOL and resource utilization,
but results did not reach significance and sample sizes were insufficient to detect a
significant effect.
Gillespie (2001) reviewed the literature to examine the impact of educational
intervention or disease management program on HF patients. Results of the studies were
fairly positive in that 13 of the 17 programs that tracked rehospitalization reported
decreased admissions. Other positive results included improvement in function, higher
QOL, improved knowledge, and increased adherence to treatment guidelines.
The review completed by D. Rutledge, Donaldson, and Pravikoff (2001) indicated
that HF management programs with a strong educational component can empower
patients with the knowledge and skills needed for successful self-care management. The
majority of programs reviewed were not theoretically based, but used methods developed
within the medical model and managed care environment. Rutledge et al. recommended
that delivery methods need to be designed to address the learning barriers of an older,
frailer population, and be modified to suit the delivery context-from ICU to home.
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Relationship of Education, Adherence, and Self Management

The review of the literature on COPD and HF identified many themes related to
adherence and self:management. The World Health Organization (WHO) utilized
research from chronic disease on adherence and described adherence as a
"multidimensional phenomenon" involving five factors that interplay among each other.
Their concept emphasized the fact that patient factors are only part of the adherence
picture. Healthcare providers need to be cognizant of all that may impact patient
adherence. The themes identified by this author's review on COPD and HF adherence and
self-management are consistent with the five-factor/dimensions identified by WHO,
which are summarized below.
1. Social economic factors: Low income may cause a patient to have to choose
between competing priorities such as health care, food, rent, clothing, or allocating
limited resources to children or parents under their care. Other factors that influence
adherence include illiteracy, low level of education, poor social support, transportation
issues, distance from treatment facilities, cost of medication, cultural and laymen beliefs
and perception about disease and treatment, and unstable family situation.
2. Health care team and system-related factors: Good relationship between
patient and health care provider may improve adherence. Factors that seem to have a
negative impact on adherence include: poorly developed health services, inadequate
reimbursement by insurance, suboptimal training/staffing in chronic disease for health
care providers, limited consultation time, weak systems for providing education and
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follow-up, difficulty establishing social support and self-management abilities, lack of
knowledge on contributors to adherence and methods to improve it.
3. Condition-relatedfactors: These are factors that the patient directly
experiences from the disease and include symptom severity, disability, progression and
disease severity, and availability of effective treatments·. Each patient may be impacted
differently depending upon their individual situation. Comorbidity complicates adherence
because the patient must simultaneously monitor and manage more than one chronic
medical condition.
4. Therapy-relatedfactors: Numerous therapy-related factors impact adherence.
They include complexity of the medical regimen, especially when comorbidities exist,
length of treatment, treatment failures, changes in treatment, positive response to
treatment, side-effects, and amount and availability of health care provider support.
5. Patient-related factors: Patient factors that impact adherence include the
individual's knowledge, resources, attitudes, beliefs, perceptions and expectations. Other
factors that impact adherence are motivation, self-efficacy to manage the disease,
expectations regarding outcomes of treatment/self-management and of the consequences
of poor self-management (Sabate, 2003).
This author's review of the literature and the WHO position paper on adherence
elucidate the multidimensionality of adherence and self-management. Key internal factors
include patient knowledge of the disease condition and beliefs in medical treatment
regimen, confidence in effecting change themselves by monitoring symptoms and making
adjustments in medications, motivation to do so in the face of complexity and challenges,
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and making lifestyle changes which involve breaking old habits and establishing new
ones.
Living with chronic disease requires patient adjustment to physical and emotional
changes and the awareness of behaviors needed to maintain optimal health and to slow
disease advancement. Patients need to make adaptive changes to manage the disease and
to maintain social relationships, emotional balance, and self-esteem, despite the inevitable
changes provoked by the disease process. Patients learn from health care providers, from
others who share the disease, and from their own experience with managing
symptoms-both successes and failures. Patients may benefit from a teaching/learning
model that encompasses the biopsychosocial factors illustrated by the review of the
Iiterature.
Self-Efficacy
Self-efficacy theory was developed within Bandura's ( 1986) framework of the
social-cognitive theory of behavioral change. Social-cognitive theory is based on the
assumption that people are able to self-reflect and self-regulate and can influence the
environment actively rather than react to the environment passively (Maddux, 1995).
Personal efficacy, or the individual's belief that his or her actions will produce the desired
effect, is the foundation for action or behavior. If people lack belief, they lack incentive to
act. Self-efficacy influences activity choice, effort put forth, perseverance against
obstacles and failure, and resiliency toward adversity. Self-efficacy influences positive or
negative thought processes, level of stress with environmental factors, and level of
accomplishment (Bandura, 1997).
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Bandura (1986) believed that multiple areas of influence could impact people's
beliefs about their efficacy. Among these factors are previous experiences of mastery,
experiences related to modeling (watching others who have mastered the activity, perform
it) and persuasion (from others who want them to be successful in the task). People also
rely on their physiological and emotional reaction to help reach a judgment regarding
their capabilities. They may judge fatigue and pain as a sign of physical dysfunction,
which results in perceived inefficacy. Positive mood enhances self-efficacy and negative
mood diminishes self-efficacy. Ultimately, people's perceived self-efficacy influences
choice of goals, amount of effort exerted, and persistence when confronted with
challenges and barriers. Self-efficacy theory proposes that the individual's self-confidence
in his or her capability to perform an activity will determine what activities will be
performed, how long it will continue, and how much effort will be put forth, especially if
the activity is complex or conditions change unexpectedly (Bandura, 1986).
In interpreting Bandura's work, Lenz, Shortridge-Baggett, and Shortridge-Baggett
(2002) emphasized that self-efficacy is not of a general nature, such as a personality trait.
Self-efficacy is thought to be task-specific. An individual may have a high self-efficacy
for some tasks, and low self-efficacy for other tasks. Self-efficacy may be then considered
to be of a more temporary nature, susceptible to influence, and situation and task specific.
Because efficacy beliefs are task specific, each domain of interest needs its own efficacy
measure. Self-efficacy measures rate the determinants of behaviors and/or the means by
which they produce effects. Traditional measures of self-efficacy ask that the individual
rate the degree of confidence they have related to the performance of specific tasks. In
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this study, the measure of self-efficacy will be taken from Riegel's Self-Care of Heart
Failure Index (Riegel et al., 2000).
Self-Efficacy and Health
Research psychologists have been active in searching for the explanation of
people's engagement in unsafe and unhealthy behaviors. Beliefs about efficacy and
personal control are major features of theories of health-behavior change. Self-efficacy
may influence health in two areas. The first area is the adoption of healthy behaviors,
quitting unhealthy behaviors, and maintaining newer healthier habits. The second area is
the positive effect higher self-efficacy may have on the body's physiological response to
stress, especially the immune system (Maddux, 1995). Bandura (1998) used results from
animal and human physiologic stress and coping research to support his assertion that
high efficacy activates health-promoting biological functions while low efficacy produces
a health-hindering autonomic system response.
Three major types of health behaviors explored by researchers are prevention,
promotion, and detection. Self-efficacy has been found to be important in each of the
three types of behaviors and all are applicable to chronic disease self-care management.
Research has demonstrated that self-efficacy has an impact on health practices as well as
adaptation to illness and treatment. In his overview of the literature, Maddux (1995) cited
numerous studies that found a positive correlation between self-efficacy and specific self
care behaviors (Maddux, 1995).
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Self-Efficacy With COPD and HF
Six COPD studies used self-efficacy as a major variable. Only one was a
randomized controlled trial. One study included self-efficacy as a variable and followed
both COPD and HF patients. Six HF studies used self-efficacy as a major variable. Four
of the studies were nonrandomized with the objective to explore the relationship of self
efficacy to other variables of interest.
Relationship of Self-Efficacy to Other Variables
Kohler, Fish, and Greene (2002) evaluated a social cognitive model of QOL with
COPD by analyzing relationships among measures of biomedical status, QOL, and self
efficacy among subjects (N = 208) enrolled in a longitudinal medication-adherence study.
This aspect of the study examined the relationship among the variables from measures
obtained at baseline. Path analysis results indicated that the association of pulmonary
function with level of functional impairment was mediated by self-efficacy for functional
activities. In other words, patients with low self-efficacy may have been more limited in
function than those with equivalent symptoms but who had higher self-efficacy in
carrying out functional activities.
R. Arnold, Ranchor, DeJongste, et al. (2005) conducted a cross-sectional study to
determine if self-reported physical functioning of COPD and HF patients could be
explained by illness-specific differences related to the diagnosis, or if other generic
factors contributed. Patients were recruited from outpatient clinics of a university hospital
and a general hospital. A total of 65 patients with HF and 56 patients with COPD agreed
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to participate in the study. Results found that COPD patients scored significantly lower
than HF patients in self-reported physical function and psychological function. Both
groups scored much lower than healthy people of the same age in the area of physical
functioning and social functioning. There were no significant differences in social
functioning or overall QOL. COPD patients perceived lower health competence
compared to HF. There were no differences between the groups in measures of mastery,
self-efficacy to control symptoms, or self-efficacy to maintain function. Regression
analysis demonstrated that the diagnosis and disease severity contributed to self-reported
physical functioning, but that self-efficacy contributed significantly to the explanation of
self-reported physical functioning.
Oka, Gortner, Stotts, and Haskell (1996) conducted a cross-sectional trial (N = 43)
to identify predictors of physical activity in HF patients. The predictive model included
fitness variables, knowledge, attitudes, beliefs including self-efficacy for general activity,
self-rating of daily exertion levels, and social factors. Self-efficacy was the stronger
predictor of physical activity.
Tsay and Chao (2002) used an exploratory correlational design to study the
relationship of self-efficacy to depression. Perceived self-efficacy had a strong direct
negative effect on depression, with functional status as a mediating factor between the
two variables. A positive relationship was shown between self-efficacy and functional
status and a negative relationship between functional status and depression.
Salamah, Wahl, and Abriam-Yago (2003) used the Cardiac Self-Efficacy
Questionnaire to measured confidence level in a convenience sample of 20 individuals
with HF in order to identify factors that influenced self-management behaviors. The
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lowest levels of confidence related to managing symptoms by adhering to prescribed
therapeutic regimens. The researchers felt that the study supported self-efficacy as a
prognostic factor.
Joekes (2007) conducted a nonrandomized repeated measures design to explore
the relationship of self-efficacy and overprotection to psychological well-being, HRQOL
and self-management. Data originated from two parallel studies of HF and myocardial
infarction. Forty-one HF participants were surveyed at Time one and again 3 months
later. Regression analysis indicated that higher levels of self-efficacy correlated with less
psychological distress, better self-management and better HRQOL, and that a greater
sense of self-efficacy predicted better self-management.
Impact ofIntervention on Self-Efficacy
Scherer, Schmieder, and Source (1996) examined the changes in self-efficacy
measures after attendance in a pulmonary rehabilitation program for COPD patients.
Twenty-nine subjects were enrolled in the outpatient program consisting of 36 one-hour
classes conducted three times weekly by a clinical nurse specialist. Content focused on
COPD and its management, training and workout sessions, and relaxation training.
Results showed a significant increase in self-efficacy for managing and controlling
dyspnea during activity. Results were maintained 6 months after completion of the
program.
Scherer and Schmieder (1997) used the same self-efficacy measure in a later study
that examined changes in self-efficacy measures, perception of dyspnea, and exercise
endurance. In this study, 60 COPD patients participated in pre- and posttesting in which
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the intervention consisted of an educational and exercise training program using methods
to increase self-efficacy. Results showed a significant difference in pre- and posttest
scores on the dyspnea measure. A negative correlation was demonstrated between self
efficacy and dyspnea measures, and a positive correlation between self-efficacy and 12minute walking distance test. Results indicated that higher self-efficacy correlated with
lower perception of dyspnea and greater distances walked.
Lox and Freehill (1999) examined the impact of 12-week pulmonary
rehabilitation on physiological, psychological, and behavioral performance variables.
Forty subjects participated and provided measures of a 6-minute walking test, efficacy
measure for the 6-minute walk, QOL, dyspnea, fatigue, and emotional function. Results
showed significant improvement in all of the measures, regardless of disease severity.
Improvements in exercise tolerance correlated significantly with increases in self
efficacy, which in tum correlated significantly with improved QOL.
Wong, Wong, and Chan (2005) conducted a randomized controlled study in
which 60 COPD patients were recruited from an acute care hospital. The intervention
consisted of nursing telephone follow-up designed to improve self-efficacy of patients for
managing dyspnea and corresponding decrease use of health care services. A COPD self
efficacy dyspnea measure was obtained, in addition to data on resource utilization.
Results showed a significant improvement in self-efficacy scores in the intervention
group compared to controls. Telephone follow-up, participating in a pulmonary
rehabilitation program, not smoking, and less health care use were significant predictors
of self-efficacy. Although there was no statistical difference in health care utilization,
there was a trend toward less use in the intervention group.
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Davis, Carrieri-Kohlman, Janson, Gold, and Stulbarg (2006) studied the effects of
intervention on self-efficacy, and if a relationship exists between domain-specific self
efficacy, walking performance, and symptom anxiety. Data for this study were collected
as part of a larger randomized controlled study examining self-management for dyspnea
in COPD. One hundred and fifteen subjects were randomized into three treatment groups.
Data were collected at baseline and again at 8 weeks, after completion of the intervention.
There were no significant differences between treatment groups. All groups demonstrated
significant improvements in self-efficacy. Self-efficacy for walking was positively related
to walking performance. Self-efficacy for managing dyspnea was positively related to
severity of symptoms. The major finding was that a program that combined education
with a home walking program significantly improved patient's self-efficacy for walking
and for managing shortness of breath. Improved self-efficacy for walking was related to
improvement on the 6-minute walking test.
Bamason et al. (2003) used a subsample of ischemic HF Coronary Artery Bypass
Graft (CABG) postsurgical patients to study the impact of an in-home communication
device (telemonitoring) on self-efficacy, risk factor modification, and functioning.
Patients (N = 35) were randomized into usual care or the intervention group. Baseline
scores were used as covariates in the analysis. At 3 months the intervention group showed
significantly higher scores on mean-adjusted self-efficacy scores and on adjusted mean
levels of functioning. The intervention group also had significantly higher exercise
adherence, and lower reported stress as compared to the usual care group. Study results
seem to indicate that self-efficacy will increase over time as patients increase their
confidence level through successful changes and incorporation of recommended lifestyle
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changes into their daily routines. This study also supported Bandura's assertion that
mastery and habits are developed through repetition of the skill, and as mastery is gained,
scores in self-efficacy will increase.
A smaller study (Oka, DeMarco, & Haskell, 2005) randomized 24 HF patients
into usual care or a home-based walking and resistance·exercise program. Patients were
assessed at baseline before and after treadmill testing and again at 3 months. There was
no difference at baseline between groups on studied variables and no difference in self
efficacy for general activity in either group by 3 months. Self-efficacy for walking was
significantly improved in the intervention group by month 3, but not in the usual care
group. These results support Bandura's assertion that mastery of a skill is a contributor to
increased self-efficacy for that skill.
In summary, self-efficacy has been studied in both COPD and HF populations, as
a contributing factor to relationships among variables of interest, and as an outcome
variable. Studies have shown a relationship between self-efficacy and symptom and
disease severity, functional level, quality of life, skill performance, and depression. Self
efficacy was a predictor of activity level, and improved after intervention. The studies
support Bandura's assertions that self-efficacy relates to mood, influences activity level,
and increases with opportunity for mastery experiences. The negative relationship of SE
to depression and to disease/symptom severity lends support to Bandura's theory that low
self-efficacy produces a health-hindering autonomic system response. Results of these
studies indicate that Bandura's Self-Efficacy is an applicable theoretical "fit" with this
population, an important prognostic factor, and an indicator of positive changes after
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intervention. Study results suggest that positive changes in self-efficacy are associated
with improved self-management behaviors, quality of life, and emotional well-being.
Telemonitoring
During the time period reviewed, 1995-2008, healthcare providers have increased
the use of telecommunication technology to provide assessment, treatment and
monitoring of patients from a distance. Telehealth, telemedicine, and e-health are some of
the terms used to describe the use of distance technology in healthcare. A motivating
factor behind home-based telemedicine is the need for high-quality, cost-effective home
based service in the era of managed care. Patient-centered care can be enhanced by the
addition of telemedicine so the patient is assessed, progress monitored, and support
provided directly in the home (Burgiss & Dimmick, 2003). Interest in telemonitoring has
increased due to the rising cost of healthcare, advances in communication technology, and
availability of lower cost telemonitoring devices (Louis et al., 2003).
Louis et al. (2003) reported results of a literature review on telemonitoring and HF
for the time period between 1966 and 2002. The reviewers identified 18 observational
studies and 6 randomized trials. Seven of the studies evaluated patient compliance and
acceptance of telemonitoring and all showed high (80-90%) acceptance. Results of the
observational studies showed reduction of hospital days. However, many of the studies
used small number of patients and telemonitoring in combination with other components,
such as outpatient clinic visits and automatic medication reminders, so it was difficult to
attribute the effects to telemonitoring alone. Similar results occurred with mortality rates.
The reviewers concluded that telemonitoring might reduce hospitalization and improve

67
mortality and morbidity but that larger long-term studies need to occur before efficacy
could be adequately demonstrated (Louis et al., 2003). A systematic review on COPD and
telemedicine was not found.
Meystre (2005) performed an extensive review of the literature on telemonitoring
published prior to 2002, with the purpose to develop a global view of telemonitoring. 1n
the research studies reviewed, medical conditions frequently monitored were asthma,
chronic obstructive pulmonary disease and chronic heart failure. Telemonitoring allowed
patients to remain in their homes and provided better follow-up, which reduced the
effects of chronic disease. Her analysis of the literature indicated that patients' homes
were viewed as the most common, and perhaps the most promising, location for
telemonitoring. Meystre concluded that although still in the early stages of development,
telemonitoring has the potential to appreciably improve healthcare.
Overview ofTelemonitoring Studies

A similar literature review was performed for this study to identify relevant COPD
and HF studies published after the reviews performed by Louis et al. (2003) and Meystre
(2005). CINAHL and Medline databases were searched for telemonitoring studies
published between 2003-2007. Articles that provided program evaluation results were
not included. Articles that did not provide a clear description of measurement tools were
not included. A total of eight randomized and five observational studies were selected for
review.
Because a comparable COPD review was not found, the investigator searched for
articles published between 1995-2008 on the topic C.OPD and telemedicine/
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telemonitoring. There were fewer published articles compared to the HF population. A
total of two randomized and two nonrandomized were included. In addition, three other
studies (two randomized) were used with other populations, in addition to COPD.
Summary of the review is divided into the impact of telemonitoring on mortality,
resource utilization, quality of life, and other variables such as self-efficacy and
depression.
Impact of TM on Mortality
Only one of the COPD studies measured mortality as an outcome. de Toledo et al.
(2006) carried out a randomized study in which 157 COPD subjects were followed.
Patients in the intervention group were followed at home via an integrated
telemedicine/electronic health records system. As this was a pilot, the telemedicine
component was not fully implemented and patients interacted with the interdisciplinary
team via phone calls to the call center. The initial experiment lasted one year. Both
control and intervention received home-based education services but the intervention
group received an additional education session and telephone access to the call center.
Mortality was not significantly different in the intervention group, although the trend was
for less mortality, with 20.3% mortality in intervention and 16.9% in control (de Toledo
et al., 2006).
Two of the HF studies measured mortality as an outcome. Both found a strong
relationship between telemonitoring and mortality. One of those was a large multisite
randomized trial (N = 280) in the U.S. that included mortality as an outcome variable.
This study compared standard care to standard care with the addition of a monitoring
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device over a 6-month period. Both groups contained patients who were in advanced
stages of heart failure and under aggressive treatment by cardiologists. Optimal medical
management was provided to both groups, but the telemonitoring group demonstrated a
56.2 % reduction in mortality (P < .003) (Goldberg et al., 2003).
A large multisite randomized trial (Cleland et al:, 2005) in the U.K. compared
patients (N = 426) randomized into one of three groups: usual care, nurse telephone
contact, and telemonitoring. Patients were followed for 240 days. A significant difference
was found in mortality in the usual care group compared to the other groups. One-year
mortality was highest in the usual care group (45%), compared to patients in the nurse
telephone group (27%) and the telemonitoring group (29%).
Finkelstein, Speedie, and Potthoff (2006) conducted a randomized clinical trial
with patients assigned to one of three levels of homecare. Patients had a diagnosis of
COPD, HF, or chronic wound care. Levels of intervention were standard homecare,
standard homecare plus video visits/Internet access, or standard care plus video
visits/Internet access and physiologic monitoring. Patients were followed for 6-months
after discharge. There were no differences found in mortality between the three levels of
care.
Impact of TM on Resource Utilization

Two of the COPD studies measured clinical outcomes of hospitalization and
emergency room use. De Toledo et al. (2006) (study description in preceding section)
found a significant reduction in the number of readmissions in one year. No significant
differences were found in use of emergency room services. Pare, Sicotte, St-Jules, and
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Gauthier (2006) conducted a quasi-experimental study and compared effects and cost of
care a group of 19 patients under home health to a control of 10 patients receiving
homecare without telemonitoring. The cost-minimization analysis demonstrated a
reduced cost of $355 per patient, for an overall program savings of $6,750, a net gain of
15% over the traditional program. The main cost savings was through lower hospital
readmissions. Finkelstein et al. (2006) found that discharge to higher level of care
(hospital or nursing home) was highest in the control group (standard homecare) at 42%,
21% in the standard care plus video visits, and 15% in the standard care plus video visits
plus physiologic monitoring.
Eight of the HF studies, four of which were randomized, measured the impact of
telemonitoring on hospital admissions and/or costs. One of the randomized studies (N =
37) compared three models of post-discharge nursing care over a 180-day period. Results
showed 80% lower costs in the telenursing groups compared to the usual care group. Both
groups had significantly fewer emergency room visits as compared to usual care (Jerant et
al., 2003). The other randomized study (Benatar et al., 2003) compared usual homecare to
homecare with telemonitoring (N = 216) over a 12-month period and also found a
significant difference in readmissions, length-of-stay, and total charges between the
monitoring and the usual care group. Goldberg et al. (2003) found no difference in
hospital utilization rates between the control and the intervention groups. Woodend et al.
(2008) (N = 121) also found no differences in emergency department visits or hospital
admissions between intervention and control.
The four nonrandomized HF studies reported results similar to that of the
randomized studies. One of the larger studies (Berg, Wadhwa, & Johnson, 2004), a
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concurrent matched cohort study (N = 533) found overall lower hospitalizations, inpatient
days, emergency room visits, and lower nursing home days. The nursing intervention
provided telemonitoring, education, and counseling. A Minnesota project (N = 60)
reported statistically decreased hospital utilization and related costs compared to pre
study values (Bondmass et al., 1999). Another study (Heidenreich, Ruggerio, & Massie,
1999) (N = 154) matched a convenience sample to a control group from the previous year
by medical records. 1n this model the control group had received usual care managed by
primary care physicians. The intervention group received a multidisciplinary program of
daily self-monitoring, patient education, and physician notification of abnormal
symptoms. This program also reported significantly lower hospital utilization and costs in
the intervention group compared to the control. The last study (Cordisco et al., 1999)
compared 30 patients with telemonitoring to 51 without. Both groups received specialized
CHF care. By the end of 6-months the telemonitoring group had significantly lower rates
in hospitalization and use of the emergency room.
Impact of TM on Quality ofLife Measures
Results on measurements of quality of life are not as definitive as mortality and
utilization. There is little agreement across studies on the impact of telemonitoring on
QOL. Artinian et al. (2003) found that QOL as measured by the Minnesota Living with
Heart Failure Questionnaire (MHFQ) improved significantly by 3 months over baseline
compared to the control group. Improvement occurred in the physical, not emotional,
subscale of the tool. Bondmass et al. (1999) had also used the MHFQ in their
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observational study. They collected measures on a monthly basis through the 12-month
follow-up and found that QOL improved significantly over baseline (P < 0.002).
Goldberg et al. (2003) used the MHFQ, the Medical Outcomes Study Short Form12 (SF-12) and the Health Stress questionnaires. No difference between control and
intervention were noted at baseline. Results showed that both groups improved in all
measures over baseline and there was no statistical difference at 6-months follow-up.
Another randomized study (LaFramboise et al., 2003) utilized the Medical Outcomes
Study Short Form-36 (SF-36) to measure QOL. Results of this study of 90 HF patients
demonstrated improvement over baseline in both the intervention and control, with no
significant differences by the two-month follow-up. Whitten and Mickus (2007) used the
SF 36 as an outcome measure to follow COPD and HF patients assigned to traditional
homecare, or homecare with the addition of video visits. SF 36 scores were available for
37 patients in the experimental and 30 in the control who completed the study. The
authors found that the addition of telehealth to standard homecare was not a si·gnificant
predictor of health or well-being. Woodend et al. (2008) also used the SF36 and assessed
QOL at baseline, and I, 3, and 12 months. They found significant improvements over
time in both groups, with the intervention group having higher QOL on five of the eight
subscales by 3 months, but in only one of the subscales by 12 months.
Impact of TM on Other Variables
Other variables examined in studies were patient satisfaction, patient function,
self-efficacy, depression, changes in physiologic measures and adherence to self-care
behaviors. Bondmass et al. (1999) measured mean arterial pressure (MAP) in HF patients
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who required blood pressure reduction. Patients who required blood pressure reduction
had significantly reduced MAP by the end of 12-months. Lusignan et al. (2000) studied
the feasibility of a wireless monitoring device in the homes of patients with COPD, HF,
and atrial fibulation. They found that the system was satisfactory for patients and the
equipment functioned well in the home setting.
Demiris, Speedie, Finkelstein, and Harris (2003) described a qualitative study
which examined the content of video phone visits provided to 10 home health patients
with diagnoses of either HF, COPD, or who required diabetes wound care. One hundred
and twenty-two visits were reviewed for technical quality and received an average overall
rating of 95%, with 78 visits conducted without any type of technical problems. Content
analysis revealed 13 themes, with the most prevalent relating to patient assessment,
promotion of compliance, psychosocial issues and education.
Artinian et al. (2003) found that HF patients in the intervention groups
demonstrated a higher rate of compliance to the self-management behaviors of daily
weights and blood-pressure checks. LaFramboise et al. (2003) found no difference in
functional status or depression between HF groups but did find that the telephonic and
monitoring groups had higher confidence than the usual care.
Finkelstein et al. (2004) conducted a study designed to examine the usefulness of
telehomecare using connectivity via the plain old telephone system (POTS) in providing
high-quality, clinically useful and patient satisfactory interactions. Patients with COPD,
HF, or chronic wounds were randomized to receive standard care, standard care plus
videoconferencing/Internet access, or standard care with videoconferencing/Internet
access plus physiological monitoring. Fifty-three patients completed the study. Results
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showed high level of satisfaction across all three groups, but with higher satisfaction
among the telehealth groups, with the highest in the group receiving
videoconferencing/Internet access plus telemonitoring. The technical ratings of video
visits were 94.7%. Patients rated them as useful as face to face visits in 90.7% of the
cases.
Quality of Telemonitoring Evidence

The results of the above studies present a positive outlook regarding the feasibility
and efficacy of telemonitoring. Studies that measured impact on hospital utilization found
a positive effect, with the exception of the randomized trial performed by Goldberg et al.
(2003). One explanation for the difference is that the subjects were undergoing aggressive
treatment apart from the telemonitoring and received care that met or exceeded published
guidelines. None of the other studies enrolled patients treated exclusively by cardiologists
who specialized in heart failure. The U.K. study found similar results, despite differences
in the credentials of the primary care provider.
Cleland et al. (2005) purposely enrolled subjects from hospitals that did not
provide specialty care for HF patients. They had a stronger comparison design by
including a nurse telephone group as well as the usual care and telemonitoring group. The
researchers were not measuring mortality as a primary outcome, and were surprised when
results showed a significant reduction in mortality in the telephone and monitoring
groups. Telephone groups and monitoring groups actually increased number of hospital
and physician services but used fewer days and had a higher survival rate than the usual
care group. There were no significant differences in mortality or utilization between the
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telephone group and the monitoring group. Like Goldberg's group, these researchers
hypothesized that improved mortality was a direct result of improved disease
management by the physician and nurses in response to frequent monitoring of the
patients (Cleland et al., 2005). Of interest to note is that the telephone group experienced
similar benefits to the more costly and technologically-complex telemonitoring
intervention.
The majority of studies reviewed showed a positive impact of telemonitoring,
although the degree of effect varied across studies and variables. All studies provided
intervention that enabled close monitoring of patient status, education of the patient, and
a mechanism to communicate relevant information to the primary care physician. Those
studies that compared telephone interventions to telemonitoring found a positive effect
from both. Only five of the studies reported controlling for confounding variables
(Bondmass et al., 1999; Cleland et al., 2005; Goldberg et al., 2003; Heidenreich et al.,
1999; Jerant et al., 2003). However, the fact that those studies' results were similar to
results of the others gives added credibility to the overall results from all of the studies
reviewed. Compilation of results supports that there is a clinical benefit to patients who
receive regular in-home monitoring of their health status by qualified healthcare
professionals. Quality of life, depression, self-efficacy, and self-management need further
study to determine if telemonitoring has a positive impact on these variables and to
determine what aspects of monitoring produces the greatest effect.
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Purpose of Current Study
The results of the literature review suggest that there is an urgent need for
programs that can improve HF and COPD disease management, reduce hospitalization,
and increase survival. Multidisciplinary programs that address critical biopsychosocial
factors may be the most efficacious. Telemonitoring may be a valuable tool for helping
patients improve their confidence in their self-care management skills and simultaneously
may improve their emotional well-being. This study will examine the impact of a home
health telemonitoring program on self-efficacy, emotional well-being, and the clinical
outcomes of mortality, hospitalization, and use of emergency department services. It will
also explore the relationships among those variables at baseline and at 3 months.

CHAPTER Ill
METHODS
The primary purpose of this study was to examine the impact of telemonitoring on
self-efficacy, emotional well-being, and clinical outcomes of mortality, emergency room
use, and hospitalization in patients with HF or COPD. The secondary purpose was to
determine if there is a relationship among the variables of telemonitoring, diagnosis, self
efficacy, emotional well-being, and clinical outcomes.
Research Questions and Hypotheses
Primary Research Question

Do patients who receive telemonitoring (TM), in addition to standard homecare,
show differential improvement when compared with those who receive standard care only
(SC) in the following outcome variables: (a) self-efficacy for disease management, (b)
sense of emotional well-being, and (c) clinical outcomes of mortality, emergency room
use, and hospitalization?
Secondary Research Question

ls there a significant relationship among the variables of self-efficacy, emotional
well-being, and clinical outcomes at 3-months post index hospital discharge?
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Experimental Hypotheses
The following hypotheses were examined within this study:
H 1: Patients with HF or COPD who are randomly assigned to receive standard
care plus telemonitoring, compared with patients with HF or COPD who
receive standard care only, will demonstrate greater improvement in the
following variables:
a.

Self-efficacy as measured by Section C (SCI-C) from the Self-Care of
Heart Failure/COPD Index at 3-months post hospital discharge
compared to baseline.

b.

Emotional well-being as measured by the SF 36 Version One Mental
Health Component Score (MCS) at 3-months post hospital discharge
compared to baseline.

c.

Clinical outcomes of mortality, emergency room use, and hospital
admissions at 3-months post hospital discharge, with the TM group
experiencing less mortality, emergency room use, and hospitalization.

H2 : Three-month scores in self-efficacy and emotional well-being will correlate
positively with each other, and negatively with 3-month clinical outcomes of
emergency room use and hospitalization; the relationships will be of greater
magnitude in the TM versus SC groups.
A model of the theoretical relationships for the study was displayed by Figure 1 in
Chapter I. The following Figure 6 represents the full study framework and displays the
main variables and hypothesized relationships.
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Figure 6. The comparison of standard care and standard care plus telemonitoring on
COPD and HF patients' self-efficacy, emotional well-being and clinical
outcomes at 3-months post index hospitalization.
Research Design
This study was a randomized controlled trial designed to investigate the difference
between standard care (SC) and standard care plus telemonitoring (TM) treatments in
terms of patient perception of self-efficacy (SE) and emotional well-being (EWB), and
clinical outcomes. Data to conduct this study were gathered as part of a larger project
(Western Michigan University HSIRB approved protocol number 05-02-22) in which
home health patients recruited from a Midwestern home health agency had been
randomly assigned to either the control or experimental group and were followed over a
12-month period. The goal for the larger study was to recruit 100 subjects each to
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participate in the HF and COPD arms of the main study. It is those subjects whose
baseline and 3-month data were analyzed in this study.
Population and Study Sample
The targeted sample for the dissertation study was 200 adult patients, with 100
randomized into the SC control condition, and 100 randomized into the experimental
condition of SC+TM. Criteria for the selection of patients for the primary study are
described in th� following list. If eligible, patients were provided the opportunity to
consent to participate in the primary study. To be included in the dissertation research,
they must have provided additional consent, which was included as a checkbox on the
informed consent form from the parent study. Approval from the Human Subjects Review
Board of Western Michigan University andBorgess Health were obtained before this
study was implemented. Copies of those approval letters are provided in Appendices A
andB.

Inclusion Criteria
1. Patient meets admission criteria for home care per agency policy.
2. Patient has a documented diagnosis of HF or COPD.
3. Patient has a recent hospital admission for HF or COPD.
4. Patient's treatment plan includes optimum medical management.
5. Patient is able to read and speak English.
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Exclusion Criteria
1. Patient is physically unable to participate.
2. Patient does not have functioning land-line phone service.
3. Patient is physically unable to use equipment safely.
4. Patient has end-stage HF or COPD, or the focus of care is symptom
management and quality of life.
Demographic data, with the exception of education, were obtained from the
Outcome and Assessment Information Set (OASIS), which is a comprehensive clinical
assessment and interview typically completed on patient admission into homecare and
which generally coincided with enrollment into the parent study. Demographic variables
used for this study were gender, age, educational level, severity of disease, and level of
caregiver support.
Patient Enrollment
This study analyzed a portion of the baseline and 3-month data obtained from
patients with HF or COPD who consented to participate in the parent study and who also
consented to have their data utilized in this dissertation research. Those patients who met
inclusion criteria in the main study, and who signed the informed consent to participate,
were randomized into the control or experimental group. The control group received the
usual SC and the experimental group received SC+TM. Patients in both groups
completed study questionnaires at admission and again at 3 months post hospital
discharge (index hospitalization).
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SC consisted of assessment, establishment of treatment goals in collaboration with
patient and family, education of the patient and family on disease management, and
coordination of care with the primary physician. Care was directed toward the key patient
outcomes of adherence to prescribed medication and treatment, demonstration of self
management behaviors, and advice seeking from health care provider as needed. At
minimum, patients received intervention from a registered nurse. Other professionals that
may have been involved in the standard care of subjects were social workers, physical
therapists, occupational therapists, and dieticians.
The experimental group hence referred to as TM, received SC+TM. Patients in the
experimental group independently, or with the assistance of a caregiver, took daily
physiologic measures using the medical peripherals attached to the Health Buddy®
monitoring device. The telemonitoring device (TD) included a computer-aided education
program that provided daily sessions so that patients were able to test their knowledge of
their disease, and receive recommendations for proper steps in management,
reinforcement for correct responses, and corrective feedback for incorrect responses.
In this study, patients used either the COPD or HF disease program designed by
the Health Hero Network, the developer and marketer of the Health Buddy®. Some of the
educational content was modified to reflect regional practices in the treatment of HF and
COPD. These data (physiological measures and responses to questions) were transmitted
automatically on a daily basis through the phone lines to a secure website. Home health
nurses received additional information from the telemonitoring device after analysis by
system software that allowed them to individualize the disease management program.
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The COPD disease management program available through the HB provided
medication reminders and educational content on medications and the importance of
taking those medications. The curriculum also provided instruction on different
medication delivery systems (such as inhalers), the importance of nutrition, prevention of
complications, lifestyle modification, safe use of oxygen, the importance of physical
activity, and psychosocial factors that may affect the patient and the caregiver. The HB
curriculum also provided content on signs and symptoms to report, the disease process,
and risk factors.
The HF disease management program available through the HB contained
medication reminders, and educational content about medication and the importance of
taking medications, dietary guidelines, and information on the importance of physical
activity and psychosocial factors that may affect both patient and caregiver. The HB
curriculum also provided information on signs and symptoms to report, emergency
procedures, ways to manage HF, the disease process, and risk factors.
Patients received the telemonitoring device within 2 days of enrollment into the
study. Installation and training (with the patient and sometimes the caregiver) took
approximately 3 hours. Patients were then encouraged to use the device on a daily basis.
The device was removed from the home when the patient was discharged from home
health care. Because the length of home health treatment varied among study participants,
so did the length of time patients had access to the Health Buddy® device and the
educational content.
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Key Variables and Measurement
Variables that were examined in this study are self-efficacy and emotional well
being, as well as clinical outcomes of mortality, emergency room use, and hospitalization.
Self-Efficacy
Self-efficacy for HF management was measured by the Confidence Component
score (section C) from the Self-Care of Heart Failure Index (SCHFI) (Riegel et al., 2000)
version R4 updated 9/15/03. Reigel described self-care management as a cognitive
decision-making process consisting of four stages: (a) recognizing that a change in
symptoms is related to the illness, (b) evaluating the change, (c) implementing a selected
treatment strategy, and (d) evaluating the effectiveness of the treatment strategy. The four
stages are often sequential but may occur simultaneously. This construct of self
management was utilized to develop the Self-Care of Heart Failure Index (SCHFI). Each
of these four stages was queried specifically by one of the four questions in the SCI-C,
which were designed collectively to assess patient confidence in the four stages of self
care management.
The SCHFI can be completed by self or by an interviewer and takes
approximately 5 minutes to complete. The complete survey form contains 15 items
divided into subscales of self-care maintenance, self-care management, and self-care
confidence. Riegel et al. (2000) included a measure of self-care self-confidence in the tool
due to recognition that self-efficacy impacts behavior, and because research by others
showed self-efficacy to be predictive of performance.
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Riegel et al. (2004) reported findings of psychometric testing of the SCHFI.
Construct validity was analyzed by confirmatory factor analysis, exploratory factor
analysis, known-groups technique, and assessment of subscale-to-subscale correlations.
Internal consistency of the SCHFI and subscales were estimated with coefficient alpha.
The mean SCHFI score was 192.0 ± 17.2 (range 80 to 268 of300) in a sample of 98.
Internal consistency was calculated and coefficient alpha of the full scale was . 76. Riegel
and colleagues concluded that reliability and construct validity were sufficiently
supported for use of the tool for research.
For purposes of the parent study, the SCHFI was modified to create a parallel
version, the Self Care of COPD Index (SCCOPDI), that could be administered to the
COPD subjects enrolled in the study, and allow comparisons between the diagnoses using
the SCHFI and SCCOPDI. After obtaining consent from the creator of the SCHFI (B.
Riegel, personal communication, January 31, 2005), the new tool was constructed to
replicate the SCHFI as closely as possible but to address symptoms and healthcare
regimen applicable to COPD. The initial version was developed by a clinical nurse
specialist from the home health agency. This version was then reviewed for content
validity by a pulmonary nurse specialist. The next version was reviewed by the creator of
the SCHFI, who evaluated it to be consistent with the original tool in terms of
organization of content, appearance, format, and scoring. The final version of the tool was
not pilot-tested prior to implementation in this study and the parent study.
The questions, format, and scoring on subscale Section C of the SCHFI and
SCCOPDI are identical. Subjects responded to four questions and rated their level of
confidence on a 4-point Likert scale with the anchors, 1 = Not Confident and 4 =
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Extremely Confident. Questions are listed here, numbered according to how they appear
in Section C.
1. How confident are you that you can evaluate the importance of your
symptoms?
2. Generally, how confident are you that you can recognize changes in your
health if they occur?
3. Generally, how confident are you that you can do something that will relieve
your symptoms?
4. How confident are you that you can evaluate the effectiveness of whatever you
do to relieve your symptoms?
Items were scored as follows: 1 = 6.25; 2 = 12.5; 3 = 18.75; 4 = 25. The range for
possible scores on Section C is from 25 (4

x

6.25) - 100 (4

x

25).

Emotional Well-Being
In this study, emotional well-being was measured by the SF-36 Vl Mental
Component scores using Version 2 norms. The SF 36 is a multipurpose, short-form health
survey. The 36-question tool produces an eight-scale profile of functional health and
well-being scores and a psychometrically-based physical and mental health summary. The
tool allows comparison of the burden of disease and treatment benefits. The SF-36 has
been widely evaluated and found to exceed minimum psychometric standards for in
group comparisons (McHomey, Ware, & Raczek, 1993; Ware et al., 1995; Ware &
Sherboume, 1992). Deficiencies in the original version were corrected in the 1996 SF-36
Version 2. Norms were also updated at that time. Validity studies have demonstrated that
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both versions of the SF-36 have content, concurrent, criterion, construct, and predictive
validity. Reliability studies on the SF-36 have consistently exceeded the recommended
minimum standard of .70.
The SF-36 may be administered by self, computerized version or by in-person or
by phone interviewer. This tool can be administered in 5-10 minutes (Ware, 2005). The
SF36 Version II was intended for the parent study. Due to an administrative error,
however, Version I was used instead. Therefore, for consistency, Version I was used for
the remainder of the study. The SF36 Version 1 was administered in person at enrollment,
and by phone at subsequent time intervals.
Four subscale measures of the SF36 contribute to the Mental Component Score:
Vitality, Social Functioning, Role Emotional, and Mental Health. The Mental Health
subscale has been found the most valid measure of the Mental Component Score. The
Vitality subscale measures subjects' perception of level of energy from the lowest
possible of feeling tired and worn out all of the time, to the highest possible of feeling full
of pep and energy all of the time. The Social Functioning subscale measures subjects'
perception of ability to carry out social activities free from physical and emotional
interference. The Role Emotional subscale measures subjects' perception of ability to
carry out work or other daily activities without interference from emotional problems.
The Mental Health subscale measures subjects' perception of mental health from the
lowest possible of feeling nervous and depressed all of the time, to the highest possible of
feeling peaceful, happy, and calm all of the time (Ware, 2005). Refer to Appendix C for
questions and response choices for each of the subscales.
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The SF36 Mental Component Score has been evaluated for its utility in screening
for depression. Additionally, the Mental Health subscale, by itself, has been found to be a
valid screening tool for mental health status, including as a screening tool for anxiety and
major depression (Berwick et al., 1991; Friedman, Heisel, & Delavan, 2005; Hoeymans,
Garssen, Westert, & Verhaak, 2004; Kelly, Dunstan, Lloyd, & Fone, 2008; Means
Christensen, Arnau, Tonidandel, Bramson, & Meagher, 2005; Rumpf, Meyer, Hapke, &
John, 2001; Yamazaki, Fukuhara, & Green, 2005).
MCS score ranges (shown in Table 1) were derived based on the percentage of
adults that screened positive for depression, using the receiver operating curve (ROC)
analysis. ROC is a graphical method (N. Anderson, 2001) to evaluate a diagnostic test in
terms of its ability to discriminate between a healthy person and a diseased person. The
analysis helps to provide a "cut point" in the score above which the test is considered to
be normal. The best all-around cut-off for the MCS in regards to depression is at the score
of 42 or below, which achieves an area under the ROC curve of 0. 77 and is considered to
be "fair" in the ability to discriminate depressed from nondepressed individuals. These
guidelines may be used to interpret differences in scores throughout the score ranged for
clinical relevance and are provided in Table l (Ware, 2005).
Scoring of the SF36 is accomplished in three steps. First, the subscale scores are
standardized using means and SD from the 1998 general U.S. population. They are then
aggregated using weights from the 1990 general U.S. population. Last, the aggregate
Physical Component and Mental Component scores are standardized using a linear T
score transformation so as to have a mean of 50 and a standard deviation of 10, in the
1998 general U.S. population. All scores above and below 50 are above and below the
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Table 1
MCS Levels as Indicators of Possible Depression

Rates of Possible Depression Based Upon SF36 Mental Component Score
in the General U.S Adult Population (N = 2,393)

Levels

Score
Range

n (Percentage)
Screened for
Depression

Levels

Score
Range

n (Percentage)
Screened for
Depression

65-74

28 (10.7)

6

40-44

190 (58.9)

2

60-64

269 (12.3)

7

35-39

153 (73.9)

3

55-59

729 (18.4)

8

30-34

102 (89.2)

4

50-54

512 (29.1)

9

9-29

123 (93.5)

5

45-49

287 (45.6)

average respectively. A I-point difference in score is 1/10th of a standard deviation
(Ware, 2005). Scoring for the parent study was calculated using the QualityMetric Health
Outcomes™ Scoring Software Version 2.0.
A sample size of 140 is needed to detect a 2-point difference in PCS or in MCS
scores over time within one group. A sample size of 23 is needed to detect a 5-point
difference in either score over time within one group. A sample size of 201 is needed to
detect a 2-point difference between two experimental groups on post-intervention scores
using pre-intervention scores as covariates. A sample size of 33 is required to detect a 5point difference in scores in the same situation. The previous sample size estimates
assume alpha = 0.05, two-tailed test (Ware, 2005).
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Clinical Outcomes
Mortality data were retrieved from medical records and family report at the time
of scheduled phone interview (if not previously known from medical record).
Data for hospital and emergency services were derived from information retrieved
from electronic medical records and from patient interview using the Stanford Patient
Education Research Center Survey Health Care Utilization (PERCHCU) during the
follow-up phone visits. Data gathered included incidence of emergency room visits and
hospital admissions.
The Health Care Utilization Survey asks questions regarding physician office
visits, emergency room use, and hospitalization. For this study, all but the question
regarding physician office visits were utilized. The PERCHCU questions are as follows:
1. In the past 3 months, how many times did you go to a hospital emergency
room?
2. How many different times did you stay in a hospital overnight or longer in the
last 3 months?
3. How many total nights did you stay overnight in the last 3 months?
The PERCHCU items are scored individually. The original tool was evaluated on
1,130 chronic disease subjects with 51 involved in test-retest for reliability. Reliability
measures for the questions used in this study are as follows: ER visits = .94;
hospitalization = .89; nights in hospital = .97((Lorig et al., 1996).
Due to differences between patient reported healthcare utilization, and
information retrieved from the regional healthcare system electronic medical records, data
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were treated separately. Differences may have been due to subject confusion regarding
timelines, how days are calculated for inpatient stays, or, in the case of regional health
records, possible use of another healthcare system.
Statistical Methods
Descriptive and inferential statistical tests were completed to determine if there
was a significant difference at baseline on demographic and key variables between the
control and experimental groups. Analyses were also completed on baseline and 3-month
measures to check for normality and other assumptions related to the statistical methods
utilized. As is typical with small sample sizes, normality of data was not achieved on the
majority of the measures. In research, parametric assumptions are met in a less than
perfect fashion and yet researchers opt to use parametrics, or a combination of
parametrics and nonparametrics to analyze the data. For purposes of this study, both were
utilized and comparisons of statistical differences were made across the two methods.
Three-month data were analyzed using survivor data only. The majority of
analyses were completed within the diagnostic categories (HF and COPD). Survivors
were those subjects "active" (alive and participating) at the 3-month timeline. Paired t
tests and Wilcoxon Signed Rank tests were utilized to determine if there was a significant
change in scores from baseline to 3 months within each group. Independent t test and the
Mann-Whitney Uwere used to compare differences in change scores on main variables
between the groups. Chi-square was used to determine if was a difference in the
frequency of mortality, emergency room use, and hospitalization between the groups by 3
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months. The Pearson correlation and Kendall's tau were utilized to assess for the degree
of relationship between variables at baseline and again at 3 months.

CHAPTER IV
RESULTS
This study was conducted with patients with COPD and patients with HF who
consented to participate in this dissertation research study in addition to a larger parent
study. Patients in the parent study were randomized into standard (usual) care (SC) or
standard care with the addition of telemonitoring (TM) groups and were followed for 12
months. This study used secondary data to compare 3-month outcomes between TM
patients and SC patients on several measures collected in the parent study. Dependent
variables for this study were self-efficacy for disease management (SE) based on
responses to SCI-C (Riegel et al., 2000), emotional well-being (EWB) based on SF36
MCS (Ware et al., 1995), and clinical outcomes based on mortality, hospitalization, and
emergency room use. Data used in the analysis included demographics collected at
baseline, baseline measures in SE and EWB, 3-months measures in SE and EWB, and
clinical outcomes obtained from the hospital system database and from patient or family
report.
The chapter is divided into three main sections. The first section provides
descriptive data for demographic characteristics of patients enrolled in the study and data
for treatment received during the time period that they were enrolled in home health. The
second section presents results for comparison of groups at baseline in order to determine
if the randomization had produced equivalent groups. The third presents results of
93
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statistical analyses used to answer the research questions. These results are presented in
order ofthe primary and secondary research questions with their corresponding
hypotheses. Results are shown separately by diagnostic group, comparing the COPD-TM
and COPD-SC (experimental and control) groups first, and repeating the pattern for the
HF-TM and HF-SC groups in response to each question,
Descriptive Statistics for Sample Participants
Participant Demographics
The sample for this study consisted of46 home health patients enrolled in the
parent study, with two diagnostic subgroups consisting of26 patients with COPD and 20
patients with HF. Problems in the parent study with the screening process resulted in
groups ofunequal size. Randomization ofpatients in the COPD group resulted in 11
patients in the COPD-TM group and 15 in COPD-SC. The HF group consisted of8
patients in the HF-TM group and 12 in HF-SC. By 3 months, 38 patients remained active
in the study. Five patients had died, and 3 had withdrawn. Analyses ofall pre-post
dependent variables, with the exception ofmortality, are examined for the 3-month
survivors, with subgroup numbers as follows: 9 COPD-TM, 13 COPD-SC, 6 HF-TM,
and 10 HF-SC.
Table 2 summarizes patient demographics and data on education, living situation,
and disease severity. Only limited information was available on disease severity; thus, it
was not feasible to compare the groups for equivalency on this variable. The diagnostic
group of26 COPD patients (mean age = 72.96, SD= 9.42, range = 51-90) included 18
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Table 2
Patient Demographics

Characteristics of Enrolled Patients
HF

COPD
TM

SC

TM

SC

11

15

8

12

74.8(9.46)

71.6( 9.48)

79.6(4.95)*

67.76(10.79)*

18.2%

40%

50%

33.3%

9.1%

6.7%

0

0

High School Grad

54.4%

20%

50%

58.3%

< High School

36.4%

46.7%

12.5%

41.7%

26.7%

37.5%

N
Age: Mean and (SD)
Gender(% male)
Education
College Grad

Unknown
Living Situation
Alone

36.4%

20%

12.5%

8.3%

Spouse

27.3%

33.3%

50%

16.7%

Family/friends

27.3%

46.7%

37.5%

66.7%

Unknown

9.1%

8.3%

Heart Failure
NYHA class

NIA

NIA

3

87.5%

58.3%

2

0

8.3%

12.5%

33.3%

Unknown
COPD
Continuous oxygen

36.36%

40%

NIA

NIA

*Statistically significant difference between telemonitoring and standard care groups.
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women (mean age = 71.85, SD = 10.19, range = 51-84) and 8 men (mean age = 75.45,
SD = 7.36, range = 65-90. The diagnostic group of 20 HF patients (mean age = 72.48, SD
= 10.56, range = 44-88) included 12 women (mean age = 69.34, SD = 10.42, range = 4485) and 8 men (mean age = 77.20, SD = 9.49, range = 61-88).
Self-Efficacy at Baseline
Baseline self-efficacy scores for the total group of COPD patients (mean = 66.10,
SD = 15.12, range = 37.5-100) were similar to those for the total group of HF patients
(mean = 69.3, SD= 17.19, range = 37.5-100). Similar proportions of patients with each
diagnosis (54% for COPD and 60% for HF) reported feeling very confident or extremely
confident in their ability to evaluate the importance of their symptoms. A lower
proportion of patients with COPD than with HF (65% for COPD and 80% for HF)
reported feeling either very confident or extremely confident in their ability to recognize
changes in health status. Patients in the two groups reported similar levels of confidence
in their ability to do something to relieve their symptoms (46% for COPD and 50% for
HF). Confidence in ability to evaluate the effectiveness of strategies they used to relieve
symptoms was slightly higher for patients with COPD (58% for COPD and 45% for HF)
than for those with HF. Table 3 displays the baseline group SE scores on the composite
measure (SCI-C), as well as the scores on the individual questions, which are added
together to calculate the composite SE score. Table 4 displays the frequencies of
responses to the individual questions across the four groups.
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Table 3
Self-Efficacy at Baseline
Baseline Self-Efficacy Mean Scores for 3-Month Survivors
Chronic Obstructive
Pulmonary Disease

Heart Failure

Telemonitoring

Standard Care

Telemonitoring

Standard Care

Mean (SD)

Mean(SD)

Mean(SD)

Mean(SD)

SCI-C

63.8 (14.9)

67.7(17.4)

71.8(20.0)

66.8(17.6)

Q. 12

15.9(6.3)

17.2(6.0)

17.7(7.3)

16.2(7.9)

Q. 13

16.6(6.2)

18.2(4.2)

21.8(5.2)

18.7(5.1)

Q 14

15.9(3.3)

15.6(6.2)

14.5(6.4)

16.2(4.3)

Q. 15

15.3(3.3)

16.6(5.5)

17.7(6.1)

15.6(5.3)

Note. SCI-C score range: 25-100. Question score range: 6.25-25
Emotional Well-Being at Baseline
Baseline emotional well-being(EWB) baseline scores on the SF36 MCS were
similar for patients with COPD(mean = 46.97, SD= 14.96, range = 23.85-68.13) and
with HF(mean = 45.39, SD = 12.5, range = 19.92-62.67). These are norm-based,
standardized scores. At the most basic level of interpretation, the "mental component
score"(MCS) indicates above-average overall mental health when compared to the U.S.
population when the SF36-MCS > 50; whereas scores< 50 indicate below-average
mental health compared to the U.S. population. As scores drop below 50, the likelihood
of the existence of depression rises proportionately. Table 5 displays baseline scores
across groups in the overall measure of EWB(SF36 MCS), as well as scores on the
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Table 4
Responses to Self-Efficacy Questions

Baseline Self-Efficacy Response Frequencies for 3-Month Survivors
COPD-TM

COPD-SC

HF-TM

HF-SC

Number Responding

9

13

6

10

Q. 12. How confident are you that
you can evaluate the importance of
your symptoms?
Not confident
Somewhat confident
Very confident
Extremely confident

1
4
2
2

1
4
5
3

1
1
2
2

3
1
3
3

Q.13. Generally, how confident are
you that you can recognize changes
in your health if they occur?
Not confident
Somewhat confident
Very confident
Extremely confident

1
3
3
2

.0
3
7
3

0
1
1
4

0
3
4
3

Q.14. Generally, how confident are
you that you can do something that
will relieve your symptoms?
Not confident
Somewhat confident
Very confident
Extremely confident

0
4
5
0

2
5
4
2

1
3
1
1

0
5
4
1

Q. 15. How confident are you that
you can evaluate the effectiveness
of whatever you do to relieve your
symptoms?
Not confident
Somewhat confident
Very confident
Extremely confident

0
5
4
0

2
1
9
1

0
3
1
2

1
4
4
1
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Table 5
Baseline Emotional Well-Being of Patients With COPD and With HF

Baseline Emotional Well-Being Mean Scores for 3-Month Survivors
Patients with COPD

Patients with HF

TM
n=9

SC
n = 13

TM
n=6

SC
n = 10

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

SF36-MCS

51.3 (2.4)

45.9 (16.6)

50.7 (9.1)

43.2 (12.8)

Vitality

41.4 (4.4)

39.7 (9.6)

32.1 (10.1)

32.7 (8.8)

Social Functioning

39.6 (10.1)

37.2 (13.9)

30.9 (9.9)

30.5 (13.1)

Role Emotional

45.9 (12.2)

41.2 (15.1)

50.1 (12.9)

46.9 (12.9)

Mental Health

47.4 (13.8)

42.1 (17.6)

53.1 (7.1)

39.1 (11.9)

subscales that contribute to the overall measure. Forty-two percent of the group with
COPD and 50% of the group with HF at baseline had scores < 50. Thirty-eight percent of
patients with COPD scored in the lower three levels, which indicated an even higher risk
for depression. Thirty percent of patients with HF also scored in the lower three levels.
Table 6 displays the frequencies of scores in the MCS categories. Refer to Appendix C to
view questions and response items used to calculate each of the subscales.
Group Equivalence
Equivalence on Demographic Variables and Baseline Measures

Groups were compared on demographic variables and baseline measures of SE
and EWB. With the exception of disease severity (for which there were insufficient data)
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Table 6
Baseline Emotional Well-Being by SF36 MCS Levels
Baseline SF36 Mental Component Score Frequencies
by MCS Levels for 3-Month Survivors
Frequency of Responses
Patients with COPD
TM
n=9

Patients with HF

SC
n = 13

TM
n=6

SC
n = 10

2

0

0

1

1

0

MCS
Levels

SF36-MCS
Range

1

65-74

2

60-64

3

55-59

4

50-54

2

2

2

3

5

45-49

0

0

0

1

6

40-44

0

1

7

35-39

0

8

30-34

0

3

0

0

9

9-29

1

3

0

2

2

2

2

1

comparisons were made for each of the variables between the diagnoses of COPD and HF
using t tests, chi-square, and Pearsons r. When comparing the COPD-TM and COPD-SC
participants at baseline, several of the measures were not normally distributed. Therefore,
Mann-Whitney Uwas utilized to confirm the results of the t tests and Kendall's tau to
confirm the results of the Pearsons r.
There were no significant differences between the diagnostic groups on any of the
baseline variables with the exception of the relationship between baseline SE and baseline
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EWB. Patients with COPD did not demonstrate a relationship but patients with HF
demonstrated a positive relationship between baseline SE and baseline EWB (r = .416;
p (one-tailed)= .056; r = .244; p (one-tailed)= . IO 1).
Experimental (TM) and control (SC) groups were also compared within both
diagnostic groups on the demographic variables and baseline measures of SE and EWB
There were no significant differences between the COPD TM and SC groups on any of
the variables when using either parametric or nonparametric statistical tests. Variables
were also compared between HF-TM and HF-SC groups using t tests and chi-square, and
confirming the t tests with the Mann-Whitney U. Two significant differences were found
between the HF-TM and HF-SC groups. First, a significant difference was found for age
(t = 2.88; p = .010), z = .452; p= .007), with participants in the HF-TM (mean age 79.57;

SD 4.95) older than those in the HF-SC group (mean age 67.76; SD 10.79). Second, a
significant difference was found in the relationship between baseline SE and baseline
EWB. HF-TM did not demonstrate a relationship between the variables but HF-SC did
demonstrate a positive relationship between baseline SE and baseline EWB (r= .530;
p (one-tailed) = .057; r = .349; p (one-tailed)= .086).
The above analyses showed that patients in the HF-TM group were significantly
older than those in the HF-SC group and a positive relationship was found between SE
and EWB for the HF group, which further analysis showed to be confined to the HF-SC
group only. Otherwise, randomization was effective in creating equivalent groups within
diagnostic categories between SC and TM. Although demographic and baseline scores
were similar between the two diagnostic groups, analyses addressing the experimental
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questions were conducted separately so as not to obscure differences in how patients with
the two conditions might respond to treatment as their diseases progressed.
Equivalence of Treatment Data
Length of intervention for this study was directly related to the number of days
each subject was enrolled in home health care. Length of intervention varied among
individual patients due to factors such as how quickly they reached care plan goals,
medical stability, and functional status, which then removed them from homebound status
and allowed discharge from home care. When patients were discharged from home
health, the TM device was removed from their home. For this study, treatment is
quantified for describing treatment groups according to the number of days the patients
received home health services, number of skilled nursing visits provided, and number of
TM sessions in the TM groups.
The purpose of describing the frequency of treatment was to provide data that
could indicate whether level of treatment was similar across the groups. Days were
tracked to indicate span of time patients received the SC components of direct care and
disease management education by nursing and rehabilitation specialists. Some patients
did not received rehabilitation services, but all patients received visits from RNs, making
it a variable that could be compared across all groups. Telemonitoring sessions were
tracked separately because placing the device in the home did not guarantee that patients
used the device on the recommended daily basis. Session adherence was calculated to
indicate the degree of adherence among those patients who received TM. Figure 7
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displays the number of TM sessions in the TM groups. Table 7 presents data for all
treatment variables across the four groups.

Comparison of Groups by Number of Telemonitoring Sessions
4
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Figure 7. Number of telemonitoring sessions.
The t test and Mann-Whitney U were used to test for differences. There were no
significant differences between HF and COPD diagnostic groups, or between the TM and
SC subgroups within the diagnostic categories on any of the treatment measures.
Primary Research Question and Results
Do patients who receive telemonitoring (TM), in addition to standard homecare,
show differential improvement when compared with those who receive standard care only
(SC) in the following outcome variables: (a) self-efficacy for disease management,
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Table 7
Frequency of Treatment Sessions
Treatment During Home Health Enrollment
Among 3-Month Survivors
HF

COPD
TM
Mean (SD)
Home Health Days

SC
Mean (SD)

34.7 (15.5)
34.7 (10.5)
(range: 11-58) (range: 14-58)

TM
Mean (SD)

SC
Mean (SD)

52.6 (40.9)
(range: 20111)

43.0 (25.6)
(range: 14-93)

5.8 (1.8)

5.2 (1.9)

9.7 (8.9)

7.0 (4.0)

Telemonitoring
Sessions

21.2 (12.6)

NA

39.6 (29.9)

NA

TM Adherence
Based upon daily use

81.3%
(range: 7-47
days)

NA

91.34%
(range: 19-96
days)

NA

Skilled Nursing Visits

3

a One patient treated as outlier and not used in calculation due to patient request to have TM
removed from home 3 days after installation.

(b) sense of emotional well-being, and (c) clinical outcomes of mortality, emergency
room use, and hospitalization?
H1: Patients with HF or COPD who are randomly assigned to receive standard
care plus telemonitoring, compared with patients with HF or COPD who
receive standard care only, will demonstrate greater improvement in the
following variables:
a. Self-efficacy as measured by Section C from the Self-Care of Heart
Failure/COPD Index at 3-months post hospital discharge compared to
baseline.
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b. Emotional well-being as measured by the SF 36 Version One Mental
Health Component Score at 3-months post hospital discharge compared
to baseline.
c. Clinical outcomes of mortality, emergency room use, and hospital
admissions at 3-months post hospital discharge, with the TM group
experiencing less mortality, emergency room use, and hospitalization.
SelfEfficacy Results at Three Months
Paired t tests were used to analyze changes in SE scores from baseline to 3 months
within each group. Because data for some of the measures did not meet assumptions of
normality, the Wilcoxon Signed Ranks test was used to confirm the results of the paired t
tests. Independent t tests were used to compare change scores at 3 months between the
two groups within each diagnostic category. Because distributions for some of the scores
did not meet assumptions of normality, the Mann-Whitney Uwas used to confirm the
results of the t test.
SelfEfficacy at Three Months for Patients With COPD
Members of the COPD-TM group demonstrated significant improvement in SE
on the SCI-C composite measure of their confidence for self-management of their disease
from baseline to 3 months. However, change scores were not significantly different
between COPD groups by 3 months.
Members of the COPD-TM group demonstrated a significant improvement in
confidence in their ability to evaluate the effectiveness of strategies they used for
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symptom management (Q.15) from baseline to 3 months and the extent of improvement
compared to members of the COPD-SC group was significant. Refer to Table 8 to view
changes in SE from baseline to 3 months.
Although COPD-TM improved in the composite scores on SE compared to
baseline, there was only a marginally significant difference between the groups on that
measure. There were no significant differences between SE measures on three of the four
individual questions of those who had received TM, and those who had not. The null
hypotheses could not be rejected for the composite SE (SCI-C) measure, or for questions
12 through 14. The null was rejected for Q.15. The extent of change in the COPD-TM
patients' SE for evaluating the effectiveness of strategies used for symptom management
was significantly greater than patients in the COPD-SC group. Refer to Table 9 to view
comparisons on SE between TM and SC.
Self-Efficacy at Three Months for Patients With HF
Members of the HF groups did not demonstrate significant improvement in SE for
self-management of their disease from baseline on either the composite measure (SCI-C)
or on any of the individual questions. There were no significant differences in SE change
scores between the TM and SC groups and so the null hypothesis regarding a significant
treatment effect could not be rejected. Table 10 displays changes in SE measures by 3
months. Table 11 displays the comparison between the HF groups change scores.
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Table 8
Changes in SE in Patients with COPD by 3 Months
SE Change Scores by 3-Months Patients with COPD
Telemonitoring
Change Score

Standard Care

Within Group
Dependent t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

SCI-C

I I.I (18.16)

.052

Q.12

2.77 (7.06)

Q.13

Change Score

Within Group
Dependent t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

.052

-2.08 (27.35)

.60

.47

.13

.12

-1.56 (11.34)

.67

.31

1.38 (6.83)

.27

.31

-1.56 (7.59)

.75

.25

Q.14

2.08 (6.98)

.19

.17

1.56 (6.03)

.19

.20

Q.15

4.86 (2.75)

.000

.004

-.52 (7.75)

.59

.45

Table 9
Comparison of SE Between Patients With COPD by 3 Months
Comparison of 3-Month SE in Patients With COPD
TM
Change Score

SC
Change Score

t test

Mann-Whitney U

M(SD)

M(SD)

p

p

SCI-C

11.1 (18.16)

-2.08 (27.35)

.11

.13

Q.12

2.77 (7.06)

-1.56 (11.34)

.I6

.21

Q.13

1.38 (6.83)

-1.56 (7 .59)

.18

.15

Q.14

2.08 (6.98)

1.56 (6.03)

.42

.43

Q.15

4.86 (2.75)

-.52 (7.75)

.03

.024
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Table 10
Changes in SE in Patients With HF by 3 Months
SE Change Scores by 3-Months Patients with HF
Telemonitoring
Change Score

Standard Care

Within Group
Dependent t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

SCI-C

-5.2 (23.52)

.69

Q.12

.000 (7.9)

Q.13

Change Score

Within Group
Dependent t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

.25

-.62 (18.26)

.54

.39

1.0

1.0

-.62 (9.52)

.58

.42

-3.12 (6.55)

.85

.12

-1.2 (5.74)

.74

.24

Q.14

.000 (6.84)

1.0

1.0

1.25 (4.93)

.22

.20

Q.15

-2.08 (9.40)

.69

.25

.000 (5.89)

1.0

1.0

Table 11
Comparison of SE Between Patients With HF by 3 Months
Comparison of 3-Month SE in PatientsWith HF
TM
Change Score

SC
Change Score

t test

Mann-Whitney V

M(SD)

M(SD)

p

p

SCI-C

-5.2 (23.52)

-.62 (18.26)

.67

.31

Q.12

.000 (7.9)

-.62 (9.52)

.44

.43

Q.13

-3.12 (6.55)

-1.2 (5.74)

.27

.28

Q.14

.000 (6.84

1.25 (4.93)

.33

.43

Q.15

-2.08 (9.40)

.000 (5.89)

.32

.39
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Summary of Results for SE in COPD and HF Groups
The COPD-TM group made significant improvements in the composite SE
measure over baseline but the results were not significant when compared to COPD-SC
on the composite SE measure and three out of four of the individual questions. The
COPD-TM made significant improvement in the confidence in their ability to evaluate
the effectiveness of what they did to manage their symptoms (Q. 15) and the change was
significantly greater than patients in the COPD-SC group.
The HF groups did not make any significant improvements on the SE main
measure or any of the questions. Patients in COPD-TM demonstrated greater
improvement in SE over baseline compared to patients with HF.
Emotional Well-Being Results at Three Months
Paired t tests were used to calculate change in EWB (SF36 MCS) scores from
baseline to 3 months within each group. Because distributions for some of the measures
did not meet assumptions of normality, the Wilcoxon Signed Ranks test was also
calculated to confirm the results of the paired t tests. Because some of the scores did not
meet normality criteria, the Mann-Whitney Uwas used to confirm the results of the
independent t tests comparing the effect of treatment between the two groups.
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Emotional Well-Being at Three Months for Patients With COPD
Members of the COPD-TM group demonstrated significant improvement in
overall emotional well-being (SF36 MCS) from baseline to 3 months. The extent of
change for the COPD-TM compared to the COPD-SC group was not significant.
When additional analyses were conducted for the subscale measures, members of
the COPD-TM group demonstrated significant improvement in scores on Social
Functioning (impact of physical and/or emotional problems on social activities) from
baseline to 3 months. The extent of change for the COPD-TM compared to the COPD-SC
group was not statistically significant. Members of COPD-TM group also demonstrated
significant improvement in scores on Role Emotional (impact of anxiety or depression on
ability to perform daily activities) from baseline to 3 months. The extent of change for the
COPD-TM compared to COPD-SC group was not significant.
Although COPD-TM demonstrated significant improvement in overall EWB
(SF36 MCS), and on subscales Social Functioning and Role Emotional from baseline to 3
months, there were no significant differences between EWB measures of those who had
received TM and those who had not. Therefore, the null hypotheses could not be rejected.
Table 12 displays change scores at 3 months. Table 13 displays the comparison of change
scores between groups.

Emotional Well-Being at Three Months for Patients With HF
Members of the HF-TM group did not make significant improvement in overall
emotional well-being (SF36 MCS) from baseline to 3 months. Members of the HF-SC
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Table 12
EWB at 3 Months in Patients With COPD
EWB Change Scores by 3-Months Patients with COPD
Standard Care

Telemonitoring
Within Group

Change Score

Change Score

Within Group
Dependent
t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

.033

2.3(19.0)

.34

.31

.20

.20

1.2(8.5)

.31

.28

I 0.2(8.3)

.003

.005

5.8(17.2)

.13

.12

Role
Emotional

5.8(9.3)

.047

.051

1.7(18.9)

.37

.33

Mental
Health

3.8(10.2)

.14

.20

4.2(16.8)

.20

.14

Dependent t

Wilcoxon
Signed Rank

M(SD)

t test p

Zp

SF36
MCS

5.4(7.8)

.034

Vitality

1.8(6.3)

Social
Function

Table 13
Comparison of 3-Month EWB Between Patients With COPD
Comparison of3-Month EWB in Patients With COPD
TM
Change Score

SC
Change Score

t test

Mann-Whitney U

M(SD)

M(SD)

p

p

SF36 MCS

5.4(7.8)

2.3(19.0)

.32

.27

Vitality

1.8(6.3)

1.2(8.5)

.42

.45

Social
Function

I 0.2(8.3)

5.8(17.2)

.24

.40

Role
Emotional

5.8(9.3)

1.7(18.9)

.28

.25

Mental
Health

3.8(10.2)

4.2(16.8)

.53

.45
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group did demonstrate significant improvement in overall emotional well-being (SF36
MCS) from baseline to 3 months. Change scores on SF36 MCS were significantly greater
in the HF-SC group when compared to the HF-TM group.
When additional analyses were conducted for the subscale measures, members of
the HF-SC group demonstrated significant improvement on subscale Mental Health
(happy/calm vs. nervous/downhearted) from baseline to 3 months. The extent of change
compared to the HF-TM group was significant. Members of the both groups
demonstrated significant improvement in subscales Vitality (energetic/pep vs. tired/worn
out) and Social Functioning compared to baseline but there were no significant
differences in change scores between the groups.
Members of the HF-SC group demonstrated significant improvement in Role
Emotional subscale scores. The extent of change compared to the HF-TM group was not
significant.
Although both HF groups improved in EWB compared to baseline, there were
significant differences between the groups but in an unexpected direction. HF-SC patients
had significantly greater change scores in EWB (SF36 MCS and subscale Mental Health)
as compared to HF-TM patients. The null hypothesis was rejected but the experimental
hypothesis was not supported because the change was in favor of the SC patients. Table
14 displays the 3-month EWB change scores for patients with HF. Table 15 displays the
comparison in change scores between the groups.
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Table 14
Change in EWB by 3 Months in Patients With HF
EWB Change Scores by 3-Months Patients with HF
Telemonitoring
Change Score

Standard Care

Within Group
Dependent t

Change Score

Wilcoxon
Signed Rank

Within Group
I

Wilcoxon
Signed Rank

Dependent

M(SD)

t test p

Zp

M(SD)

t test p

Zp

SF36
MCS

4.2(7.1)

.102

.12

13.2(8.4)

.000

.002

Vitality

9.8(12.4)

.055

.07

13.7(13.19)

.004

.004

Social
Function

13.5(9.5)

.009

.02

21.2(I 2.6)

.000

.002

Role
Emotional

1.75(4.2)

.18

.15

6.3 ( I 0.2)

.04

.029

Mental
Health

.75(9.2)

.42

.39

13.2(5.7)

.000

.002

Table 15
Comparison of 3-Month EWB Between Patients With HF
Comparison of3-Month EWB in Patients With HF
TM
Change Score

SC
Change Score

t test

Mann-Whitney U

M(SD)

M(SD)

p

p

SF36 MCS

4.2(7.1)

13.2(8.4))

.023

.015

Vitality

9.8(12.4)

13.7(13.19)

.28

.28

21.2(12.6)

.11

.13

Social
Function

13.5(9.5)

Role
Emotional

1.75(4.2)

6.3(10.2)

.11

.21

Mental
Health

.75(9.2)

13.2(5.7)

.01

.01 I
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Summary of Results for EWB in COPD and HF Groups
The COPD-TM group made significant improvements in EWB over baseline but
the results were not statistically significant when compared to COPD-SC on the SF36
MCS measure or on any of the subscales and so the mill was not rejected Both of the HF
groups made improvements in EWB over baseline and the difference was significant, but
in an unexpected direction. Patients in the HF-SC group made greater gains in EWB
(SF36 MCS and subscale Mental Health) as compared to patients in the TM group. The
null was rejected but the experimental hypotheses could not be supported. Table 16
illustrates the difference between HF and COPD by displaying baseline and 3-month
EWB frequency scores per MCS levels.
Clinical Outcomes at Three Months
Chi-square tests were used to evaluate associations between group membership
(TM vs. SC) and the clinical outcomes of mortality, emergency room use, and
hospitalization. A comparison of hospitalization and emergency department services was
made using hospital database information for the first comparison and patient-reported
data for the second comparison.
Clinical Outcomes at Three Months for Patients With COPD
One patient in the COPD-SC group had died by 3 months. There were no deaths
in the COPD-TM group. The chi-square test was used to analyze association between
group membership and mortality. A significant relationship between group membership
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and mortality (X2 (1) = .115, (.735)) was not found. Because chi-square assumptions were
not met for cell size, the Likelihood Ratio was also calculated (L X2 (1) = .113, (.736)),
which confirmed results of the chi-square test showing no difference between the COPD
TM and COPD-SC groups on mortality by 3 months.
Table 16
MCS Scores by MCS Levels
SF36 Mental Component Scores by MCS Levels of 3-Month Survivors
Baseline and 3-Month Frequencies
Patients with COPD

Patients with HF

TM

SC

TM

SC

9

13

6

10

N
Levels

Range

Tl

T2

Tl

T2

Tl

T2

Tl

T2

1

65-74

1

2

2

0

0

0

0

0

2

60-64

2

3

1

4

1

0

3

3

55-59

1

1

2

3

1

3

2

6

4

50-54

2

1

2

0

2

1

3

0

5

45-49

0

1

0

0

0

1

1

0

6

40-44

1

0

0

1

1

0

1

0

7

35-39

1

1

0

0

1

0

8

30-34

0

0

3

2

0

0

0

1

9

9-29

1

0

3

2

0

0

2

0

33%

11%

46%

38%

33%

16%

50%

10%

MCS
<50
a Data missing

on one patient.

a

0
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By 3 months, two COPD-TM patients and three COPD-SC had experienced at
least one database-retrieved hospitalization event. Data were missing for one patient. The
chi-square test was used to analyze association between group membership and
hospitalization events. A significant association between group and hospitalization (X2 (1)
= .010, (.920)) was not found. Because chi-square assumptions were not met for cell size,
the Likelihood Ratio was also calculated (LX2 (1) = .010, (.920)), which confirmed
results of the chi-square test showing no difference between the COPD-TM and COPD
SC groups on this measure.
Database-retrieved hospitalization information matched patient-reported
hospitalization information. Data were missing for two subjects. By 3 months, two
COPD-TM patients and three COPD-SC had experienced at least one hospitalization
event. A significant association between group and hospitalization (X2 (1) = .000, (1.00),
LX2 (1) = .000, (1.00)) was not found.
There were differences between database-retrieved emergency room events (ER)
and patient-reported ER, so they are reported separately. According to database-retrieved
data by 3 months, three COPD-TM patients and three COPD-SC patients had experienced
at least one ER event. Data were missing for one patient. A significant association
between group and emergency room events (X2 (1) = .505, (.477), LX2 (1) = .497, (.481))
was not found.
Data were missing for two subjects for patient-reported ER events. By 3 months,
two COPD-TM patients and four COPD-SC patients reported that they had experienced
at least one ER event. Chi-square was used to test for an association between group
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membership and hospitalization events. A significant association between group and ER
visits (X2 (]) = .159, (.690), LX2 (I)= .161, (.688)) was not found.
To summarize, there were no differences in any of the clinical outcome measures
between COPD-TM and COPD-SC, and so the null hypotheses could not be rejected.

Clinical Outcomes at Three Months for Patients With HF
A total of 4 patients with HF had died by 3 months, 2 in each group. The chi
square test was used to analyze association between group membership and mortality. A
significant relationship between group membership and mortality (X2 (1)= .208, (.648))
was not found. Because chi-square assumptions were not met for cell size, the Likelihood
Ratio was also calculated (LX2 (1)= .205, (.651)), which confirmed results of the chi
square test showing no difference between the HF-TM and HF-SC groups on mortality by
3 months.
There were differences between database-retrieved hospitalization and patient
reported hospitalization events, and so data are reported separately. By 3 months, 2 HF
TM patients and 2 HF-SC had experienced at least one database-retrieved hospitalization
event. Data were missing for 1 patient. The chi-square test was used to test for an
association between group membership and hospitalization events. A significant
association between group and hospitalization (X2 (1) = .227, (.634)) was not found.
Because chi-square assumptions were not met for cell size, the Likelihood Ratio was also
calculated (LX2 (1) = .225, (.636)), which confirmed results of the chi-square test.
Data �ere available from all patients for patient-reported hospitalization events.
By 3 months, 4 HF SC-TM patients and 1 HF-SC reported at least one hospitalization. A
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significant association between group and hospitalization (X2 (1) = 5.60, ( .018), LX2 (1) =
.5.73, (.017)) was found, with HF-TM patients reporting more hospitalization.
There were differences between database-retrieved emergency room and patient
reported emergency room events, and so data are reported separately. By 3 months,1 HF
TM patient and 3 HF-SC patients had experienced at least one database-retrieved
emergency room event. Data were missing for 1 patient. A significant association
between types of treatment and emergency room events (X2 (1) = .511, (.475), LX2 (1) =
.533, (.465)) was not found.
By 3 months, 4 HF-TM patients and 3 HF-SC patients reported that they had
experienced at least one ER event. A significant association between group and ER
events (X2 (1) = 2.049, (.152), LX2 (1) = 2.075, (.150)) was not found. To summarize, a
significant difference was found in patient-reported hospitalizations, with more patients
in the HF-TM group reporting hospitalization. All other clinical outcomes were
nonsignificant when compared between the two groups. The null was retained on the
outcome measures of mortality, database-retrieved hospitalization, and emergency-room
use. The null was rejected for patient-reported hospitalizations. TM patients reported
hospitalization more frequently compared to SC. Although the null was rejected, the
experimental hypothesis was not supported because SC patients reported hospitalization
with lower frequency than TM patients.
Summary of Clinical Outcome Results for COPD and HF Groups
Deaths occurred in both diagnostic categories, with four of the five occurring in
the HF groups. All groups experienced a similar level of hospitalization and emergency
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room events. The only significant difference was reported in the HF groups with HF-TM
patients reporting significantly more hospitalizations as compared to HF-SC patients.
Table 17 displays the frequencies of the clinical outcome events and Figure 7 displays
cumulative survival for each of the treatment groups. The small cell sizes evident in
Table 17 are considered in Chapter V.
Table 17
Clinical Outcomes Among 3-Month Survivors
Clinical Outcomes Among 3-Month Survivors
Frequency of Incidents
COPD

HF

TM

SC

TM

SC .

Death

0

1

2

2

Hospitalization

2

3

2

2

Patient-reported Hospitalization

2

3

4

1

Emergency Room

3

3

1

3

Patient-reported Emergency Room

2

4

4

3

Secondary Research Question and Results
Secondary Question: Relationships Among Variables
ls there a significant relationship among the variables of self-efficacy, emotional
well-being, and clinical outcomes at 3-months post index hospital discharge?
H2: Three-month scores in self-efficacy and emotional well-being will correlate
positively with each other, and negatively with 3-month clinical outcomes of
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emergency room use and hospitalization; the relationships will be of greater
magnitude in the TM versus SC groups.
Analyses were conducted separately for each diagnostic group. Pearson's product
moment correlation and Kendall's tau were utilized to compare the variables of EWB and
SE. Primary measures were tested first, and then the subscales and individual questions.
Pearson's product-moment correlation and Kendall's tau also were utilized to examine
the relationship between EWB and clinical outcomes, and the relationship between SE
and clinical outcomes. Clinical outcomes were coded as dichotomous variables with 1 =
the event had occurred, and O = the event had not occurred. The hypothesis is directional
and tests for significance are one-tailed.
Relationships Between SE and EWE
Relationships Between SE and EWE for Patients With COPD
At baseline, there was no statistically significant relationship between primary
scores of SE and EWB in either group. By 3months there was a significant positive
relationship in the COPD-TM group (r = .566; p = .056), (r = .487; p = .040). Scores on
composite SE (SCI-C) accounted for 32% of the variability found in overall EWB (SF36
MCS). The COPD-SC group did not show a significant relationship (r = -.007; p =.491),
(r = -.016; p = .472).
To further explore the relationship between the two constructs, examination at the
submeasure level was completed to determine if significant relationships existed among
subscale measures of EWB and individual SE questions. By 3 months, the COPD-TM
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group demonstrated a significant negative relationship between Vitality and Question 12
and significant positive relationships between Social Function and Questions 12 and 13,
and Mental Health and Questions 13, 14, and 15. The COPD-SC group demonstrated a
significant negative relationship between Social Function and Question 15, indicating that
as Social Function scores increased, Q. 15 scores decreased. Results of correlations
between the individual questions of SE and the subscales of EWB are provided in Table
18.
Table 18

3-Month Relationships Among EWB Subscales and Individual SE Questions in Patients
With COPD
COPD
Relationship Between SE and EWB at 3 Months
Individual SE Question and EWB Subscales
Standard Care

Telemonitoring
Q.12

Q.13

Q.14

Q.15

Q.12

Q.13

Q.14

Q.15

-.49*
-.44*

.32
.15

.16
.00

.15
.00

-.18
-.15

-.02
.00

-.15
-.12

-.39
-.30

Social
Functioning

.43
.48*

.56*
.49*

.06
.07

.27
.19

-.26
-.17

-.26
-.10

-.04
-.15

-.42*
-.36*

Role
Emotional

.00
.00

.19
.28

.37
.30

.26
.27

.34
.35

.13
.26

-.05
.00

-.01
.11

Mental
Health

.05
.18

.14
.47*

.56*
.66**

.37
.61**

.14
.05

.01
.IO

-.01
.04

-.09
-.02

Vitality

Note. The top row in each cell is the Pearson r. The second row is the Kendall's tau.
All tests are one-tailed.
*p < .IO. **p < .05. ***p < .01.

The null was rejected in the TM group. There was a significant positive
relationship between the composite measures of SE (SCI-C) and overall EWB (SF36
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MCS). Additionally, several of the MCS subscales had significant relationships to
individual SE questions. The null could not be rejected in the SC group with the
exception of the negative relationship between Social Functioning and SE for evaluating
the effectiveness of methods used to relieve symptoms (Q. 15). More subscale measures
in SC were negative, while all but Vitality in TM were in the expected positive direction.
The null for equivalency of the magnitude of relationship between SE and EWB
in COPD-TM as compared to COPD-SC could be rejected. The COPD-TM group had a
positive relationship between composite SE and overall EWB and the magnitude of the
effect was greater than COPD-SC. The fact that significant relationships among the
variables existed in the TM group, but were nonsignificant for most of the relationships in
the SC group, does suggest that there may be an influence by another variable, such as
treatment, to account for the differences between the groups.
Relationships Between SE and EWB for Patients With HF
At baseline, there was no significant relationship between composite SE (SCI-C)
and overall EWB (SF36 MCS) in the HF-TM group. There was a significant relationship
in the HF-SC group (r = .530; p = .057), (r = .349; p = .086). By 3 months there was no
significant relationship between composite SE and overall EWB measures in HF-TM, but
there was a significant relationship in the HF-SC group (r = .328; p = .178), (r = .497; p =
.031).
To further explore the relationship between the two constructs, examination at the
submeasure level was completed to determine if significant relationships existed between
subscale measures of EWB and individual SE questions. By 3 months, HF-TM group
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showed a significant negative relationship between Vitality and Question 15 and a
significant negative relationship between Role Emotion and Question 14. HF-SC showed
a significant positive relationship between Vitality and Question 12 and a significant
positive relationship between Mental Health and Questions 12, 14, and 15. Results of
correlations between the individual questions and subscales are provided in Table 19.
Table 19
3-Month Relationships Among EWE Subscales and Individual SE Questions in Patients
With HF
HF
Relationship Between SE and EWB at 3 Months
Individual SE Question and EWB Subscales

Standard Care

Telemonitoring
Q.12

Q.13

Q.14

Vitality

-.34
-.23

.11
.18

.06
.19

Social
Functioning

-.42
-.38

.00
.00

Role
Emotional

-.20
-.20
.1
.12

Mental
Health

Q.15

Q.12

Q.13

Q.14

Q.15

.04
.08

-.01
.00

.34
.27

-.90***
-.80**

.54*
.53**

-.05
.00

-.53
-.48

.38
.28

-.24
-.31

-.24
-.31

.21
.24

.00
.00

-.63*
-.63*

-.44
-.45

.33
.33

-.17
-.17

-.17

-.17

.25
.32

.28
.18

.00
-.09

-.40
-.26

.46*
.37

.10
.16

.29
.46*

.57**
.45*

Note. The top row in each cell is the Pearson r. The second row is the Kendall's tau.
All tests are one-tailed.
*p < .10. **p < .05. ***p < .01.

Correlations between the primary measures of EWB and SE were nonsignificant
in the HF-TM group and so the null could not be rejected. The relationship was
significant in HF-SC and so the null could be rejected. The null were also rejected in the
SC group for several submeasure relationships. There was a positive relationship between
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Vitality and SE in ability to evaluate the importance of symptoms (Q. 12). There was also
a positive relationship between Mental Health and SE in ability to evaluate importance of
symptoms (Q. 12), do something to relieve symptoms (Q. 14), and evaluate the
effectiveness of methods used to relieve symptoms (Q. 15). In the HF-TM group the null
was rejected but the experimental hypotheses were not supported. Although significant
relationships were present for two submeasure relationships, they were negative versus
positive. Vitality was negatively related to SE to evaluate the effectiveness of what was
done to relieve symptoms (Q. 15). As Vitality scores decreased, SE Q. 15 scores
increased. Role Emotional was also negatively related to SE for doing something to
relieve symptoms (Q. 14).
Summary ofRelationships Between SE and EWB
There was a significant positive relationship in the COPD-TM group between the
primary SE and EWB measures and several of the submeasures across the two scales.
There was the suggestion of a positive trend between primary measures in the HF-SC
group and significant positive trends between several of the submeasures. In contrast, the
HF-TM group had significant negative relationships between several submeasures.
Overall, there appeared to be trends toward the hypothesized positive relationship
between EWB and SE in the COPD-TM and HF-SC patients, with the subscale Mental
Health having the strongest correlation across the individual questions in those two
groups. When scores increased on the Mental Health subscale for patients in COPD-TM
and HF-SC, scores also increased on SE for doing something to relieve symptoms (Q.14),
and on SE for evaluating the effectiveness of those symptoms (Q.15).
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Relationships Between SE and Clinical Outcomes
Relationships Between SE and Clinical Outcomes for Patients With COPD

There were no significant relationships between SE (SCI-C) and database
retrieved hospitalization, or SE and patient-reported hospitalization in either of the COPD
groups. There were no significant relationships between SE and database-retrieved
emergency room events, or SE and patient-reported emergency room events in either of
the COPD groups. The null hypotheses could not be rejected for patients with COPD in
either group.
Relationships Between SE and Clinical Outcomes for Patients With HF

There was no significant relationship between SE (SCI-C) and database-retrieved
hospitalization in either HF groups. There was a trend toward a positive relationship
between SE and patient-reported hospitalizations in both the HF-TM group (rpb = .600;
p = .104), (r = .490;p = .117) and the HF-SC group (rpb = .327;p = .178), (r = .389; p =

.103).
There was no significant relationship between SE and emergency room events in
the HF-TM group but there was a significant negative relationship in the HF-SC group
(rpb = -.552; p = .062), (r = -.438; p = .09). There was no significant relationship between
SE and patient-reported emergency room events in either group.
The null hypotheses were retained with the exception of the negative relationship
between SE and ER events in the HF-SC group. Although the null was rejected, the
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experimental hypothesis was not supported because the relationship was in the HF-SC
(control) group.
Relationships Between EWB and Clinical Outcomes
Relationships Between EWB and Clinical Outcome Measures for COPD
There was no significant relationship between overall EWB (SF36 MCS) and
hospitalization in the COPD-TM group (rpb = -.380; p = .177), (r = -.327; p = .159)
although there was a trend toward a negative relationship. There was a significant
positive relationship in the COPD-SC group (rpb = .479; p = .057), (r = .403; p = .058).
As EWB scores increased, so did hospitalization events. There was a significant negative
relationship between EWB and patient-reported hospitalizations in the COPD-TM group
(rpb = -.834; p =.005), (r = -.655; p = .023). As EWB scores increased, patient-reported
hospitalization events decreased. There was no significant relationship in the COPD-SC
group.
There was no significant relationship between EWB and ER events in the COPD
TM group (rpb = .373;p =.182), (r = .146;p =.327) although there was a trend toward a
positive relationship. There was no significant relationship in the COPD-SC group. There
was no significant relationship in either group between EWB and patient-reported
emergency room events.
The null was rejected for COPD-TM patients who had a negative relationship
with EWB and patient-reported hospitalization events (expected direction). The null
could be rejected for the SC group with a significant positive relationship between EWB
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and hospitalization events (unexpected direction) but the experimental hypothesis was not
supported. Null hypotheses for the remainder of the tested relationships could not be
rejected.
Relationships Between EWB and Clinical Outcome Measures for HF
There was no significant relationship between overall EWB and hospitalization in
the HF-TM group but there was a significant negative relationship in the HF-SC group
(rpb = -.568; p = .055), (r = .178; p = .279). There was no significant relationship between
EWB and patient-reported hospitalization in either HF group.
There was no significant relationship between EWB and emergency room visits in
the HF-TM group. There was a significant negative relationship in the HF-SC group (rpb
= -.644; p = .030), (r = -.707; p = .010). The trend continued with patient-reported
emergency room events. There was no significant relationship in the HF-TM group.
There was a significant negative relationship in the HF-SC group (rpb = -.537; p = .055),
(r = -.358;p = .105).
No significant relationship was found between EWB and the clinical outcomes of
hospitalization and emergency room in the TM group and so the null was retained.
Several significant relationships were found in the SC group and in the expected
direction: as EWB increased, database-retrieved hospitalization decreased, as did both
database and patient-reported emergency room events. The null was retained for patient
reported hospitalization in the HF-SC group, but rejected for the other clinical variables.
The experimental hypothesis was not supported because HF-SC demonstrated stronger
negative relationships among the tested variables as compared to HF-TM.
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Summary of Relationships Between SE, EWB, and Clinical Outcome Measures
There were no significant relationships between measures of SE (SCI-C) and any
of the clinical outcomes in patients with COPD. Measures of overall SE at 3 months did
not seem to have any relationship with hospitalization or ER events. COPD-TM did
display a negative (expected direction) relationship between patient-reported
hospitalization and EWB (SF36 MCS). COPD-SC patients displayed a positive
relationship (unexpected direction) between hospitalization and EWB (SF36 MCS).
There were no significant relationships between 3-month measures of SE or EWB
and clinical outcomes in the HF-TM patients. Several significant relationships, and in the
expected direction, were found in the HF-SC group. As SE scores increased, ER events
decreased. As EWB scores increased, hospitalization, ER events, and patient-reported ER
events also decreased.
In both COPD and HF patients, there seemed to be a greater relationship between
EWB and clinical outcomes than between SE and clinical outcomes.
Summary
The Primary Research Question addressed differences between TM and SC
groups on the dependent variables of SE, EWB, and clinical outcomes by 3 months.
COPD-TM patients had greater changes in their SE for evaluating the effectiveness of
what they did to manage symptoms (Q. 15) as compared to COPD-SC. The null
hypothesis was rejected for the individual question 15, but retained for composite SE, the
remainder of the individual questions, for EWB, and for clinical outcomes. HF-SC
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patients had greater changes in overall EWB, subscale Mental Health, and had fewer
patient-reported hospitalization events as compared to patients in HF-TM. The null was
rejected for these measures, but the experimental hypotheses were retained because the
greater changes occurred in HF-SC (control group). The null were retained for the
remainder of the measures in the HF groups.
Secondary Research Question One addressed the relationships among dependent
variables at 3 months. COPD-TM had significant positive relationships among the
primary measures of SE and EWB as well as several of the submeasures. The magnitude
of the relationships was greater than COPD-SC and so the null was rejected. COPD-TM
and COPD-SC had significant positive relationships between EWB and hospitalization;
TM with patient-reported events and SC with database-retrieved events. The null was
rejected for both but the experimental hypotheses were not supported because the
relationships were in an unexpected direction. Neither group demonstrated significant
relationships between SE and ER events.
HF-SC had significant positive relationships among the primary measures of SE
and EWB as well as several of the sub-measures. The magnitude of the relationship was
greater than HF-TM. The null was rejected but the experimental hypotheses were not
supported because the HF-SC (control) group displayed the strongest relationships among
the tested variables. HF-SC displayed significant negative relationships between EWB
and ER events, and SE and database-reported ER events. The magnitude of the
relationships was greater than in the HF-TM group. The null was rejected for these
measures but the experimental hypotheses were not supported because the HF-SC
(control) group displayed the strongest relationships among the tested variables.
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This chapter presented results from the analysis of the dependent variables of
EWB and SE in order to examine the effect of TM on patients with COPD and patients
with HF enrolled in a home health program after hospital discharge. The next chapter
provides an overview of the most salient findings from this study and a comparison to
previous research, identifies study limitations, discusses ·applicability of findings to
patient self-care management programs, and makes recommendations for further research
in this topic area.

CHAPTER V
DISCUSSION
This chapter is divided into four sections. The first summarizes results of the
study. The second compares results from this study to results from published studies of a
similar nature. The third contains conclusions and practical implications, followed by the
study limitations. The final section presents recommendations for future studies in this
topic area.
Sample Characteristics, Procedural Issues, and Treatment Results
Comparison ofSample Characteristics
This study was designed to study self efficacy (SE) and emotional well-being
(EWB) among patients with COPD and HF who, after an episode requiring
hospitalization, were receiving home health care, either using the standard care (SC)
model of home health visits, or standard care plus telemonitoring (TM). The sample for
this study consisted of 46 home health patients with 26 having a diagnosis of COPD and
20 having the diagnosis of HF. The average length of patient enrollment for the home
health agency involved in this study was 45 days. Mean days for home health treatment
for patients in this study was 42 days (11-111 days), which was comparable to the agency
average.
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Patients in the parent study were randomly assigned to the SC or TM group. Thus,
a preliminary question asked whether the two COPD groups (COPD-TM and COPD-SC)
and two HF groups (HF-TM and HF-SC) were equivalent at baseline on demographics
and measures of self efficacy and EWB. Baseline demographic variables were equivalent
between both COPD groups and with HF groups with two important exceptions. First,
patients in HF-TM were significantly older than patients in HF-SC. Second, patients in
HF-SC showed a positive relationship between SE and EWB at baseline, whereas none of
the other patient groups showed any relationship between the two variables.
In this study, the tool used to measure SE was Reigel's (2000) Self-Care of Heart
Failure Index Section C. The same four SCI-C questions were used to measure SE for
both the COPD and HF patients. The findings of the study showed that levels of SE were
similar within the experimental and control groups for the two diagnoses, and also
between the diagnoses of COPD and HF. That is, no significant differences were found in
SE for patients with COPD or HF at the beginning of this study. This result was similar to
findings by R. Arnold, Ranchor, DeJongste, et al. (2005), who also compared SE between
COPD and HF patients using a different SE scale with subscales control symptoms and
maintainfunction. In their study investigating whether self-reported physical functioning
was explained by illness-specific or generic factors, Arnold et al. found no difference
when they compared SE measures between COPD (n = 56) and HF (n = 65) patients on
specific SE measures of SE control symptoms and SE maintain. Although only one study
was available for comparison, similar results between the studies indicate it may be
feasible to compare SE between COPD and HF using a generic measure of the construct
of self-efficacy for recognizing and managing symptoms of chronic disease.
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A theoretically related but distinct variable of interest in this study was EWB.
EWB was measured with the SF36, which is a tool that has been studied extensively. The
SF36 Mental Component Score (MCS) has been strongly correlated to standardized
depression screening tools and thus has some utility with identifying patients at risk for
depression. An analysis of data on 30,801 adults from the 1999 National Health Interview
Survey determined that the 12-months prevalence (age/sex adjusted) odds of major
depression for HF was 7.9% and 15.4% for COPD, almost twice the rate of HF (Egede,
2007). In this study, 33% of patients with COPD and 12.5% with HF had scores that
placed them into MCS level 7 or 8, which are scores indicating high risk for depression.
The patients in this study, therefore, seem to reflect the prevalence for depressive
symptoms in the larger U.S. population of individuals with COPD and HF, and the trend
toward higher incidence of depressive symptoms in COPD compared to HF. Both
diagnoses in this study had SF36 MCS means below that of the general U.S. population
but comparable to published MCS norms for both CHF and chronic lung disease.
Although baseline analysis of EWB scores showed no difference between the
experimental and control groups for the two diagnoses, or between the diagnoses of
COPD and HF, the proportion of patients at risk for depression were comparable to the
proportion found in the analysis of national data on HF and COPD.

Procedural Issues
This study was conducted as secondary analysis of data collected from a larger
randomized clinical trial (referred to in this document as the "parent study"), which was
conducted with patients with HF and patients with COPD recruited through a home
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health agency in southwest Michigan. All patients received SC, which included visits by
registered nurses. Visits varied from once weekly to as often as three times weekly, with
frequency based upon patient need. As part of routine care, nursing staff evaluated the
patient's physical status and physiological measures such as pulse and blood pressure.
Nurses also provided patients in both experimental and control conditions with education
on the disease process and self care management. Patients who received only SC were
instructed to contact the home health agency with any concerns regarding health status in
between scheduled nursing visits.
Patients in the experimental group received the same SC as those in the control
group and analysis showed no significant differences in the frequency of nursing visits
between TM and SC patients in each diagnostic group or between the diagnoses. In
addition to SC, patients in the TM groups engaged in daily telemonitoring activities using
the Health Buddy (HB) device. Thus, the TM group received two additional treatment
components-patient control of physiological monitoring on a daily basis and immediate
access to disease management education via technology. TM patients were responsible
for measuring their own blood pressure, weight, and oxygen levels in the blood (pulse
oximeter), which were then transmitted to a secure website via the telemonitoring device
(TD). In addition, TM patients responded to HB curriculum questions about their
understanding of their disease and symptoms, and appropriate actions to take in response
to symptoms. Built into the HB program were reminders and reinforcers for appropriate
disease management behaviors. Responses to questions were recorded via the
telemonitoring device, and were transmitted to the secure website. Daily physiological
data and question responses were available to nursing staff for review. If responses
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exceeded pre-set parameters, an "alarm" was created to bring the attention of the reviewer
to the situation.
The Health Buddy was chosen by the home health agency in this study for the fact
that it included a disease-specific educational curriculum in addition to physiological
monitoring. An issue that complicates the comparison of TM across studies is that the TD
is not always identified by manufacturer name, although all provide a general description.
Educationa.1 curriculum, if provided, may differ between devices. In fact, the HB
curriculum may be modified to the specifications of the purchaser. Several studies
identified in the literature review utilized the Health Buddy device (Bamason et al., 2003;
Laframboise et al., 2003), while others identified TM without an educational component
(Cleland et al., 2005; Goldberg et al., 2003; Woodend et al., 2008) or devices with both
components but not Health Buddy (Cordisco et al., 1999). An issue that further
complicates comparison across studies is the difference in length of time that patients
used the TD. In studies that controlled intervention, length of treatment varied from 6
weeks to 8 months.
In this study patients received TM during the time that they were under the care of
the home health agency and the TD was removed upon patient discharge from home care.
Only two other home health care studies were found using TM with COPD or HF
(Finkelstein et al., 2006; Whitten & Mickus, 2007) with the duration of TM dependent
upon the length of time the patient was enrolled in home health. Providing TM in a
controlled manner does allow objective comparison of an intervention effect between
groups. However, in actual clinical practice, a TD provided by and monitored by the
home health agency would be removed at discharge. Thus, this study elucidates the
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challenge involved with evaluating the effectiveness of an intervention provided within
the current parameters of skilled home health services in the U.S.
Summary ofResults
Data were analyzed to answer the primary question about whether TM, in addition
to SC, would have an effect on perception of self-efficacy (confidence) for managing
disease, overall emotional well-being, and clinical outcomes by patients with COPD or
HF. Independent variables were diagnosis (COPD or HF) and treatment group (TM or
SC). Dependent variables for this pilot study were measures of self-efficacy (SCI-C from
the Self-Care of Heart Failure Index (SCHFI)) and emotional well-being (MCS from
SF36 V.l). Data were also collected on mortality, emergency room use, and
hospitalization. These data were analyzed to describe relationships among 3-month
posttest scores and outcome variables.
By 3 months, patients in the COPD-TM group showed greater improvement in
their perceptions of SE for evaluating the effectiveness of strategies to relieve symptoms
than patients in the COPD-SC group. A significant positive relationship was also found
between EWB and SE for the COPD-TM patients when compared to the COPD-SC
patients at 3 months. There were no differences between the experimental and control
groups for patients with COPD on EWB, mortality, emergency room use, or
hospitalization.
Contrary to the experimental hypothesis that TM would be beneficial, results for
the HF patients in the area of EWB went the other way. That is, patients in the HF-SC
group showed greater improvement on EWB than those in the HF-TM group. They also
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showed a significant positive relationship between EWB and SE, and a significant
negative relationship between EWB and hospitalization, and EWB and emergency room
use, when compared to the HF-TM patients. There were no differences between the
experimental and control groups for patients with HF on SE, mortality, emergency room
use, and hospitalization, with the exception of patient-reported hospitalizations. Patients
who had received TM reported hospitalization more frequently than patients who
received SC only.
Discussion of Results
Self-Efficacy
Reigel (2000) described self-care management as a cognitive decision-making
process consisting of four stages: (a) recognizing that a change in symptoms is related to
the illness, (b) evaluating the change, (c) implementing a selected treatment strategy, and
(d) evaluating the effectiveness of the treatment strategy. This construct of self
management was utilized to develop the Self-Care of Heart Failure Index (SCHFI). Each
of these four stages was queried specifically by one of the four questions in the SCI-C,
which were designed collectively to assess self-efficacy in the four stages of self-care
management (Riegel et al., 2000). A modified version of the tool was constructed for use
with COPD for the parent study (Self-Care of Chronic Obstructive Pulmonary Disease
Index [SCCOPDI]).The SCI-C (SE) for both COPD and HF tools is identical.
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Discussion ofCOPD Results

In this study, the COPD-TM group made significantly greater changes in SE when
compared to COPD-SC as measured by a single question (Q.15) on the SCI-C. This was
the question that was aligned with the fourth stage, in that it asked patients how confident
they were of their ability to evaluate the effectiveness of what they did to relieve their
symptoms. Pre-post test comparisons showed that patients with COPD who received TM
also made significant positive change from baseline on the composite SE score on the
SCI-C. The fact that the extent of change was not significantly greater than change made
by the COPD-SC group means that no treatment effect on overall SE can be attributed to
adding TM to a SC protocol. Although construct validity has been established for the
SCI-C for use with patients with HF (Riegel et al., 2004) analysis at the discrete question
level has not been reported in the literature, and so analyses at the single question level
should be interpreted with caution.
Despite a thorough review of the literature, previous research that examined the
impact of TM on SE of patients with COPD was not found. However, several studies of
patients with COPD have demonstrated a positive impact of other interventions (e.g.,
pulmonary rehabilitation) upon SE for this diagnostic group. All of these programs
included an educational component (Davis et al., 2006; Lox & Freehill, 1999; Scherer et
al., 1996; Wong et al., 2005). In the current study, transmission of physiological data
through TM was accompanied by computer-supported education. The HB curriculum
provided educational content on the COPD disease process and symptoms, and
information for applying appropriate strategies to relieve symptoms. The HB also
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provided experiential training and feedback for monitoring health status and symptoms.
Results indicated that TM, in combination with SC, was more effective in improving
patient's SE for evaluating strategies used to relieve symptoms compared to SC alone. It
may be that the educational component, in combination with the experience of obtaining
physiological measures and self-monitoring symptoms on a daily basis, is helpful in
improving perceived SE for specific disease management behaviors.
Discussion ofHF Results
Analysis of pre-post test changes showed patients in neither the HF-TM nor HF
SC group to demonstrate significant improvement in SE from baseline to 3 months, nor
were there significant differences in the extent of change when gain scores for the two
groups were compared at 3 months for the composite score and for each of the four
questions analyzed separately.
Previous researchers have examined the impact of TM on SE in HF patients and
have found different results. Two studies found significant improvements in HF patients
who received TM in addition to usual care (Bamason et al., 2003; Laframboise et al.,
2003). Those prior studies also used the Health Buddy TM system, which provided
similar disease-specific educational curriculum along with physiological monitoring for
patients with other forms of heart disease. In Bamason's (2003) randomized study (n =
35), 18 postsurgical HF patients received daily TM for 6 weeks, with a curriculum
designed for postcoronary bypass patients. Patients in the control group received the
typical patient education and counseling provided before discharge from the hospital. In
the LaFambroise (2003) randomized study (n = 90), 46 HF patients received daily TM for
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8 weeks using a curriculum designed for patients with HF and based upon the literature
and the Agency for Healthcare Policy and Research Guidelines. Patients who received
phone contacts only showed decreased SE while those who received home visits, HB
visits only, or both home visits plus HB significantly improved SE for self-care
management. There were no differences between the groups where patients had improved
SE measures (LaFramboise et al., 2003).
A number of explanations might account for the fact that, in the current study,
neither patients in the HF-TM nor HF-SC made improvements in SE for self-care
management of their disease. Differences in sample size and variation in length of
intervention may help to explain the lack of change in the HF-TM patients enrolled in this
study. However, it is difficult to determine the contributing factors to the lack of change
in both the TM and the SC groups in SE for disease management.
Another possible reason for the different findings is that HF patients in this study
were at a later stage of the disease process. Patients in this study were predominantly
NYHA class III. Van der Wal, Jaarsma, Moser, et al. (2006) found that patients with a
NYHA classification of Ill or IV experienced more barriers to effective symptom
recognition and adherence. Patients with depressive symptoms also perceived barriers to
medication and diet regimens. Van der Wal et al. also found that patients with a low
level of knowledge perceived more barriers to medication and diet regimen as well as
symptom recognition, results also reported in other studies. In this study, all but one
patient enrolled in the HF groups (exception of missing data) was classified as NYHA
class III. Fifty percent of HF patients scored < 50 on the baseline MCS, and 30% scored
in the lower three levels, indicating significant risk for depression. Previous studies have
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shown that depression has a negative impact on SE. Although knowledge level was not a
variable examined in this study, it is possible that knowledge barriers existed in the HF
patients which could have had a negative impact on SE for disease management, in
addition to the other factors identified by van der Wal et al. (2006).
Emotional Well-Being
EWB describes patient perception of satisfaction with quality of life, including
happiness and pleasant emotions, and the perceived ability to meet personal goals and
fulfill important life roles. In this study, EWB was measured with the SF 36 Mental
Component Summary Scale (MCS) (Ware, 2005). Patients responded to all questions of
the SF36, which includes eight subscales The SF36 MCS score reflects responses to all
eight subscales, but greater weight is given to scores on the subscales of Vitality, Social
Functioning, Role Emotional, and Mental Health in computing the MCS. Both the MCS
and the four subscales that were used in this study yield standardized scores with a mean
of 50 and a standard deviation of 10. Measures from the four subscales-Vitality, Social
Functioning, Role Emotional, and Mental Health-were analyzed in this study to obtain
additional information on patients' EWB.
Discussion of COPD Results
Pre-post changes for patients in the COPD-TM group reflected improved EWB
(as measured with the SF36 MCS) by 3 months. The COPD-TM group made significant
changes from baseline on overall EWB (MCS) and on the subscales Social Functioning
and Role Emotional. Because EWB gain scores were not significantly greater for the
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patients who received TM in addition to SC, no additional benefit was found when TM
was added to SC. As a group, COPD patients improved EWB from baseline (Mean = 46)
to 3 months (Mean = 51), a change equivalent to .5 of one standard deviation and
suggesting that standard care alone was sufficient in improving EWB.
Previous research has found multidisciplinary self-management intervention to
have a positive impact on QOL and emotional factors in COPD (Blackstock & Webster,
2007) but very little prior research is available on the impact of TM on these factors in
patients with COPD. Whitten and Mickus (2007) studied a group of patients with COPD
and HF. They compared usual home care to home care plus telemonitoring. Theirs was
one of the few studies similar to this one in that TM was not provided in a standardized
manner (i.e., not all patients received exactly the same number of sessions). Rather, TM
equipment was removed from patients' homes after discharge from home health, which
varied based on individual patient factors. A difference in that study was that intervention
was provided once weekly, versus once daily, as in the current study. Neither the
experimental nor control group demonstrated significant improvement in SF36 physical
or mental composite scores over baseline (controlling for variables) in the Whitten and
Mickus study. The researchers concluded that the addition of TM did not predict physical
health and well-being.
1n the current study, patients in the COPD-TM group did improve significantly on
the composite MCS measure and on the Social Functioning and Role Emotional
subscales for EWB. However, the difference in gain scores between the groups was not
significant and so it must be concluded that TM did not improve EWB in patients with
COPD. Thus, the results from this study are consistent with those from the Whitten and
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Mickus (2007) study in indicating that for COPD patients, TM did not show an effect on
EWB. The results of these two studies differ from other studies of TM that controlled for
the length of intervention. Traditional home health care with the addition of TM, may not
have the same impact on physical and emotional well-being as home care that provides
TM consistently over longer periods of time.
Discussion ofHF Results

Contrary to the hypothesis, the HF-SC group made significant changes in overall
EWB and on all of the subscales. Furthermore, the extent of change, when compared to
HF-TM, was significantly greater on overall EWB and on the subscale Mental Health.
Although patients in HF-TM did not show significant improvement on overall EWB, they
did improve on the subscales Vitality and Social Functioning. As a group, HF patients
improved EWB from baseline (Mean = 45) to 3 months (Mean = 55), suggesting that
standard care alone was advantageous for them. Patients in the HF-TM group did not
make significant improvements in overall EWB; whereas patients in the HF-SC group did
improve in the overall EWB and on all of the subscales and to a greater degree than HF
SC. The conclusion from this study is that TM did not contribute significantly toward
improving EWB in patients with HF.
Unlike COPD in which few studies of TM have been published, numerous
randomized studies have examined the impact of TM on QOL and emotional measures in
patients with HF. A review of the relevant literature showed mixed results. Two studies
found significant improvements (Bondmass et al., 1999; Woodend et al., 2008) associated
with TM, whereas another found no difference (Laframboise et al., 2003) between
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groups although pre and post measures did improve within groups. The result from this
study has more similarities to the latter study.
Clinical Outcomes
Utilization rates for hospital and emergency services were derived from data
retrieved from medical records and from structured patient interview. Mortality was
determined by review of hospital records and other valid sources, such as family report.
Discussion of COPD Results
There were no significant differences in the clinical outcomes of mortality, ER
events, or hospitalization events between COPD-TM and COPD-SC. Other studies that
have used a randomized design have reported the impact of TM on clinical outcomes of
patients with COPD. Finkelstein et al. (2006) found no differences in mortality between
groups by 6 months. De Toledo et al. (2006) found that by the end of 12 months, there
was no significant difference in mortality, although a trend toward lower mortality was
reported for the intervention group. De Toledo et al. also found a significant reduction in
hospitalization, but not in emergency room services, in patients who had received TM.
When interpreting the results of the current study, it may be that the 3-month time
was insufficient to detect any effects of TM on clinical outcomes. It is possible that an
effect from TM may appear when data are analyzed at 6 and 12 months in the parent
study.
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Discussion of HF Results
The results of the current study revealed a significant difference in patient
reported hospitalization between experimental and control groups. 1n this case, patients
who received TM reported more hospitalization more often compared to patients who
received SC only. Differences in the other clinical measures were nonsignificant.
Other randomized HF studies that provided TM for at least 6 months and over
multiple sites have found evidence that TM reduces mortality (Cleland et al., 2005;
Goldberg et al., 2003) but not hospitalization (Goldberg et al., 2003). Other studies
(Benatar et al., 2003; Bondmass et al., 1999; Cordisco et al., 1999; Jerant et al., 2003)
have found that TM was associated with lower hospitalization and use of emergency
room services. On the other hand, Woodend et al. (2008) found no difference in
hospitalization between usual care and TM.
1n general, clinical trials that have provided TM over an extended period of time
(> 2 months) have found an association between TM and improved clinical outcomes.
Thus, it appears that the length of intervention may be a crucial factor in determining the
impact of TM over time. 1n this study, TM was not associated with lower patient-reported
hospitalization events, database-retrieved hospitalization, ER events, or mortality. It is
possible that an effect from TM may appear when data are analyzed at 6 and 12 months in
the parent study.
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Relationship Between EWB and SE
Discussion of COPD Results

In the current study, a significant positive relationship was found for the COPD
TM group between overall EWB and composite SE at 3 months that was not present at
baseline. In addition, several significant relationships were found between EWB subscale
measures and SE individual questions. There was an unexpected negative relationship
between the subscale, Vitality, and SEQ. 15, which asked patients to evaluate the
effectiveness of strategies to relieve symptoms. Social Functioning was positively related
to both the SE question that asked patients to rate their ability to evaluate the importance
of symptoms and the SE question that asked about their ability to recognize changes in
health if they occur. Mental Health was positively related to the SE question that asked
patients to rate their ability to recognize changes in health if they occur and the SE
question that asked about their ability to relieve symptoms. Although there was no
significant relationship between overall EWB and composite SE in the COPD-SC group,
a significant negative relationship was found between Social Functioning and SE for
evaluating the effectiveness of strategies to relieve symptoms.
Caution should be exercised when interpreting results of multiple statistical tests
regarding relationships between subscales and single questions from the SCI. Due to the
pilot nature of this investigation and the small sample size, the Bonferroni correction was
not applied. Any time there are multiple comparisons on the same data set, the likelihood
increases that spurious results may be found purely by chance. It is also the case that the
SCI-C from the Self-Care of Heart Failure Index (SCHFI) has been subjected to less
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rigorous research than the SF36, and it is not entirely clear that the four questions
analyzed separately in the current study are really measuring different things.
These results are consistent with previous research that has found a relationship
between SE and emotional factors in COPD. Specifically, R. Arnold et al. (2006) found
that patients (n = 39) with COPD improved in both SE for symptom management and
QOL during rehabilitation and that the changes in SE contributed significantly to changes
in social functioning and psychological function subscales of the SF36. Arnold et al.
suggested that results indicated that perceptions of personal control and SE play an
important role in the adjustment to COPD and that positive changes in SE and well being
can occur during intervention, even with patients in advanced stages of the disease.
According to Bamdura's (1998) theory on SE, positive mood enhances SE, and
social support strengthens SE. In the current study higher Mental Health was associated
with higher SE on three of the four SE questions and higher Social Function was
associated with higher SE on two of the questions. These findings lend support to
Bandura's theory. An unexpected result, however, was that Vitality was negatively
associated with SE for evaluating the effectiveness of strategies used to relieve
symptoms. It may be that despite limitations in Vitality, COPD patients are able to
accommodate and still demonstrate improvements in SE for disease management.
Discussion ofHF Results

A positive relationship was found between overall EWB and composite SE at
baseline and at 3 months in patients who received SC only. In addition, a positive
relationship at 3 months was found in SC between subscale Vitality and SE for evaluating
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the importance of symptoms. There also were positive relationships between the subscale
Mental Health and three SE questions for evaluating importance of symptoms, doing
something to relieve symptoms, and evaluating effectiveness of strategies used. Results
indicate that in the HF-SC patients a more positive mood state was associated with higher
SE in symptom management. There were no significant relationships between measures
of SE and EWB in the HF-TM group at baseline or by 3 months. The HF-SC patients
showed a positive relationship between EWB and SE at baseline and again by 3 months.
Other studies have found an association between EWB and SE. Tsay and Chao
(2002) studied the relationship of depression to SE in patients with HF (n = I 00) and
found a negative relationship between SE and depression, with functional status as a
mediating factor. A positive relationship existed between SE and functional status, and a
negative relationship between functional status and depression. They interpreted their
results as suggesting that SE helps to maintain physical and emotional function in HF
patients and that patients with higher SE have higher function, which decreases the
likelihood of depressive symptoms. Joekes (2007) found that higher levels of SE in HF
patients (n = 41) were associated with lower levels of psychological distress, better self
management, and better HRQOL. His research was consistent with previous research and
supported the idea that patients with higher SE and well-being were "protected" from
negative emotions after an exacerbation event.
In this study, TM was not associated with a positive relationship between EWB
and SE for HF patients. Although a positive relationship was identified in the HF-SC
group, it was present at baseline, indicating that SC treatment may not have been a factor.
Although EWB in the HF-SC group significantly improved from baseline, this change
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was not accompanied by a corresponding increase in SE, nor was a strengthening found
for the association between the two variables.
Relationship Between EWB and SE to Clinical Outcomes
In the current study, there was a significant positive relationship between patient
reported hospitalizations and EWB in the COPD-TM group, which was unexpected.
However, this was based upon only two events and should be interpreted with caution.
There was a significant positive relationship between database-retrieved hospitalization
and EWB in the COPD-SC group which was also unexpected. These results also were
based upon only a few patients who required rehospitalization, and therefore should be
interpreted with caution.
HF-SC demonstrated significant negative relationships between EWB and both
database-retrieved ER events (three patients) and patient-reported hospitalizations (one
event). They also had a significant negative relationship between SE and database
retrieved ER events (two events). No significant relationships were identified in the HF
TM group. Due to the low numbers, these results should be interpreted with caution.
Bandura (1998) asserted that personal efficacy influences health and that people's
belief in their ability to cope with stressors activate biological systems that can actually
improve health. After SE is strengthened, people manage the same stressors without
experiencing as much distress, and the negative physiological consequences such as
suppression of the immune system (Bandura, 1998) may also be reduced. Patients in the
COPD-TM group improved SE and EWB from baseline to 3 months and demonstrated a
positive relationship between the two variables. It may be that hospitalization did not
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negatively impact EWB due to adequate coping strategies present in those particular
patients.
Research has demonstrated the interrelationship of depression and worsening HF
symptoms (Joynt et al., 2004). Research also has demonstrated that in HF patients lower
EWB (or higher rates of depression in some studies) has-a negative impact on health,
which could result in the need for urgent care or hospitalization (Bennett et al., 1997;
Murberg, Bru, Svebak, Tveteras, & Aarsland, 1999). Patients in the HF-SC group in the
current study had significantly improved EWB from baseline at 3 months, and also had
demonstrated a positive relationship between SE and EWB. The relationship between
EWB and clinical outcomes was in the expected direction for these patients and may have
been associated with the fewer patient reports hospitalization compared to patients in HF
TM group.
Conclusions
Differences were found on several measures between COPD-TM and COPD-SC
in favor of the TM patients, which supported the hypothesis that TM may improve SE, as
well as strengthening the relationship between SE and EWB in COPD patients.
Significant differences occurred on several measures between HF-TM and HF-SC but the
differences were in favor of the SC group. No evidence was found that TM made a
difference in 3-month clinical outcomes of mortality, emergency room use, or
hospitalization for COPD or for HF patients.
A significant improvement was found in both EWB in COPD-TM and HF-SC.
TM was associated with improved SE and a positive association between SE and EWB in

151
the COPD patients but not with the HF patients. This may indicate differences in the way
in which patients with different medical conditions respond to TM in the home health
setting, although the small sample size and failure of randomization to yield equivalent
groups within and between the diagnoses at baseline reduces the confidence that these
differences represent a true difference between the diagnostic groups.
Practical Application

Implications for practice are limited due to the fact that this was a pilot study with
a relatively small sample size. At the very least, descriptive information and the trends in
the data can be compared to findings from previous research. In this study, patients with
either COPD or HF had lower EWB compared to the general population. Many were at
risk for depression, which is underdiagnosed, undertreated, and yet has been found to
have a significant impact on SE, adherence to self-care management, and to clinical
outcomes (De Jong et al., 2005; T. Rutledge et al., 2006; Yohannes, Roomi, Baldwin, &
Connolly, 1998). Although EWB had improved by 3 months, none of the patients with
HF and the patients in the COPD-SC group improved in their perception of SE for self
care management. This was the case even though all had received education from home
health nurses, and many had additional education from rehabilitation professionals.
Patients in the COPD-TM group did seem to benefit from the addition of daily
telemonitoring and reporting of health status and symptoms, as well as participating in
additional education content provided in a novel manner through the TM system.
Information gained in this study suggests that it would be valuable to include
EWB and SE measures as part of the ongoing assessment process so that members of the
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multidisciplinary team (nurse, social worker, rehabilitation professionals) are able to
provide targeted intervention that improves emotional health and empowers patients to
improve self-care management. It may also be helpful to assess learning needs of patients
and belief in their ability to make positive changes in their health status, taking into
consideration factors such as education level and emotional status, so as to provide self
management intervention tailored to the needs of the individual. TM and other
information technology may be a useful adjunct to SC if the content and methods are
designed in such as way as to enhance SE for self-management, which in turn may
improve adherence and clinical outcomes.
Study Limitations
This was a pilot study and the sample size was small, so results should be
interpreted with caution. Due to problems in the parent study randomization did not
produce numerically equivalent groups. By 3 months, 5 patients had died and 3 had
withdrawn or were lost to follow-up. This substudy also analyzed just a small portion of
the total data from the parent study. It was intended that results from this analysis could
be used to guide the direction of the analysis for the parent study. The larger dataset for
the longitudinal study will utilize rigorous analysis methods with alpha <.05. The small
sample size significantly reduced the power of this pilot, which made it difficult to
establish significant differences in the studied variables. Analyses were completed as one
tailed based upon directional hypotheses specific to the 3-month time point. Alpha was
set at p < . l O so as to identify pertinent trends. Another limitation was that corrections

153

were not made for multiple statistical tests on the same data set. Although this was done
so that trends were not obscured; it increased the risk for Type I error.
Several other limitations also should be noted. The TM intervention was not
uniform in length, and so the content dosage (experiential training and education) was not
distributed evenly across patients who received the intervention. This was because the
treatment length was controlled by home health agency procedures rather than by the
investigators. Many of the patients were not enrolled long enough to complete the
educational curriculum provided in the HB TM system. Another weakness is that the tool
selected for measuring SE, from which the SCI-C was extracted, had been tested
previously for use with patients with HF, but not with COPD patients, as included in this
study. Although SE questions were not changed from the original version, there is the
chance that there may be unanticipated differences when using the questions with patients
with COPD. Finally, clinical outcome information was gathered from hospital database
and patient report. There is a chance that patient information was not accurate or that the
hospital database might not have included events that occurred in another health care
system. Mortality information was not available for patients who were lost to follow-up.
Recommendations for Future Studies
It is apparent that there is a need for methods to improve self-management skills
in patients with chronic disease such as COPD and HF. Evaluation research is needed to
follow patients longitudinally to study the impact of multidisciplinary self-management
programs and to also evaluate the cost-benefit of adjunctive intervention and follow-up
activities. The development of assessment tools that formally evaluate self-management
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would provide objective measures of program outcomes. Previous research shows SE is a
valuable construct to measure and many disease-specific tools have been developed. A
standardized generic SE tool for patients with chronic disease would also be valuable to
compare the impact of self-management programs across diseases, programs, and
. disciplines. Such a tool was not found in the review of the literature.
Information technology, such as the TM device used in this study, may be a
valuable adjunct to standard self-management programs provided through the
multidisciplinary heath care team. Other studies have shown equivalent benefit between
telephone follow-up and the more costly TM devices. This study was not designed to
provide qualitative data about the nature of differences. In the case of the patients with
COPD, it may be that it is the follow-up process, beyond the traditional face-to-face
limited interaction reimbursed through the current healthcare system that is of value.
Methods for achieving these aims may vary depending upon patient access to technology,
user preferences, and third-party reimbursement available to fund those services.
Larger randomized trials are indicated with adequate power to detect differences
between groups and identification of meaningful predictors that will allow health care
providers to tailor programs to the needs of patients identified to be at low, medium, and
high risk for "failure" with self-care management. A mixed methods approach would
capture both quantitative and qualitative information and allow researchers to answer
specific questions related to user issues such as preference for different types of
technology, and impact on learning self-care for disease management. Qualitative
information may help explain trends identified in this and other studies, for example,
increase in hospitalization in HF patients who receive TM.
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lt is also suggested that research focus on an array of methods to deliver enhanced
self-management care via information technology. Studies that compare low cost methods
such as regular phone contact, email, video visits on home computer systems, are
examples of lower cost services that would require minimal adjustment to the patient's
home situation. Ultimately, reimbursement for enhanced services needs to be addressed to
cover the cost of the time for the health care professionals as they engage in non face-to
face follow-up activities.
Low-cost information technology (IT), such as the telephone, is fairly ubiquitous
in the U.S. More sophisticated information technology, such as cell phones and
computers with Internet access, has become more commonplace. Patients are more
receptive, skilled, and expectant of enhancing health care management through the use of
IT. The cost of health care, the shortage of health care professionals, and the growing
aging population should be an impetus toward aggressively examining alternative
methods for health care delivery and evaluating the cost-benefit of programs that
empower individuals with chronic disease to effectively manage their health.
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uddition. if Urnre are any unanticipated adverso rencti.ons or unanticipated evenis
associaJed "vi(h the conduct of this research, you should immediately suspend the project
and contact the Chair of the HSIRB for consultation.
The Board wish , y u 311ccess in the po;suit <if yo,ur research �Qals.
Approval Term:ination:

November 2, 2001

1/lalW-Ood ttall, K�lama�o. Ml 49008-5456
PllOIU.1 (2&9) U7�82 S FflXt (289) 387•8276

Appendix B
Institutional Review Board Approval
From Borgess Health

175

176
1521 Gull Roo I
Kalomliroo. Ml 11904
1269) '.l.� .7000

BORGES5

December 20, 2006

Medical Center

Jaclyn ·west.,Prnsier
Department of Occupational T11erapy
Wes tern Michigan 1Jnivers:ity
1249 Earl Wilbar Bui1rung
Kalamazoo, Ml 4900S
Protocol: Relationships.Among Self-efficacy, Emotional WdJ-bci11g, Clinical Outcomes,
Telen1on:it01:ing and Diagnosis in Patients witl1 Heart failure or Chronic Obstructive
Pnln10nruy Disease

As the Chajtman of the lnstitt1tio11al Review Board (JRB) of Borgess Medic,tl Center, .I have
R
received aud·reviewed the-above-named protocol. A,ccordi11g to Borgess Medical Center 1B
Guicfelines1 Section 6.21 this protocol meets the qualifications for Expedited Review. The
prot.ocol meets onr stanrurrds ··of research and l have approved the study for nse in tl1is institution.
As yo_u condnct your .r�ea:rch., you are responsible tor coniplying with all policies ,md procedures of
the FDA, OHRP, EIPAA, Borgess Medial Center, aud the Borgess Institutional Review Board.
The appro al is granted with the ·Ull!iimltanding that m1y changes in the protocol are prnmptly
rqiorted to the Committee· that changes in the approved protocol cannot be initiated without
•Cqnimittte review an:d approval unleSs !:hr.re a:re imruediafe hazards to human subjects; and that all
\IDm:tticipa:ted or scmou.s ·problems involvirtg risks to human subjects arc also promptly reported to
the Cointnittee,
Approval for this protocol is granted for a period of 011c year and will expit:e on December l 4, 2006.
The.FDA, :m,d this Qon;tllittce, require you sub�iHn V.'l."lting a Continuation Re\'iew Applicatiot1 by
Friday, November 2, 2007. The protocol �of continue airer D eceniber 14, 2007 unl11 re
approved by tbeBorgess IRB even if closed to patient eoro]hnent Yon nmst complete a Close Out
Rcporlif -yourprcitocol'ha.s been,con:,plelcd. tcnninat:ed·or if you a:re not renewing the protocol. We
wi1l determine 'if theTeseareh was carried out as plmmed. and that patient benefit outweighed the
risk.
1fyon have any questions in tliis regard, please feel free to cont-a.ct me.

[0_,j

ta

�\)-frv�

R:icbard Lanmiers, MD, Chair
Institutional Re\<iew Board

f, �

Appendix C
SF36 Version One Subscale Questions
for Mental Health Summary Score
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SF36 Version I
Question Items for Subscale Scoring
Note: Questions are not in the order of appearance in the SF36 Health Survey
( 4-week recall)
Vitality
How much of the time during the past four weeks did you feel full of pep?
How much of the time during the past four weeks did you have a lot of energy?
How much of the time during the past four weeks did you feel worn out?
How much of the time during the past four weeks did you feel tired?
Responses to above
•

All of the time

•

Most of the time

•

A good bit of the time

•

Some of the time

•

A little of the time

•

None of the time

Social Functioning
During the past four weeks, to what extent has your physical health or emotional health
problems interfered with your normal social activities with family, friends, neighbors or
groups? Has it interfered ....
Response to above:
•

Not at all

•

Slightly

•

Moderately

•

Quite a bit

•

Or Extremely?
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During the past four weeks, how much of the time has your physical health or emotional
problems interfered with your social activities like visiting with friends or relatives? Has
it interfered...
Response to above:
•

All of the time

•

Most of the time

•

Some of the time

•

A little of the time

•

Or None of the time?

Role Emotional
During the past four weeks, have you had to cut down the amount of time you spent on
work or regular daily activities as a result of any emotional problems, such as feeling
depressed or anxious?
During the past four weeks, have you accomplished less than you would like as a result of
any emotional problems, such as feeling depressed or anxious?
During the past four weeks, did you do work or other regular daily activities less carefully
than usual as a result of any emotional problems, such as feeling depressed or anxious?
Responses: Yes of No
Mental Health
How much of the time during the past four weeks have you been very nervous?
How much of the time during the past four weeks have you felt so down in the dumps
that nothing could cheer you up?
How much of the time during the past four weeks have you felt calm or peaceful?
How much of the time during the past four weeks have you felt downhearted and blue?
How much of the time during the past four weeks have you been happy?
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Responses:
•

All of the time

•

Most of the time

•

A good bit of the time

•

Some of the time

•

A little of the time

•

None of the time

